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ABSTRACT
Study of Rsm/Gac post-transcriptional regulation by Quorum sensing, extracellular and
intracellular signals in Pseudomonas aeruginosa
Bacteria have evolved ways to sense and respond to changes in their population density through
quorum sensing (QS) systems, and to adapt to changes in the extracellular environment through two
component systems (TCS). In Pseudomonas aeruginosa, QS and the GacS/GacA TCS are global
regulatory systems that modulate the expression of virulence genes at the transcriptional and post-
transcriptional level, respectively. Although in P. aeruginosa the QS network has been extensively
characterized, the way the GaclRsm global regulatory system is regulated is still unclear. The study of
QS and GaclRsm networks is crucial for the development of new drugs able to interfere with these
regulatory systems.
This thesis is dedicated to the study of the GaclRsm global regulatory system and its interaction with
the QS network. An introduction to these systems is presented in Chapter 1.
The materials and methods used in this study are described in Chapter 2.
In Chapter 3 the methods to detect and identify the extracellular signals modulating Gac/Rsm system
are investigated. This analysis led to the identification of the Pseudomonas Quinolone Signal (PQS)
molecule, which is responsible for the activation of the gene coding for the small RNA RsmZ. RsmZ
(in synergy with RsmY) antagonises by titration the effects of the global post-transcriptional regulator
RsmA, a small RNA-binding protein which targets specific mRNAs.
Since the discovery of QS, there have been many studies showing the importance of this type of
regulatory mechanism in the global transcriptional control of gene expression. However, there has
been no clear evidence to attribute to QS a key role in post-transcriptional regulation of terminal gene
targets. In Chapter 4, the importance of PQS in the control of lecA is demonstrated. lecA encodes for
the PA-I galactophilic lectin protein whose translation rates is modulated by the activity of the
regulatory small RNA rsmZ in concert with RsmA. These results demonstrate that QS not only
controls terminal target gene expression at the transcriptional level, but also at the translational level.
Using a genetic bank, a transposon mutagenesis and a promoter pull-down approach, new regulators
were identified together with regulatory networks involved in the modulation of the global Gac/Rsrn
system. These results are described in Chapter 5.
Chapter 6 is focused on the effect of a library of compounds available in our laboratory, for their QS-
inhibiting potential. The conclusions and future directions are presented in Chapter 7.
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1 Introduction
1.1 BACTERIAL VIRULENCE
A bacterium that is capable of causing a disease is defined as a bacterial pathogen and its
ability to cause a disease is called pathogenicity. The quantitative assessment of pathogenicity
or its potential to cause disease is measured by virulence. Bacteria produce many virulence
factors that enable them to survive and establish themselves within a host, enhancing their
potential to cause a disease. The first step in bacterial pathogenicity is the adhesion to the
host; this is usually accomplished by the adherence of the bacteria to a surface. To achieve
this, bacteria have evolved attachment mechanisms for example pili and fimbriae. Some
bacteria are invasive and have developed mechanisms that enable them to invade the
eukaryotic cells; others have evolved virulence factors that act as protective mechanisms
enabling their survival in the host (production of capsules, biofilm formation). Furthermore,
in order to evade the host's immune responses, bacteria have evolved virulence factors that
inhibit the host's immune system defenses. Finally, many virulence factors consist of toxins
that cause tissue damage, thus facilitating host colonization [1].
In order to fine-tune the production of all these virulence determinants, bacteria have evolved
complex regulatory networks, which enable them to respond to particular environmental
conditions in a very efficient and specific manner.
1.2 PSEUDOMONAS AERUGINOSA
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Pseudomonads are Gram-negative, motile, ubiquitous bacteria capable of colonizing a wide
variety of environmental niches due to their remarkable metabolic and physiological
versatility [2]. These microorganisms are studied for their role as mammalian and plant
pathogens, plant growth-promoting bacteria, and for their huge biodegradative potential. In a
disease context, the Pseudomonas pathogens of humans and animals are characterized as
having a "low virulence", i.e., they are opportunistic and do not produce disease unless the
animal's constitutive or immune defenses are compromised [3]. This does not mean that they
lack any determinants of virulence. P. aeruginosa indeed contains a number of structural,
biochemical and genetic properties that contribute to its virulence, which may be compared to
those of leading pathogens such as Staphylococcus or Streptococcus [4].
In this genus, most attention from scientists has been focused on the opportunistic human
pathogen P. aeruginosa. This microorganism is a highly adaptable bacterium that can
colonize various environmental niches, including soil and marine habitats, plants, animals and
humans [5]. Its versatility is reflected by its ability to tolerate low oxygen conditions and to
grow at a wide range of temperatures [6]. The ability of P. aeruginosa to colonize and thrive
in diverse environments is reflected by its relatively large genome (6.3 Mbp) and genetic
complexity (at least 5570 open reading frames, ORFs) [5]. Compared to the majority of
known sequenced bacterial genomes, the genome of P. aeruginosa possesses a larger overall
number of genes coding for outer membrane proteins, efflux systems and multiple chemotaxis
systems, which may contribute to its pathogenesis. Moreover, about 10% of the predicted
ORF are predicted to be gene expression regulators, reflecting the ability of P. aeruginosa to
respond and adapt to sudden and constant environmental fluctuations [5, 7].
P. aeruginosa may cause acute infections in hospitalized patients and is often associated with
infections of immuno-compromised individuals, for example those affected by AIDS, cancer,
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or severe burn wounds. It also causes many chronic infections, for example hospital-acquired
pneumonia in patients receiving artificial ventilation and keratitis in users of soft contact
lenses [5, 8]. Moreover, it has recently been recognized as one of the main causes of chronic
wounds [9] and as the predominant cause of mortality in cystic fibrosis (CF) patients [10, 11].
CF is a genetic disorder affecting approximately 1 in 2,500 individuals, primarily Caucasians,
and is a consequence of a mutation in the gene coding for the transmembrane conductance
regulator, CFTR. The inability to regulate sodium and chloride transport due to an aberrant
CFTR increases airway secretion viscosity. P. aeruginosa find a favorable niche in the lung
within the resulting thick mucus [12]. Indeed, there is evidence of lung colonization by P.
aeruginosa in 95% ofCF affected children [13].
According to the National Nosocomial Surveillance System of the Centres for Disease
Control and Prevention, P. aeruginosa infection in U.S. hospitals between 1985 and 1991
accounted for 10.1% of all hospital-acquired infections [14]. Another more recent survey
indicated that, of the patients who developed nosocomial pneumonia, P. aeruginosa was
isolated in at least 21% of cases [15].
P. aeruginosa possesses and produces a large variety of both cell-associated and extracellular
virulence factors, a characteristic that reflects the various clinical diseases caused by this
typical nosocomial pathogen [4]. Evaluations in various animal models of the roles of these
different virulence factors led to the understanding that pathogenesis of P. aeruginosa is not
related to a single virulence factor, but on the precise and delicate interplay between different
factors, leading from efficient colonization to tissue necrosis, invasion and dissemination
through the vascular system, as well as to activation of both local and systemic inflammatory
response (Fig. 1)[4].
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P. aeruginosa is capable of causing both chronic and acute infections by regulating the
virulence determinants required for each of this type of infection [16]. In particular, chronic
infections are defined as the one where the bacteria are mostly organized in biofilm structures,
such as in the case of CF lung infections [17]. On the other hand, acute P. aeruginosa
infections are characterized by bacterial penetration on the host epithelium and systemic
spread, such as in severe burn wound infections.
1.2.1 Bacterial cell surface virulence factors
The first step in the pathogenic sequence of P. aeruginosa infections is the colonization of an
epithelial surface [4].
Flagella are complex proteic structures forming a filamentous polar appendage at the surface
of P. aeruginosa. As well as being involved in motility and chemotaxis, flagella have a
critical role in pathogenesis by adhering to epithelial cells through the binding with a common
membrane component, asialoganglioside gangliotetraosylceramide (asialoGMl) [18]. They
also participate in virulence by eliciting a nuclear factor kappa B (NFkB)-dependent
inflammatory response through interaction with the Toll-like receptors TLR5 and TLR2,
leading to interleukin 8 (IL-8) production [19, 20]. However, flagella are also very
immunogenic, making their presence an obstacle for P. aeruginosa once colonization is
successful. This is why P. aeruginosa is capable of adapting by selecting aflagellar mutants to
evade host response in chronic infections [21].
Pili, or fimbriae, are smaller filamentous surface appendages involved in P. aeruginosa
motility. This flagella-independent motility, called twitching, is due to the retractile properties
of P. aeruginosa pili and allows this bacterium to "spread" along hydrated surfaces rather
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than "swim" (swimming requires flagella). This feature facilitates the rapid colonization of
the airway [22]. Like flagella, pili are crucial for the adhesion phase of colonization through
binding to asialoGMl of the epithelial cell membrane [23, 24]. Studies found that both pili-
mediated adherence and twitching motility are critical for P. aeruginosa virulence [25, 26].
Although the inner face of the outer membrane resembles a typical phospholipid bilayer, the
outer face of the outer membrane is mainly composed of lipopolysaccharide (LPS). LPS is
composed of a hydrophobic domain (Lipid A), inserted into the phospholipid bilayer, and a
hydrophilic tail, composed by the core polysaccharide and the O-specific polysaccharide. The
Lipid A component of P. aeruginosa LPS activates multiple pro-inflammatory pathways [27].
LPS is also critical to virulence, mainly due to its role in adhesion to various Toll-like
receptors, through asialoGMl binding [23].
Alginate is a mucoid exopolysaccharide produced by P. aeruginosa. It consists of repeating
polymers of mannuronic and glucuronic acid. Alginate, like LPS, functions as an adhesin,
anchoring P. aeruginosa to the colonized respiratory epithelium. Particular conditions in the
CF patient's lungs and host inflammatory response increase alginate synthesis, leading to the
conversion to an alginate overproducing mucoid phenotype [28]. This mucoid alginate-
producing phenotype is commonly found in CF airways during P. aeruginosa chronic
infections [29].
1.2.2 Secreted virulence fadon
P. aeruginosa produces several extracellular products that, after the initial step of
colonization, can cause extensive tissue damage, bloodstream invasion and dissemination.
The relative contribution of a given factor may vary with the type of infection [30].
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Pyocyanin is a blue pigment metabolite of P. aeruginosa that has numerous pathogenic
effects such as increasing IL-8, depressing host-response, and inducing apoptosis in
neutrophils [31-33]. In animal models of acute and chronic lung infection, pyocyanin was
found to be essential for P. aeruginosa virulence [34]. Additionally, due to its oxidoreductive
properties, pyocyanin oxidizes glutathione and inactivates catalase in respiratory epithelial
cells, thus participating in oxidative-stress related damage [35].
Hydrogen cyanide (HeN) is a potent poison that blocks cytochrome oxidase, leading to the
inhibition of mitochondrial respiration. This secondary metabolite of P. aeruginosa is
responsible for rapid paralytic killing of the nematode Caenorhabditis elegans [36]. Its role
during human infections is unclear, but it could participate in tissue destruction and might
contribute to toxicity in P. aeruginosa infected bum wounds [37].
Pyoverdine and pyochelin are siderophores, small molecules chelating iron from the iron-poor
environment encountered in the host, allowing its utilization in P. aeruginosa metabolism.
Siderophore-dependent iron acquisition is key for the production of biofilm and for virulence
in different animal models, possibly by regulating the secretion of other P. aeruginosa
virulence factors [38].
Exotoxin A (ExoA) is an ADP-ribosyl transferase secreted into the extracellular space that
inhibits the elongation factor-2 (EF-2), thereby inhibiting protein synthesis and leading to host
cell death [39]. ExoA has also been found to depress the host response to infection [40].
Among a wide range of proteases, alkaline protease is one of the most important. This
enzyme is a fibrin-lysing protease secreted by P. aeruginosa. Alkaline protease has been
shown to degrade the complement components, as well as interferon Y [41].
The ability of P. aeruginosa to destroy elastin is considered to be a major virulence
determinant during acute infection. The concerted activity of two enzymes, LasA and LasB
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elastases, is responsible for elastolytic activity [42]. These enzymes, secreted into the
extracellular space, have been discovered to have a role in the pathogenesis of P. aeruginosa
respiratory infections by damaging the respiratory epithelium through tight-junction
destruction, thus increasing epithelial permeability and facilitating neutrophil recruitment
[43]. Elastases are also pro-inflammatory factors increasing IL-8 levels [44].
Among the hemolysins produced by P. aeruginosa, phospholipase C and rhamnolipids have
been studied extensively. These virulence factors contribute to tissue invasion by cytotoxic
effects [45].
1.2.3 Type III secretion system
Type III secretion systems are used by Yersinia, Salmonella, Shigella and Pseudomonas
species as mechanisms to directly inject toxins into the host cells. The type III secretion
system (TTSS) of P. aeruginosa is a complex pilus-like structure that allows the translocation
of effectors proteins from the bacteria into the eukaryotic cytoplasm through a needle-like
appendage that forms a pore in the eukaryotic membrane [46].
The TTSS system is involved in pathogenesis through the translocation of multiple toxins
(ExoS, ExoT, ExoY and ExoU) into the host cell, however, it also appears that TTSS may
participate in P. aeruginosa virulence by itself [47]. A complex regulon is involved in the
biogenesis and regulation of TTSS. This reflects the importance of TTSS for P. aeruginosa
pathogenicity. There appear to be five types of genes: those involved in the formation of the
needle complex for the transport of the toxins from the bacteria cytosol into the extracellular
environment; the proteins that are involved in the transport of the toxins into the host cells;
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the proteins that regulate the secretion process; the chaperone proteins that assist the secretion
of the TTSS machinery and finally the effector proteins which are injected into the host cells.
The type III proteins are transported from the bacterial cytosol into the extracellular
enviroment through a needle like complex, which facilitate their movement past the bacterial
cytoplasmic membrane, the peptidoglycan layer and the outer membrane. This needle
structure is organized in a multi-ring base and a needle filament. The filament, which consist
of protein PscF subunits, is thought to act as a channel through which the secreted factor
move into the external environment [47].
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Figure 1-1. Overview of P. aeruginosa virulence determinants.
P. aeruginosa has both cell-associated (flagellum, pili, lipopolysaccharide, alginate) and extracellular virulence
factors (elastases, exotoxin A, phopholipase, proteases, pyocyanin, siderophores HeN, and rhamonolipids). The
type III secretion apparatus is used to inject exotoxins in the host cells (Figure extracted from van Delden, 2004).
1.2.4 Biofilm
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When P. aeruginosa chronically infects patients, it adapts to the biofilm mode of growth [48].
The generally accepted definition of a biofilm is a "community of cells attached to a surface
or to each other, imbedded in a self-made, protective matrix of extracellular polymeric
substances (EPS)" (Fig. 2) [49]. The tendency of P. aeruginosa to colonize surfaces in these
organized communities makes it less susceptible to antibiotics, anchors the cells to the surface
they colonize and protects the bacteria from the host defenses [50, 51]. A number of
components essential for biofilm formation and development have been identified (flagella,
type IV pili and exopolysaccharides) [52]. Firstly, flagella enable the bacteria to swim to a
specific surface and attach. Then, type IV pili allow the bacteria to move forming micro-
colonies. The last stage of development involves the loss of flagella and type IV pili and the
production of an expolysaccharide matrix important for the three dimensional structure of the
biofilm (Fig. 2) [29].
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Figure 1-2. Representation of biofilm development in P. aeruginosa.
(A) Schematic representation of different stages of biofilm formation. In the colonization stage, planktonic cells
adhere to the substrate (I) and start to proliferate forming microcolonies (2). During the maturation stage the
microcolonies grow (3), forming three-dimensional structures known as "mushrooms" (4). Finally, bacterial
cells leave the mushrooms leading to biofilm dispersion (5). Modified from Kiristis and Parsek, 2006. (8)
Typical biofilm formed by P. aeruginosa PAOl.
Virulence factor production and the ability to form biofilms intertwine, making P. aeruginosa
a particularly dangerous pathogen.
P. aeruginosa is also notorious for its intrinsic resistance to a wide range of antibiotics and for
its ability to easily acquire new resistance phenotypes by genetic exchange, especially in the
nosocomial environment [53]. The P. aeruginosa outer membrane is relatively impermeable
to a wide range of antibiotics, as the outer membrane contains multidrug-efflux pumps
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systems such as MexAB-OmpM, which limit the access to the periplasm of hydrophilic
antibiotics [54]. The basis for P. aeruginosa resistance also resides in the expression of an
array of enzymes such as B-Iactamases, which inactivate the antibiotics by hydrolysis. These
enzymes, usually encoded on plasmids, are easily acquired by horizontal transfer [55].
1.3 REGULATION OF VIRULENCE
Bacteria have a long evolution history that allowed them to evolve into complex machines,
able to adapt and respond to different conditions. In particular, pathogenic bacteria have
evolved mechanisms to regulate the quick and effective production of virulence factors.
Bacterial virulence has to be strictly coordinated in space and time to reduce the possibility
that the host immune system will dismantle the bacterial attack, and to maximize the chance
that the assault occurs in the most favorable conditions for the bacterial community. The
regulation of virulence by bacteria can occur mainly at the transcriptional and post-
transcriptional level.
1.3.1 Quorum sensing
Bacteria have evolved ways to quickly modulate their gene expression; this adaptability
reflects their need to respond to the constantly changing environmental conditions. One way
bacteria achieve this high flexibility is by regulating genes expression at the transcriptional
level by using global regulators that are activated by specific stimuli, allowing them to
coordinate a concerted response [56]. Among these global transcriptional regulators sigma
factors (0) represent an example (reviewed in Guber and Gross, 2003) [57, 58]; histone like
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nucleotide structuring proteins (H-NS), which add stability to the DNA (reviewed by Atlung
and Ingmer, 1997) [59]; signaling molecules, such as cyclic-AMP (c-AMP) or cylcic-di-GMP
(c-di-GMP), which bind to a specific effector protein, activating a set of responses [60, 61].
In addition to these multiple levels of transcriptional regulation, a new system of regulation,
called the quorum sensing (QS) system of communication, was described forty years ago
[62]. Bacteria have been shown to posses a way of sensing and interacting with each other in
a way similar to the one observed in highly evolved organisms. This interaction can be intra-
or inter-species, and it probably evolved to allow co-existence of a bacterium into its host.
However, in pathogenic bacteria this communication system is mainly used to coordinate a
virulence response.
QS is a form of cell-to-cell communication via the use of small signaling molecules, called
autoinducers. This form of regulation allows bacteria to monitor their population density by
responding to the extra cellular concentration of autoinducer molecules they produce. Once a
critical concentration (corresponding to a particular population density) of the signal has been
reached, the whole population initiates a concerted action, activating or repressing target
genes (Fig. 3). This cell-to-cell communication system has been shown to be important for
biofilm formation, expression of virulence factors, synthesis of secondary metabolites,
competence and colonization of superior organisms [63].
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Figure 1-3. A schematic representation of QS.
The signal molecule is constitutively produced at a basal level by the bacterial cells. At low-cell densities, very
little signal molecule is present. As cell density increases, the signal molecule accumulates in the media until a
threshold level is reached. This signal molecule concentration is responsible for a coordinate transcriptome
reprogramming in the whole bacterial population. Modified from Dunn and Stabb, 2006.
Several chemical classes of microbial derived signaling molecules have been now identified.
These can be split into three main categories: 1) N-acyl-homoserine lactones (AHL),
frequently utilized by Gram-negative bacteria, 2) aminoacids and short peptides, commonly
utilized by Gram-positive bacteria, 3) the AI-2 signal, widespread in several Gram-positive
and Gram-negative species [64-66].
In the AHL-dependent QS system, a single enzyme is required for the synthesis of the signal
molecule. This enzyme is a synthetase, generally belonging to the LuxI family. The HSL ring
is conserved, while the acyl side chain can vary in length, degree and type of substitutions,
conferring strain-specificity to the signal [67]. When the cell density increases, so does the
concentration of the signal molecule, until it interacts with a cytoplasmic DNA-binding
receptor belonging to the LuxR family. The activated LuxR homologous protein modulates
the expression of QS controlled genes [68,69].
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The first QS system that employs AHL as a signaling molecule was described in the marine
bacteria Vibrio fiseheri [62]. In this organism, QS regulates different phenotypes, among
which is bioluminescence. V.fiseheri is non-luminescent when free living in seawater (at low
cell densities). When V.fiseheri lives in symbiosis with the squid Euprymna seolopes (high
cell densities), the bacteria activate its bioluminescence. The molecular basis of the
bioluminescence induction involves an interaction between the freely diffusible signal
molecule N-3-oxohexanoyl-homoserine lactone (3-oxo-C6-HSL) and the transcriptional
regulator LuxR. V. fiseheri cells express luxl, the AHL synthase gene, at a basal level when
living in a low population density. In that way, the concentration of signal molecule remains
low. However, as the population density increases within the confines of the hosts light organ,
so does the concentration of 3-oxo-C6-HSL in the immediate environment. Once the critical
concentration of the signal molecule has been achieved (corresponding to a critical population
density), 3-oxo-C6-HSL binds to LuxR. The activated regulator binds to a 20 base pair (bp)
DNA inverted repeat, known as the lux-box, located upstream from the /uxCDABE operon
responsible for the light production.
1.3.1.1 Quorum sensing in P. aeruginosa
Almost twenty years ago, Gambello and Iglewski provided evidence that the human pathogen
P. aeruginosa possesses a QS dependent system of regulation controlling a battery of
virulence factors, such as elastase [70]. Later, the AHL signal molecules at the basis of this
regulatory system were identified [53, 71]. Subsequent studies revealed that P. aeruginosa
mutants defective in the production of the QS signal molecules form an abnormal biofilm
which, in contrast to the wild-type, is sensitive to low concentration of detergents and
antibiotics [50, 72-74]. Several in vivo models showed attenuated virulence when infected
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with mutated P. aeruginosa strains incapable of producing the QS signal molecule (reviewed
by Smith and Iglewski, 2003) [75]. Furthermore, in the lungs of CF patients a clear
correlation between biofilm production and QS has been established [11].
The current hypothesis on the relationship between QS and virulence in P. aeruginosa
postulates that cell-to-cell signaling could enable this microorganism to overcome host
defense mechanisms. Indeed, isolated production of extracellular virulence factors by a small
number of bacteria would probably lead to an efficient host response, neutralizing these
compounds and the microorganism itself. Conversely, the coordinated expression of virulence
genes by an entire bacterial population, once grown to high cellular density, might allow
P. aeruginosa to secrete high levels of extracellular factors, enough to overcome host
defenses [76].
In P. aeruginosa, there are two QS systems homologous to the lux system of V.fischeri. The
las system, which consists of the LasR transcriptional regulator, and the Las! synthase. LasI
produces the signal molecule N-3-oxododecanoyl-homoserine lactone (3-oxo-C12-HSL).
LasR requires 3-oxo-C12-HSL binding in order to become an active transcriptional factor. In
the presence of 3-oxo-C12-HSL, LasR forms dimers. Only the dimeric form of this protein is
able to bind to the lux box of the genes it regulates [77]. LasR is composed of two distinct
domains: the amino-terminal domain responsible for AHL-binding, and the carboxy-terminal
domain, containing the helix-turn-helix motif important for the DNA-binding activity of the
protein. Studies proved that the interaction between the signal molecule 3-oxo-C12-HSL and
LasR leeds to the dimerization of the regulator and promotes its binding to the promoter
region of target genes [77]. The LasRlLasI system was initially shown to regulate the
expression of various virulence factors such as elastase, exotoxin A and alkaline protease, as
well as Las! itself, thereby creating a positive regulatory feedback loop (Fig. 4) [78, 79].
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The LasR-autoinducer complex also activates the expression of the rhl QS system of
P. aeruginosa. In particular, the expression of the RhIR transcriptional regulator is induced by
the 3-oxo-CI2-HSL-LasR complex [80]. RhIR binds to the signal molecule N-butyryl-
homoserine lactone (C4-HSL) produced by the cognate synthase RhlI. Like the las system, a
functional rhl system is necessary to regulate the expression of several virulence factors such
as alkaline proteases, pyocyanin, hydrogen cyanide, lectins and elastase [81]. Moreover, the
C4-HSL-RhIR complex promotes transcription of rhlI, establishing an autoregulatory loop
(Fig. 4) [82]. The las system is hierarchically located above the rhl system. Indeed, 3-oxo-
C12-HSL-LasR complex activates rhlR transcription, triggering the second signaling cascade
[80, 83]. Furthermore, the 3-oxo-CI2-HSL can compete with C4-HSL for the binding to
RhIR, thus inhibiting this activator [84]. Therefore, the las system controls the rhl system at
both transcriptional and post-translational level. Presumably, this second level of control
exerted by the las system on the rhl system ensures that the two systems initiate their
regulatory cascades sequentially and in the appropriate order (Fig. 4) [84].
In addition to LasR and RhIR, a third LuxR-like regulator was discovered in P. aeruginosa
[85]. Unlike the homologues LasR and RhIR, this regulator is not associated with a cognate
Luxl-like synthetase. Therefore, QscR is classified as an "orphan" QS signal receptor. A
P. aeruginosa qscR mutant prematurely transcribes the las! and rhlI AHLs generator genes,
producing an increment in the expression of some QS controlled virulence genes, such as
those involved in the expression of pyocyanin, elastase and HeN. Indeed, the P. aeruginosa
qscR mutant is hypervirulent [85]. Several possible mechanisms have been proposed in order
to explain the QscR mediated repression of lasR and rhlR expression. Filloux and co-workers
demonstrated that, when expressed in the heterlogous host E. coli, QscR can form
homomultimers, and also heterodimers with LasR and RhIR. Moreover, the same authors
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showed that QscR is capable of binding both 3-oxo-C12-HSL and C4-HSL, thus competing
with LasR and RhIR for these signal molecules [86]. On this basis, the role of QscR as
inhibitor of QS through the formation of inactive heterodimers or through the competition for
the signal molecules, is implicit [86]. Interestingly, it was recently demonstrated that the 3-
oxo-C12-HSL-QscR complex can regulate the transcription of target genes (Fig. 4) [87].
Indeed, transcriptomic analysis provided evidence for the existence of a QscR regulon, which
is not entirely overlapping with the LasR and RhIR ones [88].
A fourth LuxR-like protein, called VqsR (yirulence and quorum ~ensing regulator), has been
characterized in P. aeruginosa. Like QscR, VqsR is an "orphan" LuxI-like synthase. VqsR
was shown to be involved in the positive regulation of QS, since vqsR inactivation abrogated
the production of both 3-oxo-C12-HSL and C4-HSL signaling molecules. Indeed, the absence
of vqsR leeds to a decrease of las! transcription. Moreover, it was found that the promoter of
vqsR contains a putative las-box, which places vqsR under the control of the las system [89].
Further studies confirmed this hypothesis, demonstrating the direct binding of LasR to the
vqsR promoter (Fig. 4) [90].
P. aeruginosa QS response involves another chemical signal, distinct from the
aforementioned AHLs. This signal, called 2-heptyl-3-hydroxy-4-quinolone (PQS), adds a
further level of complexity to the QS network, providing another link between the las and rhl
QS systems (reviewed by Williams and Camara, 2009) [91]. The transcription of pqsABCDE
operon, and therefore PQS production, is negatively regulated by the rhl system and
positively regulated by the las system. On the other hand, PQS positively controls the
expression ofRhlR and RhlI (Fig. 4) [92-94].
Pesci and collaborators demonstrated that the effects of LasR and RhlR on the pqsABCDE
operon occur indirectly through the control of the transcriptional regulator PqsR. PqsR in turn
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has a positive effect on the transcription of pqsABCDE and phnAB, directly binding to their
promoter [95]. Thus, the production of PQS is dependent on the ratio of 3-oxo-CI2-HSLlC4-
HSL, suggesting a delicate balance between the two QS systems [96]. PqsR binding to the
pqsABCDE and phnAB promoters is augmented by the presence of PQS and HHQ, implying
that these two molecules act as co-inducers ofPqsR [97, 98].
PQS is also a multifunctional molecule, as it has an important role in iron transport, by acting
as an iron trap and associating to the cell surface facilitating siderophore-mediated iron uptake
[98]. PQS also has both oxidant and anti-oxidant properties acting on the population profile of
the bacterial community [99]. PQS promotes the formation of membrane vesicles (MVs),
which are thought to provide a mean of transporting PQS within bacteria [100]. This molecule
has also been implicated in controlling biofilm maturation [101] and cell population densities.
Under stressful conditions, PQS promotes cell lysis and the release of DNA (Fig. 5) [101,
102].
PQS is required for virulence in nematodes, plants and mice [34, 103-105]. This molecule
was also found in the lungs of CF patients infected with P. aeruginosa, and it was shown to
regulate diverse virulence genes including those coding for elastase, rhamnolipid and
pyocyanin, as well as influencing biofilm development [92, 94, 98, 104]. Moreover, both in
vivo and in vitro studies show how PQS interferes with the host during infection by
deregulating the immune response [106-108].
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Two operons are implicated in the biosynthesis of 2-heptyl-4-quinolone (HHQ), the natural
precursor of PQS: phnAB and pqsABCDE [109, 110]. More precisely, the phnAB operon is
required for the conversion of 2-amino-2-deoxy-isochorismic acid to anthranilic acid, which
is subsequently converted to HHQ by the enzymes encoded by the pqsABCD genes. HHQ is
then converted to PQS by the product of the pqsH gene.
Besides PQS and HHQ, P. aeruginosa also produces a large number of related molecules
which are part of the group of 2-alkyl-4(1H)-quinolones (AQs). The AQ biosynthetic
enzymes present in this bacterium allow for the generation of over 50 different AQs. These
can vary in the saturation of the alkyl chain and in the length (from one to thirteen carbons) or
in the ring structure (containing N-oxides (HQNO». The pqsABCD genes are involved in the
biosynthesis of all AQs. Many of these molecules seem to lack a specific biological function
[109-111].
In addition to the four biosynthetic genes encoded, the pqsABCDE operon also encodes for
the PqsE. The sequence of PqsE resembles the one of the group of the metallo-B-hydrolase
superfamily. The proteins belonging to this group have different functions such as B-
lactamases or AHL-Iactonases. However, the role of PqsE has not been unraveled, although
its crystal structure is available [112]. A pqsE mutant is defective in the production of many
virulence PQS-mediated exoproducts such as pyocianine, HeN and lectin. Moreover, the
virulence in plant and animal infection models in the absence of AQs is dependent on the
presence of this gene [113].
To summarize, PQS acts as a signal molecule controlling the expression of genes in a pqsR
dependent way (such as pqsA), in a pqsR/pqsE dependent way (such as the expression of
lecA) and in a signal independent way through the iron sequestration pathway (Fig. 5).
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In silico analysis has revealed the presence of genes potentially involved in PQS synthesis in
over 40 bacterial species. In a number of Burkholderia species such as B. pseudomallei and
B. thailandensis, the complete putative pqsABCDE operon has been identified [114]. The
main AQs produced by these species is HHQ, however, no PQS was detected, raising the
possibility that related bacterial species which occupy similar ecological niches can cross-talk
through the common molecule HHQ [115].
Since the discovery of cell-to-cell signaling in P. aeruginosa, the list of genes reported to be
controlled by QS has increased steadily. Through the analysis of the QS-regulated
transcriptome of P. aeruginosa, an overwhelmingly large number of genes were shown to be
regulated by QS, with 3-7% of all P. aeruginosa open reading frames affected [51, 116, 117].
The majority of the QS regulated genes were classified as hypothetical or of unknown
function, but a high proportion of them were shown to be secreted factors (toxins and
extracellular enzymes), reinforcing the hypothesis that QS has an important role in virulence
[118]. In addition, many genes involved in general metabolic functions, such as central
intermediary metabolism, biosynthesis of cofactors and fatty acid metabolism, were affected
by QS. This suggests that AHL signaling elicits major physiological changes in the cell,
·which reach far beyond virulence functions and may contribute to adaptation to a high cell-
density environment [118].
Although QS is defined as a mechanism by which bacteria regulate target genes in a growth
phase dependent way, in 1999 Greenberg and collaborators observed that, in P. aeruginosa,
many QS controlled genes responded to the presence of signal molecules with different
temporal patterns [119]. This observation was the first major indication that additional
regulation was superimposed to the P. aeruginosa QS network. A number of "early" QS
genes were found to respond immediately to exogenously added signals, while another group
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of QS controlled genes (called "late" genes) were able to respond to the signals only during
stationary growth phase. It was hypothesized that "late" genes might be under the control of
some unknown regulatory mechanisms preventing their "early" expression [119]. The
transcriptome analysis performed by Greenberg and collaborators at different points of the
P. aeruginosa growth curve confirmed this pattern of delayed expression for most QS
controlled genes [117].
In accordance with this hypothesis, recent studies have shown that in P. aeruginosa the QS
regulatory circuit is integrated into specific aspects of cell physiology, and that it is modulated
by environmental and metabolic signals that are independent from extracellular signal
molecules concentrations. An increasing number of regulators which modulate the timing and
level of QS-controlled gene expression has been described (reviewed by Venturi, 2006) [120].
These regulators provide additional control steps to the QS network in response to growth
phase, environmental signals and yet unidentified stimuli.
1.3.2 Two component regulatory systems
Bacteria are exposed to different and constantly changing environmental conditions and
stress. For this reason, they have evolved sensory systems that enable them to quickly and
specifically respond to a particular input. Two component systems (TCSs) are the main
mechanism by which bacteria and fungi react to their environment [121]. TCS are involved in
the regulation of different responses such as drug resistance, motility, osmoregularity, host
invasion, nitrogen fixation and virulence [122].
The TCSs are part of a transduction system, which recognizes an environmental signal and
converts this signal into a transcriptional activation. The TCSs are generally composed of an
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inner membrane-spaning sensor histidine kinase (HK), which detects the stimuli and activates
the cytoplasmatic response regulator (RR) through a set of phosphorylation steps. Then, the
RR converts the signal into a transcriptional regulation of target genes [123].
The Tess can be divided into three categories. In the "classic" systems, the HK responds to a
signal by undergoing trans-autophosphorylation at a conserved histidine residue in its
transmitter domain. This phosphoryl group is then transferred to an aspartate-containing
receiver domain of the cognate RR, which is generally a DNA binding protein [124]. In the
phosphorelay-type system, three consequent phosphoryl transfer events (within the same
sensor protein or through different proteins) result in the phsophorylation of the RR. In
particular, the phosphorylation of the RR may travel through a Histidine phosphojransfer
(Hpt) protein [125]. In the case the Hpt is a separate protein, the TeSs are termed "hybrid".
When the Hpt domain is fused to the receiver domain of the HK protein, the TeSs are called
"unorthodox" (Fig. 6).
CLASSIC TWO-COMPONENT PHOSPHORELAY
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Figu re 1-6. A Schematic representation of the different two-corn ponent systems.
The HK and RR coding sequences are often encoded adjacent to each other in the same
operon, indicating that the system responds specifically to a signal (although most of the
times the signal is unknown). However, in the case of "orphan" two-component system, the
HK gene is not transcribed with the RR and vice versa.
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One of the ways in which Tess can act on the activation of a response is through the
activation of small non-coding regulatory RNAs (sRNAs) [126-128]. Some response
regulators promote the transcription of sRNAs, which in turn post-transcriptionally modulate
target genes, thus providing a link between Tes and post-transcriptional regulation.
One way the sRNAs can act is by binding to their target mRNA, thus interfering with
ribosome binding preventing their translation [129]. On the other hand, sRNAs can positively
affect the rate of translation of a target mRNA by stabilizing their secondary structure [130].
The sRNAs can also affect post-transcriptionally gene expression in a more global way by
binding and sequestrating global post-transcriptional regulators. The most studied sRNAs that
act as post-transcriptional regulators are those that involve the CsrA global regulator in E.
coli, homologues of which are also present in many bacteria [129, 131, 132].
The esrA global regulator (carbon storage regulator A) was discovered by Romeo and
collaborators [133]. In E. coli, the Csr system is composed of the esrA protein and two small
sRNAs, namely CsrB and CsrC [l34]. CsrA binds to a site near the Shine-Oalgarno (SO)
sequence of target mRNA, competing with the binding of the ribosome and increasing mRNA
decay. Interestingly, CsrA can also act as a positive regulator by binding and stabilizing the
target mRNAs or by releasing secondary structure, preventing their translation [135]. The
activity of CsrA is in turn modulated by two sRNAs, CsrB and CsrC, which have a high
affinity for CsrA. By binding to this global regulator, these sRNAs titrate CsrA, preventing its
binding to target mRNAs [134, 136]. Finally, the transcription of these two sRNAs is
controlled by the two-component signal transduction system BarA!UvrY, which is activated
by yet unknown signal molecule(s) [137].
In E. coli, this global post-transcriptional regulatory system modulates multiple phenotypes
such as biofilm formation and motility, carbon metabolism, virulence and QS. This discovery
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links the transcriptional regulatory system of QS with CsrA global post-transcriptional
regulation, providing new insights into the complex network of gene expression. Several
homologues to CsrA have been identified in other bacterial species [138].
1.3.2.1 GacAiS and RsmA
In the P. aeruginosa genome, there is an astonishing number of putative two-component
regulatory proteins that mediate the link between external stimuli, such as an extracellular
signal, and a response. P. aeruginosa encodes 64 HK and 72 RR, 50 of which are organized
in the same operon, while there are 13 HK and 15 RR orphan components [125, 139].
Additionally, there are 3 Hpt proteins (HptA, HptB and HptC) that act with the several hybrid
kinases forming complex networks [140].
This section will focus on the Gac/Rsm transduction system in P. aeruginosa. This system is
composed of the global post-transcriptional regulator RsmA, the two regulatory RNAs (RsrnZ
and RsmY), and a sensor kinase and the response regulator (GacS/GacA) [141].
The GacS/GacA (global activator of §Iltibiotic and ~anide synthesis) TCS is one of the best-
characterized virulence regulatory pathways. Both GacS and GacA are required for
pathogenesis in vivo models such as plant, nematode, insect and mouse [105, 142-146]. GacA
and GacS are required for the modulation of multiple virulence factors such as the ones
involved in the regulation of biofilm formation and in the synthesis of the QS AHL signals
[147, 148].
The GacS/GacA system exerts its regulatory function by modulating the activity of the global
post-transcriptional regulator RsmA, which is the CsrA analogue in E. coli [149]. In detail,
the GacS/GacA TCS acts exclusively through the modulation of the two sRNAs. In response
to a still unknown stimuli, GacA positively regulates the expression of RsmZ and RsmY by
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directly binding to the sequence upstream of these genes (called the GacA-box) [150]. These
two sRNAs sequestrate RsmA protein to jointly antagonize the binding of RsmA to its target
mRNA [151].
RsmA is a negative regulator involved in the formation of several extracellular products, such
as pyocyanin, hydrogen cyanide, elastase and LecA (PA-IL) lectin. Moreover, it exerts its
global regulatory effect by modulating QS. RsmA was shown to negatively regulate the
production of QS signal molecules such as AHL, although the molecular mechanism is still
unknown [152, 153]. Interestingly, RsmA is also able to positively regulate swarming, lipase
and rhamnolipids production, although the mechanisms of its positive effect are not fully
understood [151].
1.3.2.2 RefSand LadS
In addition, the presence of two additional sensors kinases, namely RetS (regulator of
~xopolysaccharide and type III secretion) and LadS (lost ~dherence ~nsor), which work in
combination with GacS for the modulation of the phosphorylation of GacA, adds further
complexity to the system [154, 155].
RetS is a hybrid sensor kinase which inhibits GacA phosphorylation by forming inactive
heterodimers with GacS [155, 156]. The expression of the genes important for chronic
infection, such as the ones involved in the early biofilm formation linked to the activation of
the matrix exopolysaccharide pis operon, is enhanced in a rets mutant [7]. On the other hand,
the expression of genes required for acute infection (such as type III secretion system, type IV
pili and exotoxin A) is reduced [157, 158].
LadS is another hybrid sensor kinase, which was firstly identified by Ventre et al. [155]. LadS
is important in the early and maturation steps of biofilm development by positively regulating
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the exopolysaccharide operon pel. A ladS mutant is unable to form biofilm and shows an
increase cytotoxicity relative to the wild type [155]. Thus, LadS and RetS have opposite
effects on the Gac/Rsm system, although LadS was shown to be hierarchically located
'above' RetS [155].
The previous observations allowed for the establishment of a model that attempts to explain
how this TeS (GacSlLadSlRetS/GacA) and its linked post-transcriptional regulator (RsmA)
are involved in coordinating the gene expression associated with acute or chronic infection
[154, 155, 158]. In this model, during chronic infection, environmental cues activate GacS
and LadS, which in turn promote the transcription of rsmZ and rsm Y. This decreases the
levels of free RsmA causing the expression of genes involved in biofilm formation. On the
other hand, RetS is activated in an acute infection. This sensor represses GacA activation,
thus promoting RsmA activity by lowering the amount of sRNA. Once RetS is active, the
genes responsible for type III secretion system and other genes involved in virulence and thus
in acute infection, are upregulated (Fig. 7). Whilst RetS is known to regulate rsmZ and rsmY
transcription through the inhibition of GacS phosphorylation [156]. The machanism by which
LadS modulates rsmZ and rsmY transcription is still unknown. A possible explanation is that
LadS could promote GacA phosphorylation [158].
1.3.2.3 BjiRiS
Recent studies conducted using a proteomic approach, led to the identification of Bfik/S,
which is another res linked to the GacS/GacA regulatory system. In particular, the sensor
kinase BfiS was shown to be essential for the early stages of the biofilm development
regulating the irreversible attachment, by acting at the post-transcriptional level on rsmZ via
RNase G (Fig. 7) [159]. In detail, the BfiSR res is activated in a biofilm-specific manner and
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promotes the transcription of the gene cafd, encoding for RNase G. This RNase acts on the
degradation of rsmZ and eventually on the progression of biofilm development. This
discovery adds another layer of complexity to this complex regulatory network. The levels of
rsmZ in the cell are regulated at the transcriptional level by the GacASlRetSlLadS/Rsm
system, and at the post-transcriptional level by BfiSIR. Moreover, BfiSIR TeS was shown to
act also on the levels of rsmY transcripts, although this modulation does not appear to depend
on RNase G activity.
J.3.2.4 HpfB
As previously stated, P. aeruginosa codes for three Hpt proteins. Recent studies conducted on
HptB showed how this protein is part of a phosphorelay TCS. HptB is phosphorylated by four
sensor kinases, namely PAI61I, PA1976, PA2824 and RetS. This finding suggested that
HptB could be the phosphorylation relay of the RetS hybrid sensor kinase. This hypothesis
was however discharged, as further studies showed that an overexpression of HptB in the refS
defective strain was unable to restore the wild type phenotype [160]. Furthermore, it was
shown that GacA regulation is located downstream of HptB. The in vitro ability of HptB to
retro-transfer the phosphyl group to RetS, combined with the previous results, led to the
hypothesis that HptB could control target genes through the GacS/GacA system [140]. HptB
was also shown to inhibit the release of a putative sigma factor, responsible for promoting the
transcription of rsm Y, suggesting that RsmZ and RsmY are regulated through different
pathways (Fig. 7) [140, 160].
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Figure 1-7. Model for the Rsm/Gac regulatory network in P. aeruginosa.
Three hybrid sensors (PA2824, PA 1611, PA 1976) activate HptB. This protein has a negative effect on the
activity of PA3346, which activates PA3347 (an anti-anti-a factor). PA3347 can bind a putative anti-a factor,
allowing the release of a yet uncharacterized a factor. This a factor may act specifically on rsmY, but not on
rsmZ (Bordi et al., 2010). HptB has also a potential retro-transfer ability, from the three hybrid sensors to RetS
(Hsu et al., 2008). RetS is forming dimers inhibiting GacS phosphorylation (Goodman et al., 2009), while GacS
and LadS act positively on GacA phosphorylation and BfiRS act on the levels of rsmZ and rsmY transcripts
(Petrova, Sauer, 2010).
1.4 INHIBITION OF VIRULENCE
Historically, the first approach to treat bacterial diseases was to inhibit their growth
(bacteriostatic) or to directly eradicate them (bactericidal). Since the discovery of penicillin,
the development of antibacterial drugs has been exponential. However, the production of
novel antibiotics fails to compete with the fast development of anti-microbial resistance. For
this reason, new approaches for the treatment of bacterial disease are needed. A better
understanding of the capability of bacteria to coordinate the production of virulence factors in
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a multicellular way could offer a novel way to interfere with this inter and intra-species
communication. By inhibiting QS signaling, it could, therefore, be possible to interrupt the
flow of information essential for the successful establishment of the infecting pathogen in the
host.
1.4.1 Quorum sensing inhibition
Studies that have explored the role of QS in P. aeruginosa infection (in a burnt-mouse model,
a murine model of acute pneumonia, and a rat model of chronic lung infection) have
demonstrated that the inactivation of QS genes resulted in reduced P. aeruginosa virulence
compared to the wild type [161]. In humans, QS was shown to be functional during
P. aeruginosa infections. Thus, the signal molecules AHLs and AQs were directly measured
in the sputum ofCF patients chronically colonized with P. aeruginosa [11].
In addition to their role in modulating the QS regulatory system, these signal molecules were
also shown to interfere with the host immune response [162]. In particular, low concentrations
of 3-oxo-C12-HSL «10 fJM) were shown to inhibit the production of the cytokines
interleukin (IL-) 12 and the tumor necrosis factor alpha (TNF-a) by the LPS-stimulated
macrophages. The signal molecule 3-oxo-C12-HSL also inhibited the proliferation of T cells
and the release of IL-2 in vitro [106]. Finally, 3-oxo-C12-HSL was proved to be a potential
anti-inflammatory agent to treat autoimmune diseases such as diabetes in mice [163]. These
observations led the authors to believe that 3-oxo-C12-HSL was involved in shifting the host
immune response from the host protective T-helper response to the pathogen protective T-
helper response. These data suggest a scenario in which after infection, the bacterial
community starts producing AHLs, which on one side facilitate QS, and on the other
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represses the host Immune response. This eventually leads to an increased bacterial
colonization.
In another series of investigations conducted using higher doses of 3-oxo-CI2-HSL (lOO
J.lM),it was shown that 3-oxo-CI2-HSL could also induce pro-inflammatory responses in
fibroblasts [164]. These studies established that 3-oxo-CI2-HSL induced the expression of
cytokine and the chemokine interleukin-8 (IL-8). Interleukines are pro-inflammatory
cytokines involved in attraction and activation of polymorpho-nuclear leukocytes (PMNs).
Their production is important in keeping the immune response acute and morbid by constant
recruitment of PMNs [165]. High levels of chemotactic factors such as IL-8 produced at the
site of infection stimulate the migration of many different cell types to the site of infection.
Neutrophils that enter the infection site secrete multiple mediators such as reactive oxygen
species and elastases. Although the environment is filled with these caustic agents, P.
aeruginosa tends to be resistant to their effect; this resistance is probably due to the growth of
the bacteria on protective biofilms [17]. Moreover P. aeruginosa also produces catalases and
superoxide dismutases that are able to neutralize the deleterious effects of hydrogen peroxide
and oxidative stress [166]. Therefore, instead of clearing the bacterial infection, the release of
neutrophils results in tissue destruction [162, 167]. 3-oxo-C12-HSL was also shown to
activate T-cells production of interferon-gamma (IFN-Y) [165].
These observations led to the hypothesis that 3-oxo-C12-HSL was in fact acting as a promoter
of the immune response. One of the possible explanations for this pro-inflammatory function
of 3-oxo-CI2·HSL is that, during P. aeruginosa acute infection, the 3-oxo-C12-HSL
promotes inflammation and subsequent destruction of host tissue. This in turn leads to
dissemination of the bacteria and sepsis.
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Finally, AHLs have been shown to exert a pharmacological effect on the cardiovascular
system, suggesting that host cardiovascular function may be modulated by bacterial QS
molecules. In particular, it was observed that some AHLs and PQS exerted a vasodilatatory
activity, thus favoring the dispersal and the nutrient supply of the microorganisms via the
bloodstream (168].
Consequently, QS signal molecules production may not only have a role in activating the QS
response, but also in modifying host immune response to maximize its own chances of
survival and proliferation. This is achieved by increasing the supply of nutrients via the
bloodstream and by regulating the host defenses.
Since QS is crucial for virulence, biofilm formation and the direct modulation of the immune
host response, it is plausible that QS can be an ideal target for the design of novel drugs for
the treatment of P. aeruginosa infections. This new approach, based on QS inhibitor (QSI)
compounds that specifically block bacterial signaling systems, offers a novel opportunity to
control infectious bacteria in a nonlethal way. By interfering with QS, a limited selective
pressure for the survival of bacteria is exerted [169]. In contrast to traditional anti-microbial
agents, QSI compounds work at concentrations well below the minimal inhibitory
concentration. This concept is attractive, since such compounds will not create a selection
pressure for the development of resistance. Moreover, since the selected QSls are non-toxic
for bacteria at the concentrations used, they are not expected to exhibit adverse effects on
beneficial bacterial communities that live in symbiosis with the host (e.g., the gut flora) [169].
There are several strategies for disrupting P. aeruginosa AHL-dependent quorum sensing.
One way is to reduce the concentration of the signal molecules by enhancing their degradation
or by inhibiting their synthesis. Alternatively, one could block the transmission of the signal
by antagonizing the formation of the LuxR-AHL complex [51].
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1.4.2 Blockage of signal synthesis
One way of affecting QS system is by interfering with the signal production and in particular
by blocking the AHL synthetase. Studies conducted on the LuxI and its homologues have
revealed that the AHL synthesis is a conserved mechanism and that AHLs are synthesized
from precursors involved in the amino acid and fatty acid metabolism: S-adenosyl methionine
(SAM) and acyl-ACP [170]. Various analogues of SAM that compete with the natural
precursors for the active site of LuxI have been developed. In particular, in vitro studies
demonstrated that S-adenosyl-DL-homocysteine drastically reduces the activity of the RhlI
protein [170]. However, due to the fact that SAM and acyl-ACP are common and necessary
intermediates in many prokaryotic and eukaryotic pathways, this strategy has been
disregarded as a possible approach for developing QSI molecules [51].
1.4.3 Signal degradation
The inactivation or degradation of the signal molecules could represent another strategy for
the blockage of the QS systems. AHLs are very sensitive to elevated temperatures and to pH
[171, 172]. In particular, high pH causes lactonolysis (ring opening) of the AHL ring. A
number of higher organisms, such as the plant Erwlnia carotovora, have adopted this strategy
in defense against invading microorganisms, thus preventing the expression of QS controlled
genes and virulence factors.
The AHLs can also undergo a spontaneous alkylation of the B-ketoamide moiety, which leads
to the formation of tetramic acids. Although these molecules have lost their signaling
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properties, tetramic acids were shown to act as antibiotics against Gram-positive bacteria
[173].
Lactonolysis of AHL can also be accomplished by enzymatic activity, which appears to occur
in a very broad range of organisms. Numerous bacterial strains capable of either inactivating
and/or metabolizing the signal molecule have been indentified. In particular, a Bacillus
specie was found to produce an enzyme, namely AiiA, which hydrolyzes the ester bond of the
lactone ring [174]. Other species are capable of utilizing the AHL as a sole energy source,
such as Variovorax paradoxus [175]. AHL lactonases have also been reported in different
eukaryotes and in mammalian serum [176]. These enzymes have been recently reported to
interfere with QS regulation in P. aeruginosa biofilms [177].
1.4.4 Signal antagonists
Another way to interfere with bacterial QS is to prevent the signal from being perceived by
the bacteria by blocking the receptor protein, the LuxR homologue. This can be achieved by
using antagonists that compete or interfere with the cognate AHL for binding to the LuxR
transcriptional regulator proteins.
There are two types of inhibitors, the competitive ones, which are structurally similar to the
native AHL signal, and the non-competitive, which have no structural similarity to the AHL.
In the former case, the inhibitor molecules bind and occupy the AHL binding pocket without
activating the LuxR-type receptor. In the latter, they bind to allosteric sites on the regulator
protein [169].
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1.4.4.1 Natural QSI
Given the widespread occurrence of AHL-mediated cell-to-cell communication system, it is
highly probable that higher organisms may have evolved specific means to interfere with
bacterial communication and possibly escape colonization [178]. Eukaryotic interference with
AHL-mediated signaling was observed in several plants which secrete substances that mimic
bacterial AHL signal, thus affecting QS-regulated behaviors of the pathogenic bacteria [179].
Recently, a large amount of plants and fungal extracts have been screened for QSI activity.
Extracts derived from carrot, soybean, water lily, tomato, pea seedlings, habanero and garlic
have been found to produce compounds capable of inhibiting QS. However, the structure of
the QSI molecules often remains unknown [180].
The first molecule discovered to have a QSI activity was the one produced by the Australian
marine macroalga Delisea pulchra. This algae produces a number of halogenated furanones
that inhibit bacterial biofilm formation [181].
More recently, furanones have been shown to inhibit AHL regulated processes, including
biofilm formation and QS-regulated virulence genes in a number of bacteria [182]. Although
it was originally thought that these compounds acted by competing with the natural AHL for a
common binding site to the LuxR protein, recent evidence suggests that the inhibition of AHL
gene expression is a consequence of an accelerated degradation of the LuxR protein [183].
1.4.4.2 Synthetic QSIs
The potential of the natural QSI compounds to control virulence, biofilm formation and
pathogenicity, prompted researchers to focus on the development of synthetic molecules
derived from the natural AHL or from the naturally occurring QSI molecules (i.e., furanones)
capable of interfering with the microbial activity. The furanones produced by D. pulchra have
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no effect on the QS system of P. aeruginosa. On the contrary, chemically modified furanones
derived from D. pulchra were shown to repress QS by reducing the expression of virulence
factors [169, 182]. Moreover, microarray analysis demonstrated that furanones and their
derivatives specifically repress expression of QS controlled genes in P. aeruginosa [169].
However, it is important to note that furanones derived compounds are often too reactive (due
to their halogenated group) and therefore too toxic for the treatment of bacterial infections in
humans [169].
Another approach used for the development of QS inhibitors was based on the construction of
synthetic chemical libraries composed of AHL derivatives. These compounds differentiated in
the homoserine lactone ring or the acyl-side chain. It appears that the homoserine lactone ring
is very important for biological activity, while the nature of the acyl chain is not as critical.
For this reason, much effort to create effective AHL antagonists has been focused on the
modification of the acyl side chain. A study of the P. aeruginosa LasR receptor revealed that
the fully extended acyl chain geometry is necessary for its activation. This suggested that the
minimum acyl side chain length determined by the cognate AHL signal is required for
binding to LuxR-type proteins [184]. The flexibility of the acyl side chain also appears to be
important for binding to the LuxR-type proteins. For example, it was shown that the reduction
of the chain rotation by the introduction of an unsaturated bond close to the amide linkage
nearly abolished the binding to the receptor [184]. The chirality of the homoserine lactone
moiety is crucial for its biological activity. Natural AHL signals are L-isomers, whereas D-
isomers are generally devoid of biological activity; D-isomers do not bind to the LuxR-type
receptor [184]. The effects of changes in the composition and size of the homoserine lactone
ring was studied. The main conclusion was that the ring size, the keto group adjacent to the
amino group and the presence of saturated carbons in the ring strongly affected the inhibitory
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activity of the molecule on the LasRILasI system. In fact, only slight variations in these key
positions, such as change from a saturated ring to an aromatic benzene ring, transformed the
molecule from an agonist into an antagonist [184].
Screening of random compound libraries has also identified QSI. Using this method, several
compounds whose structure was unrelated to the signal molecules were identified. Among
these, the most effective was the 4-nitro-pyridine-N-oxide (4-NPO) compound. Microarray
analysis showed how 4-NPO was lowering the expression of 37% of the QS-regulated genes
in P. aeruginosa [180].
1.S AIMS OF THE PRESENTED THESIS
This study aimed to unravel the molecular mechanisms linking QS with other signaling
regulatory networks in P. aeruginosa, in order to obtain a deeper understanding of the global
gene regulation networks that determine the virulence properties of this opportunistic
pathogenic bacterium. In particular, the work presented here aimed to achieve a deeper
understanding of the modulation of the two regulatory RNAs (RsmZ and Rsm Y) by internal
and external signaling, and to uncover novel pathways regulating this post-transcriptional
regulatory network. Moreover, it was interesting to exploit QS as an antibacterial target by
conducting in vitro studies and a clinical study on CF patients infected with P. aeruginosa.
In order to achieve this. the following approaches were considered:
Construction of reporter strains, based on QS regulated genes, for the analysis of the
effect of synthetic and natural compounds on QS inhibition.
Construction of reporter strains for the study of the Gac/Rsm regulation by
environmental signal molecules and by known QS and intracellular signal molecules.
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Construction of post-transcriptional based fusions for the study of the regulation of
virulence genes by PQS.
Creation of a genetic library and a transposon mutagenesis bank of mutants for the
identification of new regulators acting on the Gac/Rsm post-transcriptional regulation.
Exploitation of the promoter-pull down approach to identify regulators directly acting
on the transcription of the two regulatory sRNAs.
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2 Materials and Methods
2.1 BACTERIAL STRAINS, PLASMIDS AND GROWTH CONDITIONS
The strains of E. coli and Pseudomonas used in this study were cultivated at 37°C and 30°C
depending on the strain in solid and liquid media, with or without antibiotics. The stocks were
stored at -80 QCin Luria Bertani broth (LB) plus glycerol 15% [v/v]. The strains used in this
study are reported in Table 1.
Unless otherwise stated the P. aeruginosa strain used was from Nottingham collection strain
P. aeruginosa PAOI-N.
Rich media: Luria Bertani (LB) (tryptone 1% [w/v], yeast extract 0.5% [w/v], NaCll% [wv],
pH 7.5, sterilized by autoclaving).
M9 Minimal Medium: Basal salt solution 2x (Na2HPO. 13.6 gil, KH2P04 6 gil NaCI 2 gil),
100x supplements solutions: NH.CI 100 mg/ml, CaCI2 2.22 mg/ml, MgSO. 24.2 mg/ml,
glucose 360 mg/ml .
Glycerol-alanine minimal medium: DL-alanine 1% (w/v), glycerol 2% (v/v), K2HPO. 0.014%
(w/v), MgCl26H200.4% (w/v). Na2SO. 1.42% (w/v), ferric citrate 0.01% (w/v), pH 7.0 to 7.2.
Casamino Acid media, CAA consists of 5 g Difco casamino acids, 20 g glycerol, 0.573 g of
anhydrate K.Hpo. and 0.75 g of MgSO..7 HO in a total of 1 liter HO.
Swarming motility agar was prepared according to a previous published method [185].
This consisted ofO.S% (w/v) Bacto agar (Difco) and 0.8% (w/v) Nutrient broth No.2 (Oxoid)
in distilled water [186]. After autoclaving, filter sterilized D-glucose (Sigma) in distilled
water was added to a fmal concentration ofO.S % (w/v). When adding signal molecules to the
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swarming media, the molecules were added in a clean Falcon tube and the solvent was then
evaporated (under the fume hood). The warm swarming agar was then added to the Falcon
tube and shaken well to allow the compound to go into solution.
For plasmid selection and maintenance, antibiotics were added to growth media at the
following concentrations: gentamicin (Gm) 10 mg/l; ampicillin (Amp) 100 mg/l; tetracycline
10 mg/l for E. coli and gentamicin (Gm) 25 mg/l; streptomycin (Srn) 1000 mg/I; tetracycline
200 mg/l for P. aeruginosa. Isopropyl ~-D-l-thiogalactopyranoside (IPTG) 0.5 mM and
5' - bromo-l' -chloro-3' - indolyl ~-D-galactopyranoside (X-gal) 40 mg/l were included in the
media, respectively for gene induction and for detection of ~-galactosidase activity.
The liquid cultures were incubated in shaking conditions (200 rpm). Agar plates contained 15
gil no. I agar (Oxoid). All the media were sterilised by autoclaving or filtration.
Table 1. Bacterial strains used in this study
Strain Genotype/Characteristics Reference/Source
Escherichia coli:
DH5Cl F- endAl hsdRI7(rK- m,') supE44 thi-l A recAI gyrA96 [187]
relA I de oR .1. (lacZYA-argF)-U 169 cp80dlacZ.1.M15 .
S17-1 Apir : rec.A, thi, pro, hsdRl7 (r-. m,'), RP4-2-Tc::Mu-Km::Tn7, : [188]
i . . J Aplr . t -
: BL21(DE3)[pLysS} ,F-, ompT, hsdS" (ro-, m,,-), dem, gal, A(DE3), pLysS, Cm' I [189]
RVH-EI . sdiA mutant derived from MGI655 (FA· rph-I sdiA::KmR) , (190]
Pseduomonas - I . -. . - . . r
I jluorescens i
I CHAO . Wild type 11191]
I Pseudomonas
f aeruginosa: ,
r PAOI-N ; Wild type, Nottingham strain
i PAOI-L 1 Wild type, Lausanne strain
: PAOI-DSM I Wild type, DSM strain
Clinical isolates 1 Strain isolated from CF pediatric patients
I •
1,4,?,9,14,23,35~73t P. aerugtnosa . __
i PAKR02 I Mas/::GmR; mini-CTX::lasB-luxCDABE obtained with! This study
I pKR6 _
PAKR04 Wild type mini-CTX::rsmY-luxABCDE obtained with I This study
I
pKR77 .
PAKR08 1 !J.pqsAmi!li-CTX::rsmZ-luxABCJ~..§_ obtained with pSH50 L This study
I
PAKR09 . !J.pqsA; mini-CTX::rsmY-luxCDABE obtained with pKR77k
.r--PA-K-R2--]----+i PASKIO mini-CTX::rsmZ-luxABCDE obtained with. This·sWdY =-------i
I
r Laboratory collectionILaboratory collection
i Laboratory collection
infected . S. Cruz PhD thesis
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pSH50
I !1.wspF obtained by transposon insertion ofTn5, GmR
!1. gacA mini-CTX::rsmZ-luxABCDE obtained with pSH50
I Masl::GmR; mini-CTX::lasll-luxCDABE obtained with
pKR7
· Masl::GmR; mini-CTX::lasI3-1uxCDABE obtained with This study
I
I i pKR9
~~_~~Q_ !1.gacSmini-CTX::rsmZ-luxABCDE obtained with pSH50
! PAKR41 : !1.pqsE in framemutant obtained with pKR3
, PAKR42 !1.pqsEmini-CTX::rsmZ-luxABCDE obtained with pSH50
PAKR43 ' !1.gacS in frame mutant obtained with pKR I -
PAKR44 i MadS mini-CTX::rsmZ-luxABCDE obtained with pSH50
PAKR45 MadS in frame mutant obtained with pKR2
- R' _ -
PAKR46 !1.lasl::Gm; mini-CTX::lasI2-1uxCDABE obtained with
; pKR8
I Masl::GmR; mini-CTX::lasI4-luxCDABE obtained with This study
_I pKRIO . . ._j .
· Spqsi: mini-CTX::rsmZ-luxABCDE obtained with pSH50 This study
I Swspl" mini-CTX::rsmZ-luxCDABE fusion, obtained with I This study
I
pSH50 and PAKR26
t !1.aguR in frame mutant obtained with pKR51 I This study
, 4relSin frame mutant obtained wit_hpKR4 I This study
MelS mini-CTX::rsmZ-luxABCDE obtained with pSH50 This study
: \vi'ld type mini-CTX::rsmZ'-luxABCDE altered lux-box; This study
: obtained with pKR5
· !1.pqsRin frame mutant obtained with pCPI • This study
!1.aguR mini-CTX::rsmZ-luxCDABE fusion, obtained with This study
I pSH50 and PAKR51
I Swspl" in frame mutant obtained with pKR57
· !1.gacAin frame mutant obtained with pME6111 ,SpR SmR
: !1.pqsA mini-CTX::lecA-luxCDABE fusion at the + 1
I transcriptionalstarting site, obtained with pMM42
'!1.pqsE mini-CTX::lecA-luxCDABE fusion at the +1 This study
i transcriptional starting site, obtained with prytM42
Spqslc mini-CTX::lecA-luxCDABE fusion at the +1 This study
i transcriptional starting site, obtained with pMM42
1 !1.pqsAI!1.pqsRmini-CTX::lecA-luxCDABE fusion at the +1 This study
; _transcrip~i(mal starting site, obtained with pMM42
· !1.pqsAI!1.pqsEmini-CTX::lecA-luxCDABE fusion at the +1 This study
transcriptional s_!arting site, obtained with pMM4~ _
i !1.rhlR mini-CTX::lecA-luxCDABE fusion at the +1 This study
I transcriptional starting site, obtained with p:MM42
r !1.1asl::GmR; mini-CTX::las/5-1uxCDABE obtained with This study
I pKR66
i.tasi·:GmR; mini-CTX::lasI6-1uxCDABE obtained with I This study
I (lKR67
r S.pqsE mini-CTX::lecA-luxCDABE fusion at the 18" codon This study
: obtained with _pCP2
: MasR::Gmll; mini-CTX::rsmZ-luxCDABE obtained with This study
! pSH50
· Srhlk; mini-CTX::rsmZ-luxC;DABE obtained with p~H50 . This study
· !1.phzl/phz2 mini-CTX::rsmZ-luxCDABE fusion, obtained This study
I with pSH50 and PAKR82IDouble6.phziiphz2 mut~nt unable to produce phenazines, : This study
obtained with pKR23 and pKR24 I1 - . -. _,
PAKR83 I MhlR mini-CTX::lecA-luxCDABE fusion at the 18" codon I This study
'--- __ . J_ obtained wit~CP~_ _ _
PAKR26
PAKR29
PAKR38
, PAKR39
I
i PAKR47
PAKR48
PAKR50
PAKR51
PAKR52
PAKR53
i PAKR54
I PAKR55
I PAKR56
PAKR57
PAKR59
I PAKR60
PAKR61
PAKR62
: PAKR63
PAKR64
PAKR65
PAKR66
-
PAKR67
I
_
PAKR68
PAKR74
, PAK:R75
I PAKR76
i PAKR82
This study
This study
This study
This study_____ _ _
· This study
· This study
This study
This study
This study
This study
I This study
· This study
This study
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Spqs A it1 frame mutant
'p"" -rsmA; rsmA constitutively expressed from the
chromosome
lac]", P,~-rsmA; inducible rsmA, (SmR/SpR) S. Kehune PhD thesis
Wild type mini-CTX::rsmZ-luxABCDE obtained with This study
pSH50
: lacls, P",-PA2567; inducible PA2567, (SmR/SpR) obtained
j with the pSH 10 suicide vector
lecA::luxCDABE fusion at the 73" codon
, Wild type mini-CTX::lecA-luxCDABE fusion at the
I codon obtained with pCP2
: Triple Masl::GmR./rhll::TcR/pqsA mutant obtained from C. Pustelny PhD thesis
the double ~pqsA lasl: :Gm" and with pSB224.12B
Double ~pqsA Slasl mutant, obtained from ~pqsA and C. Pustelny PhD thesis
pSB219.8
I MhlR in frame mutant . C. Pustelny PhD thesis
[-
: Wild type mini-CTX::lecA-luxCDABE fusion at the +1 . This study
, transcriptional starting ~ite, obtained with pMM42 .
i ~jleQ mini-CTX::rsmZ-luxCDABE obtained with pSH50 M. Messina PhD thesis
land pMM58
Unless otherwise stated all the P. aeruginosa strains that were used and generated in this study derive from
P. aeruginosa PAGI Nottingham strain.
PAKR84
PAKR85
PAKR86
PAKR87
PAKR88
PAKR89
PAKR94
--_-
i PAKRIOI
I
PAKRI02
PACPIO
I Arhl]
PASDP233
PASDPI23
I PASK09
PASKIO
PASH50
PASH51
PAOllecA-lux
PACP2
I
i PACP3D
PACP04
~ PACP05
PAMM84
PAMM94
~pqsA/~pqsR mini-CTX::lecA-luxCDABE fusion at the This study
18" codon obtained with pCP2
~pqsA/~pqsE mini-CTX::lecA-luxCDABE fusion at the This study
18'"codon obtained with pCP2
~pqsA/~rhIR mini-CTX::lecA-luxCDABE fusion at the 18" This study
codon obtained with pCP2
. ~pqsA/~rhIR mini-CTX::lecA-luxCDABE fusion at the +1 This study
transcriptional starting site, obtained with pMM42
~pqsA mini-CTX::lecA-luxCDABE fusion at the 18'"codon This study
obtained with pCP2
, flpqsR mini-CTX::lecA-luxCDABE fusion at the 18" codon ' This study
obtained with pCP2
las I: :GmR mutant, obtained with pSB219.8 This study
flpqsA Srsms' double deletion mutant obtained with flpqsA i This Stu-dy----
and pME3087 Srsmr
i flpqsA MsmZ double deletion mutant obtained with ~pqsA ; This study
and pME3332 flrsmZ
flrhlR in frame mutant , C. Pustelny PhD thesis
, rhll: :TcR. mutant (P. aeruginosa strain from Beatson : [192]
: laboratory strain col!ec!ion)
, R
lasR::Gm mutant S. Diggle
[193]
S. Kehune PhD thesis
: M. Messina PhD thesis
I
I
I [194]
18'" , This study
Table 2. Plasm ids used in this study
Plasm ids ; Characteristics Reference/Source
pBLS .~ pBluescript-IT KS (+) cloning vector; ColE I replicon , (Stratagene)
I pET28(b)+ Plasmid for the overexpression of proteins I (Novagen)
pUC6S ' Clonig vector; ColEl repli<?_on. ' [195J
! pLM) . ~ Mlni-Tn5 delivery vector, GIl1R,orNB.§K, onTRP4 - i [196]
: pET AguR I Vector derived from pET28 (b)+ for the overexpression of ! This study
. AguR 6-His (Ndel/HindlI/)_
I pDM4 ' Suicide vector, sacBR, oriR6K, Cm' I [197]
: pHKJ~S I . Mini-CTX::lux delivery vector, Tc- [198}
,-.l:.p:c.:FL::::P:_:2~ _l1_:M=o:::..:bi:.:.:1ic=_za=ble broad-host-range p:...::la=s::.:m:...::id=--J:.:pr:..=o..:...v:.:::idc:.ci~=g__fJp jJ 199]__
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recombinase, ApR
pKRI pDM4::,1gacS, for gacS in-frame deletion, made with This study
_______ ~~~rimersCmR- ~ ~ _
pKR2 pDM4::MadS, for ladS in-frame deletion, made with This study
LADS primers Cm"
pKR3 ' pDM4::,1pqsE, for pqsE in-frame deletion, made with I This study
~ ._~ __ I PQSE primers CmR _~ . ~
pKR4 pDM4::MefS, for refS in-frame deletion, made with RETS This study
. C Iprimers m"
pKR5A ' Derived from pBLS containing the promoter of rsmZ* This study
I (mutated in the lux-box) obtained using the primers
i PRSMZ2 and pSH50A
, pKR5 pHKBSl ::P".z'(mini-CTX::rsmZ·-luxCDABE), This study
, replacement of the 66-bp Hindlll-Pstl fragment of pSH50 i
, with annealed PRSMZ2 oligonucleotides. Substituted lux ,
! box
pKR6
I pKR7
I pKR8
I pKR9
I pKRlO
I pKRI4
pKRI7
I
pKRI8
!pKR19
I
, pKR20
f -
pKR23
~ pK.R24
I
}
! pKR51
: pKR57
r
; pK.R66
I
pKR67
I
I pKR69
I
, pKR70
I
i pKR71
I
: pKR72
r pKR73
~.PKR77
-
and r This studymini::CTX-Iux PlasB-lux derived from pHKBSI
: oligos PlasB !
mini::CTX-Iux P/asll-Iux derived from pHKBSI and I This study
oligos Plasl I
-
I mini::CTX-lux P/asl2-lux derived from pHKBSI and , This study
I oligos PlasI2
, mini::CTX-Iux PlasJ3-lux derived from pHKBSl and This study
oligos PlasI3
: mini::CTX-Iux Plasl4-lux derived from pHKBSI and This study
, oligos J_>lasI4
i pME6032::aguR obtained using AGUR primers This study
, pBLS containing rhlR (EcoRI/ClaI) obtained with RHLR ' This Study
I •
I prtmers
I pME6032 containing rhlR (EcoRI/Clar) derived from i This Study
, pKR17 and rsmZ::/uxCDABE from pSH50
[pME6032 containing rhlR (EcoRVClaI) derived from ; This Study
I pKRI7 and rsmZ'::luxCDABE (Xbal) derived from pKR5
; pME§032- containing rhlR (EcoRTIClal) , This Study
, pDM4::,1phz/, for phzlAG in-frame deletion Cm", made' This Study
[ with PHZl primers
I pDM4::,1phz2, for phz2AG in-frame deletion Cm", made! This StudyI with PHZ2 primers _ f
: pDM4::t.aguR, for aguR in-frame deletion Cm", made' This study
wjth AGUR primers . +
I pDM4::,1wspF, for wspF in-frame deletion Cm', made: This study
: with WSPF primers I
! mini-CTX-lux PlasI5-lux derived from pHKBS I and This study
i oligos PlasIlFW and Plasl2RV
I mini-CTX-lux PlasI6::lux derived from pHKBS 1and ' This study
, oligos PlasI4FW and PlasllRV
, Chromosomal Sau3Af fragment containing lasR cloned in I This study
I pME6000
I Chromosomal Sau3AI fragment containing rhlR cloned in i This Study
I pME6000
I Chromosomal Sau3AI fragment containing up! cloned in I This study
I pME<?_OOO ,
~pME6032 containing the third ORF of the up! 3.1 kb I This study
: fragment, and oligos UPF3 !
I
I pME6032 containing the second ORF of the up! 3.1 kb I This study
, fragment, and oligos UPF2
I mini-CTX-Iux PrsmY-lux derived from HKBSI and I This stu<b'_ _
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· oligos PrsmY .
pME6000, containing the first ORF of upf s.) kb fragment I This study
derived from_pKR71 __ . __ __ _ ~ _
· pME6000, containing the second and third ORFs of up! This study
3.1 kb fragment derived from pKR71
pME6000, containing the first and second ORFs of upf s.) t This study
___ kb fragment derived from pKR 7L _
pKR81 ---~ pME6000, containing the first and third ORFs of up! 3.1 This study
1 kb fragment derived from pKR 71 ,
pDM4::.1pqsR, for pqsR in frame deletion, Cm", made with : [113]
~__ oligos PQSR
pHKBSI ::P',eA (mini-CTX::lecA""
obtained with oligos PLECA 18
· pRIC380 suicide vector carrying lasl: :Tc' for construction [192]
of las! mutants
· pRIC380 suicide vector carrying rhl::TcR for construction [192]
of rhll mutants I
pSH50A -----" pB-LS containing the promOte;:-;eg-ion of rsmZ using-ol19c;s-r-This study - ----- "
PRSMZI
pME6032 containing the coding region for PA2567 using; This study
oligos PA2567START and PA2567H6 i
pUC6S containing the PA2567 coding region under the' This study
control of Ptac and the laclQ. Derived from pSH5
· pSH8 in which lOO bp up-stream from PA2567 coding This study
region was cloned
I pDM4 and pSH9 to construct the inducible PA2567 strain _ This study
mini-CTX::lux PrsmZ-Iux obtained with oligos PrsmZ . This study
i pMM45 containing the promoter of rsmZCIIAOand the leader i Q. WUMSc dissertation
sequence of aprAcllAo
Vector for the overexpression of RsmA derived from S. Kehune PhD thesis
I pME6031
I HindJIIIXhoT fragment of pME6013 containing 'lacZ i M. Messina PhD thesis
i cloned in pME6031 digested with HindlIl/Sall, Tc' I
· Synthetic constitutive 44-bp Pkmpro meter made with M. Messina PhD thesis
PKMFW and PKMRV inserted with Xhof and EcoRI in '
I pMMO. Reporter vector for translation control analysis TCR[
I pME6000 carrying the PA2S67 gene . j M. Messina PhD thesis
,£CoRlICla! fragment of pME6016 containing 'lacZ M. Messina PhD thesis
(including RBS) cloned in pMMI digested with the same!
I enzymes, Tc' i
I pHKBSI ::PlecA (mini-CTX::lecAC)-luxCDABE) made [ M. Messina PhD thesis
, with PLECA Iprimers, Tc' ,
j
PKm-iecA'-'cherry reporter plasmid. Synthetic 80-bp lecA i M. Messina PhD thesis
i RBS inserted in pMM45. Reports translation from lecA i
I RBS, re- .
P.m-lecA'-'lacZ reporter plasmid. Synthetic 80-bp lecA RBS I M. Messina PhD thesis
made with PLECAFWH and PLECAR VII inserted in
1 pMMI. Reports translation from lecA RBS, re- l
I pME6032 containing the DsRedE2 red cherry gene . M. Messina PhD thesis
, pDM4::.1jleQ, for the jleQ in frame deletion, made with M. Messina PhD thesis
I WSP_f primers Cm' _i
1 p'VS I-p 15A shuttle vector for translational lacZ fusions, : [200]
I Tc' 1I - - --I
· PVS l-p ISA shuttle vector for transcriptional lacZ fusions, [20 I]
Tc' 1
r pME6031 I pVS l-pl5A shuttle vector, Tc' t [20Q]
_pME=-=6_::_0;::_:32=--__ -'-, -'pVSI::.e.11Ashuttle ex ression vector, TcR [202]
pKR78
pKR79
pKR80
pCPI
pCP2
pSB219.8
pSB224.12B
pSHS
I pSH8
pSH9
I
pSH10
pSH50
1 pMW02
l
pSK61
I pMMO
pMMI
pMM-BIO
pMMII
i
I pMM42
I pMM43
I
pMM44
pMM45
I pMM58
,
! pME6013
I
pME6016
".d~.t-IuxCDABE), This study
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pME6111 ColEI suicide plasmid for gaeA::D.Sm/Sp mutation, Tc' [147]
Sm'/Sp'
Table 3. Oligonucleotides primer sequence
Oligon ucleotides
PlasBFW
PlasBRV
Plas/l FW
PlasI1 RV
Plas/2FW
PlasnRV
Plas/3FW
Plas/4FW
PHZIFWI
PHZIRVI
PHZIFW2
PHZIRV2
PHZ2FWI
PHZ2RVI
PHZ2FW2
PHZ2RV2
UPF2FW
UPF2RV
UPF3FW
UPF3RV
WSPFFWI
WSPFRVI
WSPFFW2
WSPFRV2
GA SFWI
GACSFW2
GA SRYI
GA SRV2
LAD FWI
LAOSFW2
LAOSRVI
LAD RV2
LUX -RV
PQ EFWI
POSEFW2
PO RVI
PQ RV2
PO RFWI
PQSRFW2
POSRRVI
PQ RRV2
PRSMYIFW
PR MYIRV
PR MZIFW
PRSMZIRV
Sequence 5'-3'
TGGCCCAAGCTTACCGTGCG
ACCCAGGATCCCAACGAACAAC
ATAAAGCTTTCTGTGTGAAGCCATTGCTCTGA
ATAGGATCCCTCCAAATAGGAAGCTGAAGAATT
ATAAAGCTTGCCCGGAAGGCCATGTTTT
ATAGGATCCAACTCTTCGCGCCGACCAA
ATAAAGCTTCAGAAAGTTTCCTGGCTTTCCCG
ATAAAGCTTGTGCGGGTGGCCTTTGCC
TATAAGCTTCCTGTTCCAGAGCCTTTTCCT G
TAT GAATTC CTG ACC GTT CAT GCG CCG
TAT GAATTC CTG CAA CCG TGA CGA CAC
TATTCTAGAGACCATACCGTGGCGCC
TATTCTAGACATCGGCCTGCTCAACTG
TATCTGCAGGTACTCTCGCATGGTGCG
TATCTGCAGCAACCGTGACGACACCGC
TATGATATCGTTGCCGGAACAAGCCCT
TATGAATTCATGAATGTGAACTTAGAGAACG
TATCTCGAGTCAGTCATCCTTGATGGGGAAA
TATGAATTCATGAGCACAATACCAGACCG
TATCTCGAGTCATAAGTTTATCTCCGGATG
ATATCTAGACTGGACGACGGTTCGCCG
ATAGGATCCTCCGATCCTCAACCCTGTG
ATAGGATCCTTCGATTAGCCGGGTTCGAC
ATAAAGCTTCGCCACCAGCTCGATGGC
ATAAAGCTTATCGTCGGCGCCCTGGC
ATAGGATCCGAACTCTGACCATGCGCATC
ATAGGATCCTCCTTGAACACACGTCTCTC
ATATCTAGAGAAGCCGGCCATGATGCG
TATAAGCTTTCGGCCACCGTGTCGACC
TATGAATTCGCCTGAAGCCGTTCCGCG
TATGAATTCCCAGTGCCGCATGATGCC
TATTCTAGAAAGATTTCCGCCGCCAGCT
TCGGGAAAGATTTCAACCTGGC
ATAAAGCTTGCCGGCGAGAGTCTCGAA
ATAGGATCCCTGGACTGAGACGGGACAT
A'rAGGATCCAAGCCTCAACATGGCCGGT
ATATCTAGAAGGCTGGACAGGCCATGC
ATAAAGCTTTCTTAGAACCGTTCCTGG
ATAGGATCCAGAGTAGAGCGTTCTCCA
ATAGGATCCAGGTTATGAATAGGCATC
ATATCTAGAAGTTCTGCCTGCTCGGCG
TATCTCGAGGGCGCCCTTGTCGAGGTT
TATCTGCAGCGGTTTGAAGATTACGCATCT
TATCTCGAGGGAAAACCTTAGACCCACTGA
TATCTGCAGGCAGGAGTGATATTAGCGATTC
-
Description
Forward lasB,250bpUS+ IHind"l
Reverse PlasB,250bpUS+1 BamHI
Forward Plasll & Plas/5, Hind"l
Reverse PJasll and PJas/6, Hind!!!
Forward PJasl2, HindI"
Reverse Plas/2,P/as/3, P/asI4&P/as/5,
Hind"!
Forward Plas13, Hind III
Forward Plasl4 & Plas/6, HindI II
Forward 0.5 kbUSphzlAG, Hind"!
Reverse US phz!AG, EeaR!
Forward 0.5 kb OS phz!AG,EeaRI
Reverse US phz!AG, Xbal
Forward 0.5 kb US phz2AG, Xbal
Reverse US phz2AC, Pstl
Forward 0.5 kb OS phz2AG, PSII
Reverse US phz2AG, EeoRY
Forward upfORF2 EeaRI
Reverse upfORF2 Xhal
Forward upfORF3 EeaRI
Reverse upfORF3 Xhol
Forward 0.5 kb US wspF, Xbal
Reverse US wspF, BamH!
Forward 0.5 kb OS wspF, BamH I
Reverse US wspF, HindI II
Forward 0.5 kb US gaeS, Hind"l
Forward OS goes, BamHl
Reverse US goeS, Bam H!
Forward 0.5 kb US ladS, Hind" I
Forward 0.5 kb US ladS, Hind" I
Forward OS ladS. EeoRI
Reverse US ladS, £CaRl
Reverse 0.5 kb OS ladS, Xbal
luxe reverse sequencing primer
Forward 0.5 kb U pqs£; Hind"l
Forward OS pqsE, BamHI
Reverse US pqsE, BamHI
Reverse 0.5 kb OS pqsE, Xbal
Forward 0.5 kb U pqsR; Hind"l
Forward OS pqsR, BamHI
Reverse US pqsk, BamHI
Reverse 0.5 kb OS pqsR, Xbal
Forward rsm Ypromoter, Xhol site at - 27
from the + I starting site
Reverse rsmYpromoter, Pstl site at 6
from the + I starting site
Forward rsmZ promoter, Xhol site at -250
from the + I starting site
Rever e rsmZ promoter, Pst) site at 2
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PRSMZ2FW
I PRSMZ2RV
PKMFW
PKMRV
I
~----
PLECAI8FW
PLECAI8RV
PLECAFWI
PLECARVI
PLECAFWII
I PLECARVII
RHLRFW
RHLRRV
I PRSMZCHAOF
PRSMZCHAOR
I APRAF
I
I
[ APRAR
AGURFW
r AGURRV
I AGURFWI
I AGURRVI
i AGURFW2
I AGURRV2
FLEQFWI
FLEQRVI
FL~QFW~
FLEQRV2 __
PLECARBSFW
PLECARBSRV
,AGCTTCGTAGGGTTTTCTGGCGTGTTGCGGGAGC
ACTGGGAATCGCTAATATCACTCCTGCCTGCA
GGCAGGAGTGATATTAGCGATTCCCAGTGCTCCC
GCAACACGCCAGAAAACCCTACG~
TCGAGCCGGAATTGCCAGCTGGGGCGCCCTCTGG
TAAGGTTGGG
from the + I starting site
Forward rsmZ promoter, anneals
PRSMZ2RV forming HindllI - (natural)
I and Pstl-compatible ends.
: Reverse rsmZ promoter, anneals I
I PRSMZ2FW forming Pstl - and HindlTl -
, compatible ends
Forward Km promoter, anneals PKMRV
forming Xhol- and EeoRI-compatible
ends
Reverse Km promoter, anneals PKMFW
forming EcoRI- and Xhol-compatible
I
____ j-, .:_:en.:_:.d:s __ . ._ _;
ATACTCGAGCCGGTTCGACCCCGGCTC i Forward leeA, Xhol, -373 from +1
I transcriptional starting site
I Reverse leeA, BamHI, +54 from + I
transcriptional starting site
Forward lecA promoter, XhoI site at
: position -345 from + I transcriptional
: starting site
I . .
I Reverse [ecA promoter, EeoRI site at
: position +2 from + I transcriptional
I starting site
I Forward lecA RBS, anneals PLECARV
forming EeoRI - and HindIIl -compatible
, ends
I Reverse lecA RBS, anneals PLECAFW
forming HindTll - and EcoRl-compatible
ends
Forward rhlR
Reverse rhlR
I Forward for amplification of rsmZ
, promoter from CHAO
Reverse for amplification of rsmZ
, promoter from CHAO, EeoRI
Oligo aprACIIAOleader sequence anneals
APRACHA02 forming EcoRI - and
HindIIl -compatible ends _
Oligo aprAclI'lOleader sequence anneals
I APRACHAOI forming EeoRI- and
HindIlI -compatible ends
Forward for the overexpression of AguR,
! EcoRI
, Reverse for the overexpression of AguR,
I XhoI.
I Forward 0.5 kb US aguR; Hin<!III
, Revers·e US aguR; BamHI
Forward 0.5 kb DS aguR; BamHI
I .
, Reverse DS aguR; XbaI
, Forward 0.5 kb USjleQ, XbaI
Reverse 0.5 kb USjleQ, EeoRI
Forward 0.5 kb DSjleQ, EeoRi
Reveise_-O.5 kb -DSjleQ. SpeJ.
Forward lecA RBS, anneals PLECARV
, forming EeoR}/ HindIIl compatible ends
,
AATTCCCAACCTTACCAGAGGGCGCCCCAGCTGG
CAATTCCGGC
TATGGATCCCGACGTTACCTGCCCTGC
ATACTCGAGTTGTGTTTCCTGGCGTTCAG
:ATAGAATTCCCTGTTAGCAAAGCACAG
AATTCGAAGGATCGCGAATCAGGGTTTTTCGCCT
CTTTCGTTTATGAACAGGATTCATATATCGGAGA
TCAATCATGGC
AGCTGCCATGATTGATCTCCGATATATGAATTCC
I TGTTCATAAACGAAAGAGGCGAAAAACCCTGATT
,CGCGATCCTTCG
IATAGAATTCATGAGGAATGACGGAGGCTT
I ATAATCGATTCAGATGAGACCCAGCGC
:AGCAGCACCCTTGAAGATGT
TATGAATTCACAGGGCTGATATTAGAGAGTTC
1 AATTCCTGTTCCATTGATTACAAGGAAGTGTGTT
I TATGG~
i
I~GACAAGGTAACTAATGTTCCTTCACACAAATAC
CTTCGA
I ATAGAATTCATGCAGCCCACCTCGCC
,ATACTCGAGCTATCGATTTAAATCGGATATAT
- ..
ATAAAGCTTCTGCGCTACGTCGACAGC
ATAGGATCCGGGCTGCATGTGGCGGG
ATAGGATCCAATCGATAGAAAATCCATAACAC
r ATATCTAGATGCCGCCATCGGCGTCG
ITATTCTAGAATCGGTGAGCTGGATCAGG
! TATGAATTCCCACATTTTGATCAGCTGCC
TATGAATTCGATTGACAGGTCGTTTCGCA
- -
TATACTAGTTCGCGCGGAGCGAAGCAG
AATTCGAAGGATCGCGAATCAGGGTTTTTCGCCT
ICTTTCGTTTATGAACAGGATTCATATATCGGAGA
I
TCAATCATGGC
AGCTGCCATGATTGATCTCCGATATATGAATTCC Reverse [eeA RBS, anneals PLECAF~_---,
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TGTTCATAAACGAAAGAGGCGAAAAACCCTGATT forming Hindlll! EeaRI compatible end
CGCGATCCTTCG
PA2567START - TATGAATTCATGGCAACCCCACCCTATCC Forward for the cloning of PA2567;
EeaRI
PA2567H6 TATATCGATTCAGTGAGGTGATGGTGATGCGCCG Reverse for the cloning ofPA2567, six
CAGCCAGTCCTCC _ histidine ~ag; Xhal
Sequences in 5' to 3' order; artificial restriction sites are underlined; US and OS primers indicate the oligos used
to amplify the upstream and downstream region of the genes for in-frame mutation. All the primers were
synthesised and purchased by Sigma-Aldrich. AUS: Analysis Unit Services (University of Nottingham, UK).
2.2 DNA MANIPULATIONS
2.2.1 Rapid extraction of plasmid DNA
Rapid extraction of plasmid DNA was performed as described previously [203]. Strains were
grown in LB with the addition of appropriate selective antibiotics for 10-12 hrs at 37°C in
shaking conditions. Afterwards 1.5 ml of bacterial cultures were centrifuged at 12,000 rpm for
3 min at room temperature (RT), and the bacterial pellet was resuspended in 200 III of STET
buffer (sucrose 8% w/v, Triton x-ioo 0.1% v/v, EDTA 50 mM, Tris-HC150 mM [PH 8.0]).
After addition of 4 III of lysozyme (50 mg/ml) the samples were incubated for 5 min at RT.
The samples were then boiled for 45 secs and centrifuged at RT for lO min at 13,000 rpm.
The pellet was removed and 8 III of CTAB (5% [w/v]) (Sigma) was added to the supernatant.
The samples were then centrifuged 10 min at 14,000 rmp and the resulted precipitate was
resuspended in 300 III of NaC] 1.2 M. The DNA was precipitated using 600 III of ethanol
95%, and then washed with I ml of ethanol 70%. Finally, the DNA was resuspended in 20 III
ofHO containing RNAse A at a final concentration ofO.5 mg/ml [204].
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2.2.2 Total DNA extraction
Total DNA extraction was performed as described before [205]. Strains were grown in LB
with the addition of appropriate selective antibiotics for 10-12 hrs at 37°e in shaking
conditions. Afterwards, 1.5 ml of culture was centrifuged at 12,000 rpm for 3 min, and
washed with 1 ml of TE buffer (10 ml Tris [pH7.5], 2 ml NaEDTA 0.5 M in 800 ml HO).
The bacterial cells were finally resuspended in 400 J.lIof TE buffer. Then 50 J.lIof SDS 10%
[v/v], 50 J.lIof proteinase K (2.5 mg/ml) and 10 J.lIof RNAse A (10 mg/ml) were added and
the sample that was incubated at 37°e for 3 hrs. The dense cell lysate was passed through a
syringe five times with a needle, then extracted at least three times with
phenol:chloroform:isoamylic alcohol (25:24:1). This extraction procedure was followed by a
further extraction with water-cloramfenicol, DNA in the aqueous phase was precipitated using
1 ml of ethanol 95%, and then washed with 1 ml of ethanol 70%. Finally, DNA was
resuspended in 50 J.lIofHO [204].
2.2.3 Cloning procedures
Large-scale plasmid DNA extractions were performed using the Plasmid Midi kit (Qiagen), in
accordance with the manufacturer's specifications.
In order to identify and quantify specific DNA fragments, DNA derived from plasmids was
digested with appropriate restriction enzymes (Promega) and subsequently separated by
electrophoresis on agarose gell% (w/v) [204]. The DNA ladder 1 Kb (Promega) was used as
molecular weight marker. Restriction fragments were purified from agarose gels using the
QIAquick Gel Extraction kit (Qiagen), in accordance with the manufacturer's specifications.
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PCRs (~olymerase Chain Reactions) were performed with Taq polymerase (Promega),
following manufacturer's specifications. Nucleotides (Promega) and synthetic
oligonucleotides (Sigma) were utilized at the final concentration of 0.5 mM and 0.5 ~M,
respectively. PCR products were purified using the QIAquick PCR DNA Purification kit
(Qiagen), in accordance with the manufacturer's specifications.
Ligation reactions were performed with T4 DNA ligase (Promega) in accordance with
manufacturer's specifications.
Automated sequencing was performed by Biopolymer Synthesis for Analysis Unit Services
(University of Nottingham, UK).
2.3 PLASMID DNA TRANSFER: TRANSFORMATION AND CONJUGATION
In order to create electro-competent E. coli and P. aeruginosa PAO1 or P. fluorescens CHAO
cells, the strains were grown in LB for 10-12 hrs at 37°C in shaking conditions. Once reached
OD600of 2.5, the cultures were diluted 1:200 in 200 ml of LB and then incubated at 37°C in
shaking conditions for 6 hrs. After a centrifugation at 10,000 rpm for 10 min at 4°C the
bacterial pellets were washed twice with 40 ml of Buffer 1 (MOPS ImM [pH7.2], glycerol
10%v/v) and the resuspended in 1ml of Buffer 1. Aliquots of 50 ~l were stored at -SO°C.All
the solutions were pre-cooled before using and the cells were maintained on ice during the
whole procedure.
For transformation, 80-150 ng of DNA was added to the competent cells. These were then
electoporated and incubated at 37°C in shaking conditions for} hrs. Finally, the transformed
cells were grown on LB plates with the addition of the appropriate antibiotics.
When required, plasmid DNA was transferred in P. aeruginosa PAO} or P. fluorescens
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CHAO strains by conjugation. The donor and the recipient strains were grown in LB with the
addition of appropriate selective antibiotics for 10-12 hrs at 37°C in shaking conditions. 1.5
ml of each culture was centrifuged at 4000 rpm for 5 min. After two washes with LB the
strains were mixed together in a final volume equivalent to the volume of the bacterial pellet.
The mixed cells were transferred as a drop to the centre of a LB plate and incubated at 37°C
for 6 hrs. Finally the conjugation drop was resuspended in 1 ml of NaCI 0.9% [w/v] solution
and 200 ul of the bacterial suspension was spread into the selective plates.
2.4 PLASMID AND STRAIN CONSTRUCTION
2.4.1 Construction of suicide plasmid using the pDM4 vector
All the P. aeruginosa mutants constructed are derived from P. aeruginosa PAO-N laboratory
strain. For the in-frame deletions of gaeS, lads, rets; aguR, wspF, phzl, phz2, pqsE and pqsR
a common strategy was used. Upstream and downstream flanking regions were amplified by
PCR from PAO} chromosomal DNA using the oligonucleotides described in Table 3. The
500 bp products for the up and downstream sequence were cloned separately into pBLS and
verified by sequencencing. Then, the up and downstream fragments were ligated into the
pDM4 suicide vector (XbaIlXhoI).
2.4.2 Construction of inducible PA2567 strain
The suicide plasmid pSH}O to introduce the inducible laeP Ptac promoter locus immediately
upstream of PA2567 in the chromosome was constructed in several steps. Firstly, a PCR
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product corresponding to a 0.5 kb region upstream of PA2567 was amplified from PAot
chromosomal DNA using the primers PA2567UF and PA2567Dt and cloned in pBLS as a
0.54 kb Spel-Sali fragment to produce pSHl. This construct was verified by sequencing.
Secondly, the PA2567 open reading frame was amplified from PAOt chromosomal DNA by
peR using the primers PA2567START and PA2567H6. Due to the presence of two natural
EcoRI sites downstream of a central BamHI site in PA2567, the 1.78-kb peR fragment was
digested separately with EcoRI and BamHI and with BamHI and ClaI to produce two moieties
ofO.83 and 0.95 kb respectively. The two moieties were then inserted in a triple ligation into
pME6032 digested with EcoRI and ClaI, to produce pSH5. The resulting 2.4 kb BamHI
fragment of pSH5 was then subcloned in pUC6S digested with BgnI in the NotI-KpnI-
[BgnIIBamHI]-la&-P ...-PA2567- [BamHIIBgnI] orientation to produce pSH8. The 0.54 kb
NotI-KpnI fragment ofpSHl was then subcloned in pSH8 digested with these same enzymes
to produce pHS9. Finally, the 2.9 kb SpeI fragment of pHS9 carrying PA2567-'lacQ-P ...-
'PA2567 was subcloned into pDM4 digested with the same enzymes to produce pSHlO.
Allelic replacement in the chromosome using pSH l0 allowed the construction of
P. aeruginosa strains inwhich the expression ofPA2567 could be induced by IPTO.
2.4.3 Construction of chromosomal lux-based transcriptional fusions
Transcriptional chromosomal rsmY-Iux, rsmZ-Iux, lasll-lux, lasll-Iux, lasI2-lux, Iasls-lux,
lasts-lux, lasI5-1ux, lasI6-1ux, lecA18codon-lux and lecs-s-lux fusions were constructed as
follows: the promoter regions were amplified from P. aeruginosa PAD1 genomic DNA by
peR using primers listed in Table 3. Each amplicon was digested with appropriate restriction
enzymes and cloned into pHKBSl digested with the same enzymes, in E. coli S17-1A.pir.
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After verifying the inserts by sequencing with primer LUXCRV, the resulting plasm ids were
mobilized by conjugation into the recipient wild type P. aeruginosa PAOI-N or its mutant
derivatives (Table 1). The integration of the mini CTX::lux promoter fusion-lux in the
chromosomes of the recipient strains, was revealed by Tc resistance and bioluminescence.
The luminescence phenotype was detected with a Luminograph LB980 photon video camera
(EG&G Berthold). When required, the Tc resistance marker was excised from the
chromosomes of the reporter strains by mobilizing pFLP2 followed by plasmid curing as
previously described [199].
2.4.4 Construction of PrsmZ*-lux transcriptional fusion
The promoter of rsm'Z" mutated in the lux-box region was constructed by self-annealing of
two oligos PRSMZ2FW and PRSMZ2RV which anneal forming a HindIII (natural) and PstI
compatible ends. The vector containing the natural PrsmZ fragment (PSH50A) was digested
with PstIlHindIII (thus eliminating the 62 bp region) and ligated with the annealed
oligonucleotides containing the mutated lux-box from the rsmZ promoter. The new construct
pKR5A was then digested with XhoVPstI and cloned into the mini CTX::lux vector (PHKSl)
giving rise to pKR5.
2.4.5 Construction of up/fragments derived from pKR71
For the generation ofpKR78, pKR71 was digested with HindIIIIAcn and the resulting 618 bp
fragment (containing ORFl) was subcloned into pBlueScript (PBLS) plasmid previously
digested by HindIIl/Clal (Clal and Acn generate compatible sticky ends). The resulting
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vector was then digested with SacIlXhoI and the fragment was inserted into pME6000
digested with the same restriction enzymes.
For the generation ofpKR80. pKR71 was digested by HindIII/ScaIINolI and the resulting 2.4
Kb fragment (containing ORFI and ORF2) was cloned into pME6000 previously digested
with HindIIIIEcoRV.
For the generation of pKR79. pKR71 was digested with AcnlNotI and the resulting 2.6 Kb
fragment (containing ORF2 and ORF3) was inserted into pBLS previously digested with
No/I/Cla!. The resulting vector was then digested with SacI/XhoI and the fragment inserted
into pME6000 digested with the same restriction enzymes.
For the generation of pKR8l. pKR71 was digested with MscI/PvuII (blunt ends were
generated) and the plasmid (containing ORFI and ORF3) was re-ligated.
2.4.6 Construction of double transcriptional-translational P. fluorescens CHAO
reporter
The double transcriptional-translational DsRedE2 reporter was constructed using the rsmZ
promoter amplified from P. fluorescens CHAO and cloned (XhoI/ EcoRI) into the pMM45
vector already containing the DsRedE2 fluorescent protein gene. The annealing of the
oligonucleotides of the leader sequence of the aprsooo, was carried out by a semi-cycle PCR
reaction. The oligos were diluted to a concentration of 100 nM and mixed. the starting
temperature was of 95 QC for 30 seconds. and then lowered at 0.05 cC per second until
reaching 4 "C, This resulted in the annealing of the two oligos and the formation of double-
stranded DNA having compatible extremities with EcoRI and HindIII. The leader sequence
was then inserted in pMM4S digested with EcoRI and Hint/III by ligation. resulting in the
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plasmid pMW02 that was then transformed into P. jluorescens.
2.4.7 Construction of pKR18 and pKR19
The plasmids pKRI8 and pKRI9 were constructed for the overexpression of rhlR in the
heterologous E. coli system. These plasmids are derived from pME6032. The rhlR gene is
under the regulation of the inducible Ptac promoter. The luxABCDE has also been inserted into
the plasmid and it is under the regulation of the rsmZ ptomoter (PKR18) or the rsmZ· promoter
(PKR19). The coding region of rhlR was amplified with the RHLR primers and subcloned
into pBS giving rise to the pKR17 vector. Once the sequences was checked by sequencing
analysis, rhlR was cloned into pME6032 (PKR20) with EcoRIlClal.
To construct pKR18, the rsmZ-lux fusion (comprising the promoter of rsmZ fused with the
luxCDABE operon) was excided with XbaI from pSH50 and inserted into pKR20.
In the case ofpKRl9, the PrsmZ*-lux fusion (comprising the promoter ofrsmZmutated in the
lux-box fused with the luxCDABE operon) was excided with XbaI from pKR5 and cloned into
pKR20.
2.4.8 Construction of translational fusions
Translational fusions based on 'lacZ under the control of a constitutive promoter PKm were
. constructed. In brief the 'lacZ gene truncated at the 8th codon was inserted into the vector
pME6031, generating plasmid pMMO (Tab. 2). A synthetic Km promoter was inserted
upstream of in pMMO, generating the vector pMMI. Finally the synthetic RBS (Ribosome
Binding S.ites) was inserted generating the post-transcirptional fusion PKm-lecA'RBs-'lacZ,
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generating pMM44 (M. Messina PhD thesis for details).
The PKm-lacZRBs'-'lacZ was constructed by exchanging the lecA 'RBS- 'lacZ sequence with the
lacZ'RBs-'lacZ sequence, generating pMMll (M. Messina PhD thesis for details).
2.5 GENERATION AND ANALYSIS OF THE GENETIC BANK AND THE TRANSPOSON LIBRARY
The genetic bank was generated using the PAOI-L strain chromosomal DNA. The reason is
that the PAOI-N strain was found to have a 50 Kb deletion in its chromosome (S. Heeb
personal communication). Random 2-4 Kb DNA fragments of the PAOI-L chromosome
partially digested by sau3A-l were cloned in pME6000, previously linearised by BamHI and
treated with alkaline phosphatase to avoid the plasmid re-ligating into itself. The product of
the ligation was used to transform P. aeruginosa PAOI-N rsmZ-lux (PASH50).
The genetic bank strains were screened by using autoclaved toothpicks to transfer colonies
from the selective plates onto the LB agar plates at a density of 50 colonies per plate. The
plates were incubated for 10-12 hrs at 37°C. As control the strain PASH50 with the empty
pME6000 vector, was used. The clones were then analysed under the light camera, clones
which produced a stronger or weaker light signal, were retested individually in new plates.
Once identified a clone of interest, the plasmid was extracted and sequenced using the oligos
PtacIP6032 (Tab. 3).
The transposon mutagenesis library was obtained by introducing the transposon Mini-Tn5
delivery vector pLMl into the recipient strain P. aeruginosa PASH50 (rsmZ-lux).
The transposon mutants were screened as for the genetic bank derived clones as a negative
control the PASHSO strain was used. Once identified a particular clone, to identify which
gene was the one interrupted by the transposon the following strategy was carried out. The
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chromosome of the interesting clones was extracted and digested (5 J.lI of the extracted
chromosome in 50 digestion mix) with BamHI. The chromosomal DNA was then relegated
using the T4 Ligase enzyme (Promega) generating plasmids able to replicate in E. coli (ori
contained in the transposon fragment). The plasmids, containing part of the interrupted gene
of interest were then transformed in E. coli S 17.1 Xpir. The plasmid was then extracted and
sequenced using the oligos 13.2 and 17-1 (Tab. 3).
2.6 PURIFICATION OF AGuR SDS-PAGE ANALYSIS AND EMSA
To purify AguR, aguR gene was amplified by PCR with primers FWaguR and RVaguR from
genomic DNA of the P. aeruginosa PAOI-N strain. The resulting PCR product was digested
with NdeIlHindIII and cloned into similarly digested pET28b(+) (Novagen), resulting in the
plasmid pET aguR, which was verified by sequence analysis. In this plasmid the aguR gene
was fused to a 6xHis tag at its N-terminus. The pETaguR plasmid was introduced into E. coli
BL21(DE3)pLysS strain by electroporation.
E. coli BL21(DE3)[pLysS] strain carrying pETaguR was grown over-night at 37° C in
shaking conditions in LB supplemented with Km 25 mg/l, Cm 30mg/l and glucose 1% (w/v).
The overnight culture was diluted 1:1000 in 600 ml of LB supplemented Cm 30 mg/ml, Km
25 mg/ml and glucose 0.2% (w/v). Cultures were then grown at 37° C in shaking conditions to
OD600 = 0.6. At this point, 2 ml aliquots of the non induced cultures were centrifuged and
stored at -20° C, as a control. At this stage AguR expression was induced with 1 mM IPTG
and 1mM agmatine (the natural ligand of AguR). After additional incubating for an overnight
at 37°C two aliquots of 2 and 6 ml were collected to perform analyses of the soluble and
insoluble fraction and the remaining culture was centrifuged at 4000 rpm for 45 min at 4° C.
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The resulting pellet was stored at -200 C.
The eluate containing the purified AguR, was desalted using Zeba Spin Desalting Columns
(Pierce) according to the manufacturer's instructions. Aliquots of the protein were stored at 40
C, at -200 C or at -800 C.
To estimate the protein concentration of a sample the Bradford assay was used [206].
Analysis of E.coli overexpressing AguR total proteins was performed by resuspending
bacterial pellets deriving from 2 ml of culture collected before and after the induction in
loading dye 3x (Tris-HCI 17SmM [PH 6.8], SDS 5% [w/v], glycerol 15% [v/v], dithiothreitol
50 mM, Bromophenole Blue 0.125 %[w/vD. Moreover it was interesting to analyse also the
soluble/insoluble fractions of the induced coltures [204]
The electrophoretic protein separation was accomplished following the discontinue Laemmli
method. Acrylamide was used at 12% (v/v), the ratio acrylamide/bisacrylamide used was of
13:1. The electrophoretic run was performed at 140 V for approximatively 60 min. Gels were
subsequently fixed in a 10% (v/v) isopropanol solution, stained with Comassie Brilliant Blue
G-250, and then destained with acetic acid 10% (v/v) [207].
The electrophoretic mobility shift assays (EMSAs) were performed on a probe encompassing
the promoter of rsmZ, generated by PCR using the primers FWrsmZ RVrsmZ. The resulting
PCR fragment was purified and run in a bandshift assay. Increasing concentrations of AguR
(from 0.1 ng/ml to 1 mg/ml) were incubated RT for 30 min with the digoxygenine-Iabeled
probe generated with primers FWrsmZ and RVrsmZ and labeled with the DIG High Prime
Labeling Kit (Roche) according to manufacturer's instructionat [204]. The detection was
performed with Anti-Digoxygenine-AP Fab fragment (Roche) and CDP-Star Detection
Reagent (Amersham) according to manufacturer's instruction.
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2.7 PROMOTER PULL-DoWN
The promoters of rsmZ and rsmY, were amplified with the PRSMZ and PRSMY primers
respectively, the reverse primers used where biotynilated (bio-RVPrsrnZ and bio-RVPrsmY)
at the 5'. To bind the DNA the Dynabeads M-280 Streptavidin (Invitrogen) were used.
Firstly the PCR product was optimised and purified so that the final concentration of the
product was higher than 20 ng/ul in a final volume of 200 Ill. The protein extract was
prepared from a 400 ml of LB colture taken at a specific time point depending on the maximal
activity of the promoter, usually at OD600= 1. The pellet was resuspended in 4 mllysis buffer
(100 mM NaCl, 10 mM Tris-HCI pH 8.0,1 mM EDTA, 0.05% Triton X100) and lysed using
a French press. After the lysate was centrifugate 14.000 rpm 4 "C and the supernatant was
quantified using a Bradford curve, 0.1 mg/ml of protein extract was usually obtained. To the
extract 1 mM PMSF (Phenylmethyl sulfonyl fluoride) a strong proteinase inhibitor, and 50
ug/ml of salmon DNA sperm was added before storing at -80 "C. Salmon DNA sperm was
necessary to avoid unspecific reaction between the biotynilated probe and the protein extracts.
The Dynabeads were washed three times, using the magnetic rack, with Wash Buffer 2X
(WB2X) (2 M NaCI, 10 mM Tris-HCI pH 7.4, 1 mM EDTA). Then resuspended in 200 III of
WB2X and 200 III ofbiotynilated DNA and incubated at RT for 30 min with gentle agitation.
The Dynabeads were washed in 1 ml Wash Buffer IX three times, then resuspended in the
protein extract and incubated for 2 hrs at RT with gentle agitation. Finally the beads were
washed in six times in 1 ml of lysis buffer and the final pellet was resuspended in 20 III
Elution buffer (1.2 M NaCI, 10 mM Tris-HCI pH 8.0, 1mM EDTA, 0.05 % Triton XIOO) and
incubated for 30 min at RT with gentle agitation. The eluted fraction was separated from the
beads using the magnetic rack and run on an SDS-PAGE. The visible bands were then
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analysed by Maldi Tof for protein identification. As control the protein extracts were
incubated with the Dynabeads without the PCR product, in this case no bands are expected.
2.8 GENE REPLACEMENT IN P. AERUGINOSA
Plasmid transfer from E. coli S 17-1Apir donor strains to P. aeruginosa recipient cells was
carried out by conjugation. The first step of recombination was selected by antibiotic
resistance. By sucrose counter-selection the second event of recombination was selected
[208]. The suicide plasmids used to perform gene replacements during this study derive from
pDM4 carrying the sacBR locus that allows its counter-selection. Single colonies from the
first cross over were re-streaked and grown oln in LB broth. Then they were diluted 1000
times in LB broth containing 10% (w/v) sucrose and allowed to grow over night to
counterselect for cells having achieved the second cross-over. After repeating this step,
dilutions were plated onto sucrose plates to obtain single colonies. Colonies that grew were
checked for loss of the suicide plasmid by screening for antibiotic sensitivity. All the mutants
obtained in this work were confirmed "byPCR.
Deletion of rsmY or rsmZ in a 6pqsA in-frame deletion mutant was obtained as described
elsewhere [151]. Construction of lasl, rhll, rhlR of lasR mutants were obtained using the
suicide vectors derived from pRIC380, which produces mutant by insertion of a gentamicin
resistance marker within the gene, as described elsewere [192].
Mutants with a disrupted gacA gene were constructed by allelic exchange using the suicide
plasmid pME6111 as described elsewhere [147].
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2.9 SOUTHERN BLOT ANALYSIS
The genomic DNA was digested with restriction enzymes, run on agarose gel and then
denatured. The DNA was blotted onto a nylon membrane (Hybond N+, Amersham Life
Sciences, UK) by dry capillary transfer at room temperature as described elsewhere [204].
Blotted membranes were hybridized with probe labelled with a DIG DNA Labelling Kit
(Roche Inc). After the hybridisation, the membrane was washed, saturated in blocking
solution (1% (w/v) Blocking Reagent (Roche), and then incubated with anti-digoxigenin-Al'
antibody (diluted 1:10,000 in blocking solution) for 30 min. After a series of washing, the
membrane were treated with CDP Star ready to use chemiluminescence substrate. After
incubation at 37°C for 20 min, membranes were then exposed to autoradiograph films for 5-
20 min and the films were developed [204]. The blocking reagent, antidigoxigenin-AP
antibody, and CDP Star substrate were supplied by Roche Applied Science, UK.
2.10 8-GALACTOSIDASE ACTIVITY
This biochemical assay was used to evaluate lacZ expression of strains of P. aeruginosa
which contained a post-transcriptional 'lacZ based fusion. For each analysed strain, the
bacterial growth rate was followed measuring the optical density at 600 nm in different time
intervals. At different growth points 1 ml of culture was collected and the ~-Galactosidase
activity was measuring as described elsewhere [209].
2.11 BIOLUMINESCENCE
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Bioluminescence of reporter strains carrying transcriptional luxCDABE fusion was measured
during growth as previously described [210]. To simplify the comparison between diverse
conditions the peak values were extracted from the curves. The maximal values were typically
reached at optical densities at 495 nm (the wavelength at which the Anthos Labtech LUCY 1
automated luminometer-spectometer reads turbidity) of between 0.85 and LIS. The reporter
strains were grown overnight in LB broth medium without antibiotics at 37°C. Overnight
culture of the reporters were centrifuged, supernatant discarded and the residue pellet was
washed in I ml of fresh LB medium. The cultures were diluted to a starting OD6oo 0.001 in
LB broth in a total volume of 200 ,.d for each well used in the LUCY or TECAN assay, in
triplicate.
To measure the production of bioluminescence throughout growth, light levels and OD were
monitored in 96 well microtitre plates using the Anthos LUCYI combined
photometer/luminometer controlled by the Stingray software (Dazdaq). The program
measures OD492 and luminescence from the wells every 30 min for 24 hrs. Readings were
analysed using Microsoft Excel. Alternatively the Infinite 200 (TECAN) multi mode micro-
plate reader controlled by XFluor software was used with the same procedure.
1.11.1 QS-agonist assay
Screening of individual molecules for their ability to activate PlasB-lux fusion was conducted
using 5 J.LMof 3-oxo-C12-HSL as a positive control. In the negative control the solvent used
for dissolving the compound tested was added (5% v/v of methanol). Test compounds were
added to the tubes containing the biosensor (OD6oo of 0.001) to a final concentration of
100 J.LM.Values were expressed as a percentage of the maximal bioluminescence measured
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after exposure of the bacterial reporter cells to the analogues (approximately after 8 hrs from
inoculation at 37°C) relative to positive control (100%). Measurements were conducted in
triplicates.
2.11.2 QS-antagonist assay
The assays for QS antagonists were based on testing the ability of individual molecules to
compete with 3-oxo-CI2-HSL for the activation of the PlasB-lux or the PlasI-lux based
reporter strains. To each sample tube containing the diluted reporter (final OD600 ofO.001), 3-
oxo-C12-HSL (the concentration used was specific for each reporter and corresponds to the
concentration at which the promoter activity is at its half maximal: Kind) and individual
analogues were added at a concentration range of 1 f.lM, 10 f.lMand 100 f.lM.As a negative
control the solvent used to dissolve the compounds tested was added. In the positive control
only the Kind concentrations of3-oxo-CI2-HSL were added, at 0.5 f.lMand 5 f.lMrespectively
for PlasB-lux and PlasI-lux fusions. Values were expressed as a percentage of the maximal
bioluminescence measured after exposure of the bacterial reporter cells to the analogues
(approximatively after 8 hrs from inoculation at 37°C) relative to positive control (100%).
Measurements were conducted in triplicates.
2.12 FLUORESCENCE
To measure the production of fluorescence throughout growth, the strains were monitored
using 96 well micro-titre plates and the detection was conducted with the Infinite 200
(TECAN) multimode micro-plate reader controlled by XFluor software. The wavelength
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settings for the detection of DsRedE2 were of 535 run for the excitation and 595 run for the
emission. The measurements of the optical density were conducted at OD600 every 30 min for
24 h. Readings were analysed using Microsoft Excel. The strains were treated as described
before for the luminescence assays.
2.13 THIN LAYER CHROMATOGRAPHY (TLC)
An appropriate volume of the extract was spotted onto the aluminum backed reverse phase 2
(RP-2) plate (Merck) used for separating long chain AHLs, as an alternative the reverse phase
18 (RP-I8) plate (Merck), for separating the short chain AHLs, or the normal phase (NP)
plate (Merck), for separating the quinolones molecules, were used. The sample was loaded 2
cm above the base of the plate and dried in a stream of warm air. The extracts were separated
using methanol-water 45:55 v/v (for long chain AHLs), 60:40 v/v (for short chain AHLs) or
dichloromethane-methanol 95:5 v/v (for quinolones) as the mobile phase. Once the solvent
front reached the top of the plate, the TLC plate was removed and dried.
The reporter strains used for the TLC overlaying detection PAKR08 (D.pqsA rsmZ-luz) and
P. fluorescens CHAO containing the pMW02 plasmid, were grown overnight in liquid LB at
370 C and 300 C respectively. The next day 5 ml of the reporters were mixed with 100 ml of
soft top agar and the mixture was poured onto the TLC plate as already described [210]. In the
case of the TLC performed with the PAKR08 a light camera was used. On the other hand, in
the case of the double transcriptional-translational reporter strain, a visual method for the
detection of fluorescence was used. In particular, the TLC plate was placed into a black-box
and the red fluorescence was excited using a green light. To detect fluorescence a filter was
used, this was placed on the top of the box, above the TLC plate.
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2.14 HIGH-PRESSURE LIQUID CHROMATOGRAPHY (HPLC)
The extracts from P. aeruginosa PAO were analysed by HPLC using a Waters 625 LC
System linked to a Waters 996 Photo Diode Array detector (Waters, Manchester, UK). The
250 x 2.1 mm Kromasil C8 (Hichrom, Reading, Berkshire, UK) column was equilibrated with
50% (vv) acetonitrile/water. In detail, 600 ml LB culture were grown at 37°C to an OD600
corresponding to the end of the exponential phase. The colture supernatants were extracted
and concentrated to a final volume of 50 ul. The whole volume was injected onto the column
and run on a linear gradient 20-100 % (v/v) acetonitrile/water; the samples were scanned
within the UV range, 190 to 400 nm, to determine spectral profiles. The HPLC column was
connected to a fraction collector (Gilson, UK) and seven fractions were collected each 5 min
for 35 min, the fractions were dried by rotary evaporation.
2.15 MAss SPECTROMETRY (MS)
The HPLC column was also connected to a mass spectrometer (MS). The apparatus used was
a 4000 QTRAP hybrid triple quadrupole-linear ion trap mass spectometer (Applied
BIosystems, USA) equipped with TurboIon source used in positive ion electrospray mode
[211 ].
2.16 P.AERUGINOSA SIGNAL MOLECULES
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2.16.1 Extraction from culture supernatant
P. aeruginosa wild type and mutant strains were grown in 200 ml of Casarnino Acid medium
in I-liter flask for 16MS with shaking to an OD600of2.0 to 2.5. Cells were then removed by
centrifugation. The supernatant was passed though a O.4S-m-pore-size filter, adjusted to pH
5.0, and extracted twice with 200 ml of dichloromethane. The extracts were pooled and
evaporated to dryness using a Rotavapor R-2IO machine and the dried extracts stored at 20°e.
The extracts were dissolved in methanol so that the extracted molecules were 200 times more
concentrated than in the culture media. For the luminescence and fluorescence experiments,
the ratio of reporter culture to signal extracts was 1:2, 1:4 1:6, 1:8 and 1:10. For the negative
control methanol was added.
2.16.2 Pyocyanine extraction
Pyocyanine extraction was performed following the protocol already described by Frank and
Demoss (1959) [185] . The strains were grown in 600 ml of Gylcerol-Alanine minimal
medium for 36 hrs at 37°C. The culture was then centrifuged and the supernatant was
filtered. The supernatant was then extracted three times with 100 ml of chloroform, the
organic phase was collected and re-extracted twice with HCI 0.1 M. The aqueous phase was
collected each time and 1 M borate-NaOH buffer pH 10.0 was added until the solution
become blue. The aqueous phase was re-extracted with chloroform and the organic phase was
collected. The chloroform phase was then extracted again with HC} 0.1 M into a reduced
volume. Addition ofNaOH 1M until the color turns blue.
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2.16.3 Synthetic quorum sensing signal molecules
Synthetic 3-oxo-C12-HSL, C4-HSL and PQS were made by S.R. Chhabra and A. Turman at
the School of Molecular Medical Sciences, University of Nottingham and kept as 10 mM
stocks in methanol (PQS) or acetonitrile (3-oxo-CI2-HSL, C4-HSL) as described by Chhabra
et al., (2003) [184], and Pesci et al., (1999) [92]. Compounds were stored at -20°C.
Synthetic AHL analogues for competition studies were synthesized by S.R. Chhabra and A.
Turman at the School of Molecular Medical Sciences, University of Nottingham and kept as
dry form at -20°C.
2.16.4 Calculation of IC50
The half maximal inhibitory (IC50)concentration of the tested compounds was determined by
constructing a dose response curve and examining the effect of different concentrations of the
molecule on the promoter activity of the reporter (prsmZ or PrsmY). The IC50was calculated
by determining the concentration of the compound needed to inhibit half of the maximum
activity of the reporter. In this study the IC50values were calculated with the sigmoidal dose-
response curve obtained using the program Prism2 (Graphpad, San Diego, USA).
2.17 CLINICAL STUDY
2.17.1 Patients
Patients over eight years, with CF and chronic pulmonary infection with P. aeruginosa were
enrolled when they were free of an exacerbation of pulmonary symptoms. Participant were
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only enrolled if they could expectorate sputum, perform pulmonary function tests reliably and
swallow capsules. As a result of this selection, twenty six CF patients, 14 male and 12
women, mean age of 18 years (range 11-54 years) with chronic bronchopulmonary
P. aeruginosa infection entered the study.
2.17.2 Study design
The study was a double-blind clinical trial in which patients were randomly assigned to
receive either active treatment or the placebo. Patients were divided into adult (over 16) and
paediatric (under 16).
2.17.3 Treatment
Active treatment consisted of intake of one capsule daily with their evening meal (656 mg of
garlic oil macerate and 10 mg of cardamom oil), or placebo (656 mg of olive oil and 10 mg
cardamom oil). The cardamom oil was present as an odour control agent so that it was
difficult for the patients to understand in which group they were assigned. Treatment went on
for 8 weeks. The patient therapy (enzymes, vitamins and antibiotics) was maintained
unchanged throughout the study.
2.17.4 Investigation parameten
Investigational parameters included a clinical score, the Jensen score, pulmonary function
tests, sputum samples for microbiological examination, haematological samples for clotting,
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and liver funtion (alanine transaminase and gamma glutaryl transferase), sputum and blood
samples for chemical analysis. Data were collected every two weeks, at the beginning and at
the end of the therapy.
2.17.5 Clinical score
The Jensen clinical score included evaluation of general conditions as appetite and evaluation
of lungs conditions. The parameters used in this score range from 0 to 6. A low score
indicates a good clinical condition, while a high score indicates pulmonary exacerbation. The
baseline score from the beginning of the treatment was subtracted from the final score
obtained at the end of 8 weeks. A negative value for the change in clinical score represents an
improvement in symptoms.
2.17.6 Lung function test
The pulmonary function was measured using a MicroLab 3300 spirometer (Micro Medical
Ltd, Rochester, Kent, UK) according to joint ERS/ATS criteria. Forced expiratory volume in
the first second (FEV I)was recorded and expressed in percentage of change from the baseline
(from the beginning of the treatment) to the end of the treatment.
2.17.7 Hematological tests
Liver function and blood parameters were samples were examined by routine laboratory
methods and include clotting, platelet count and alanine transaminase and gamma glutaryl
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transferase levels.
2.17.8 Sputum and plasma signal molecules extraction
Both sputum and plasma were frozen at -700 C and later analysed for 3-oxo-CI2-HSL and
C4-HSL levels. Sputum samples were resuspended in 5 ml of NaCI 0.9% (w/v) and vortexed
until a homogeneous mixture was obtained. Plasma samples were resuspended in 5 ml of
NaCI 0.9% (w/v) and vortexed. In either case equal amounts of acidified ethyl acetate was
added to the mixture, vortexed for 2 min and left for the two phases to separate. The solvent
phase, containing the QS molecules was collected and solvent allowed to evaporate to dryness
under reduced pressure. This procedure was repeated twice to maximise the extraction. The
resulting extracts were dissolved in 50 J.lI of methanol ready for analysis by liquid
chromatography coupled to tandem mass spectrometry (LC-MSIMS).
2.17.9 Sputum and plasma signal molecules analysis
The samples derived from sputum and plasma extraction were first run trough an HPLC
column, Phenomenex Gemini CIS, 150 x 2 mm (5 urn particle size) used at 500 C. Mobile
phase A was 0.1% formic acid and 200 J.LMEDT A in water. Mobile phase B was 0.1% formic
acid in acetonitrile. To the HPLC it was coupled a hybrid triple-quadrupole linear ion trap
mass spectometer (4000 QTRAP, Applied Biosystems, Foster City, CA, USA) equipped with
Turbolon source was used in positive ion electrospray mode based on a previously published
method [13]. Quantification was performed using a specific software (Analyst 1.4.1, Applied
Biosystems) in Quantitate mode and raw peak areas were used. The analytical lower limit of
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detection (LLOD) for 3-oxo-C12-HSL and C4-HSL was determined as a signal to noise ratio
of 10:1 and values below this were considered to be not measurable. Synthetic signal
molecules were run as standards.
2.17.10 Statistical analysis
Statistical analysis was conducted using SPSS version 15.0. The two treatments were
compared using the t-test for normally distributed data (percentage change in FEV} and
weight from the baseline) and the Mann-Whitney test for non-parametric variables (change in
symptoms score from baseline). The relationship between 3-oxo-C12-HSL in sputum and
plasma was compared using a Pearson correlation coefficient.
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3 Study of rsmZ regulation by signal molecules
3.1 INTRODUCTION
The ability of bacteria to colonise and thrive in a wide variety of environments is partly
facilitated by their quick response to different stimuli. In order to do this, bacteria possess
multiple two-component-systems (TCS). These regulatory systems allow them to respond
with great sensitivity to specific environmental signals such as pH, oxygen, nutrient levels,
osmotic pressure and the presence of antibiotics [212]. The importance of TCS for the
survival of the bacteria is leading to the development of anti-TeS drugs. By targeting TeS, it
would be possible to prevent them from activating growth-essential genes, or from activating
virulence genes. Several TCS are also responsible for promoting antibiotic tolerance [213].
Thus, inhibitors of the TCS could be used in synergy with antibiotics to improve their
efficacy and to prevent or slow down processes that lead to the development of resistance
[214].
One way to identify TCS inhibitor molecules is to screen among natural products and
synthetic compounds libraries using a reporter fusion regulated by this system. By using this
approach, many inhibitor molecules were successfully identified [215]. TCS can be inhibited
at different steps (reviewed by Gotoh et al. 2010) [216]. The autophosphorylation step can be
targeted, by acting on the sensor kinase. This is the case of the molecule walkmycin B, that
targets the WalK sensor kinase of the WalKlWalR Tes of Bacillus subtilis [215]. TeS can be
also inhibited at the phosphotransfer stage, as in the case of walrycin B. This molecule targets
the WalR phosphorylation by WalK of the WalKlWalR res of B. subtilis [217]. Finally,
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molecules that are able to inhibit TeS at the sensing step have also been identified. These
molecules interfere with the binding between the signal molecule and the sensor kinase. An
example is the LED209 molecule that inhibits the binding of AI-3, of epinephrine and of
norepinephrine to QseC of the QseC/QseB TCS of enterohemorrhagic E. coli [218].
P. aeruginosa contains a variety of TeS that are involved in virulence or antibiotic resistance
[219]. However, until now no synthetic or natural compounds have been shown to be capable
of inhibiting a TeS. Only recently, in the species Pseudomonas putida synthetic antagonists
of TolS have been identified. TolS is a sensor kinase part of the TolSIR TCS involved in the
metabolism of toluene [220].
This chapter will focus on the identification of the signal(s) modulating the Gac/Rsm signal
transduction pathway. Three sensor kinases (GacS, LadS, and RetS) are 'at the top' of this
pathway, as they sense putative signals and modulate the phosphorylation of the GacA
response regulator. When GacA is phosphorylated, it promotes the transcription of the two
regulatory sRNAs (RsmZ and RsmV), which in turn modulate the activity of RsmA. This
global regulator post-transcriptionally controls the expression of a vast range of virulence
factors such as biofilm formation, pyocyanin, lipase, elastase, motility and quorum sensing
(QS) [151]. Due to its central role in P. aeruginosa virulence, the search for the signal(s)
activating/repressing this TeS transduction pathway is crucial for the development of new
drugs.
The first studies on the identification of the signal molecules acting on GaclRsm were
conducted on P. jluorescens CHAO[221]. These studies demonstrate that the signal molecules
are produced at high cell population densities, suggesting that the GaclRsm pathway was the
manifestation of social behaviour such as QS. However, the signal(s) appear to be unrelated to
known QS signals such as AHL, since P.fluorescens eHAO does not possess an AHL driven
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QS system [221]. Furthermore, the signals are produced in a GacA-dependent way, thus
linking the signal transducers to the signal generators in a positive feedback loop [221].
Although the chemical structure of the signal(s) molecules remains unknown, the molecule(s)
can be extracted from culture supernatants with dichloromethane, yielding crude signal
preparations [221-223]. Moreover, studies have shown that the signals that activate
P. fluorescens Gac/Rsm cascade are also able to activate the expression of Gac/Rsm regulated
genes in P. aeruginosa and vice-versa, suggesting the existence of a possible cross-talk
between different species of Pseudomonads [221].
One of the approaches used to identify the signal molecules was to target by random
mutagenesis the genes involved in the biosynthesis of the signal. Using this approach, the
thiamine biosynthetic (hie gene was identified as being important for signal production in
P. fluorescens CHAO. However, the mechanism by which thiamine causes a reduction in the
signal concentration is not known [222]. Another way to identify the signals was to
fractionate crude signal preparations on silica gel column, and to look for the fraction where
the signal was present. This strategy was not effective because the signal appeared to be lost
during fractionation (S. Heeb, personal communication). Interestingly, studies conducted on
the sensor kinase GacS of P. j1uorescens CHAO revealed that the periplasmic loop of this
sensor is not essential for the detection of the signal and thus can activate GacS through its
cytoplasmic membrane domain [224], suggesting a lypophilic nature of the signal(s).
3.2 AIM OF THE STUDY
With the aim of identifying the GacAiS signal(s) in P. aeruginosa two approaches were used.
On one hand, it was interesting to study the regulation of the synthesis of these extra-cellular
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signal(s) molecules, as this would provide a starting point for their purification and
characterisation. On the other hand, by using specifically constructed reporters, the P.
aeruginosa extra-cellular extracts were analysed for the direct identification of the signal
molecules responsible for the activation of the Gac/Rsm system. The involvement of the cis-
2-decenoic acid (CDA) molecule in the modulation of the Gac/Rsm system was also
investigated. This molecule has been previously found to be important for biofilm dispersal in
P. aeruginosa [225].
3.3 RESULTS
3.3.1 Construction and analysis of the rsmZ-lux and rsmY-lux reporter fusions
From recent studies, it appears that GacA exerts its function on the Gac/Rsm transduction
cascade exclusively through the activation of rsmZ and rsmY transcription [226]. Thus, the
study of rsmZ and rsm Y transcriptional modulation is crucial for the understanding of the
signal(s) involved in this regulatory cascade. For this reason, rsmZ-lux and rsmY-lux fusions
were constructed and inserted into the unique attP site in P. aeruginosa chromosome using a
mini-CTX delivery system (Becher and Schweizer 2000). The plasmids produced were called
pSH50 (rsmZ-lux) and pKR77 (rsmY-lux) respectively. These vectors were then used to insert
the transcriptional fusions into P. aeruginosa PAO I-N strain to generate strains PASH50 and
PAKR04, respectively. The promoter regions cloned contained 326 bp for rsmY-lux and 249
bp for rsmZ-lux upstream from the +1 transcriptional starting site of each sRNA. Both of
these fusions contained the Gac-box responsible for the GacA-dependent transcriptional
activation (Fig. 1) [226]. The expression of the sRNAs was monitored by growing PASH50
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and PAKR04 at 37°C in static conditions in LB medium. In accordance with what has
already been found in P. jluorescens and in P. aeruginosa [202, 227, 228], the basal activity
of the PrsmZ is significantly lower than the one of PrsmY (Fig. 2). The maximal PrsmY
activity was calculated as approximately nine times higher than what was observed for PrsmZ
(Fig. 2). Moreover, both rsmZ and rsmY promoters are activated in a growth-phase dependent
manner (Fig. 2).
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Figure 3-1. Representation of rsmZ and rsmY promoter region.
The 250 bp region of rsmZ promoter used to construct the PASH50 (rsmZ-Iux) (A) and PAKR04 (rsmY-Iux) (B)
reporter fusions (in blue), The regions comprise a Gac-box (in orange). The transcriptional starting site of rsmZ
and rsm Y (in bold) and the -10 and -35 regions (double underlined), The annealing sites are also indicated (back
single underlined),
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Figure 3-2. Regulation of rsmZ and rsmYexpression in relation to growth
The transcription from rsmZ (A) and rsm Y (B) promoters was monitored by measuring the light production RLV
(filled circles) of the transcriptional fusions carried by P. aeruginosa strains PASH50 (rsmZ-Iux) and PAKR04
(rsmY-lux) over growth (empty circles).
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3.3.2 Effect of culture supernatant from P. aeruginosa WT on the activity of the rsmZ
and rsmY fusions
Previously, the regulation of rsmZ and rsmY transcription was analysed using -lacZ based
fusions. It was interesteing to analyse of the new -lux based reporter systems constructed. As
expected, the addition of extracellular extract from P. aeruginosa PADI activated the rsmZ
promoter fusion in PASH50 [221]. On the other hand, rsmY transcription could not be
enhanced by the addition of extra-cellular extracts in PAKR04 (Fig. 3). The rsmY promoter
has been reported to be one of the strongest one of P. aeruginosa (Kay et al., 2005), and
bioluminescence is a highly energy-demanding process. Thus, it is not surprising that when
the lux operon is fused to the rsmYpromoter, great quantities of energy must be consumed to
produce bioluminescence, affecting growth (Fig 28). For this reason, the growth limiting
conditions may be affecting the response of the rsmY-lux reporter to the addition of extra
cellular extracts. The light production reaches plateau levels and cannot be further enhanced
(Fig.3A).
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Flpre 3-3. R.ulation of rsmZ and rsmYexpression in P. aeruglnosa by extra-cellular extracts.
Maximum expression ofPAKR08 (rsmY-lux) (A) and PASH50 (rsmZ-lux) (B) reporters in strains growing in the
presence of increasing amounts of extracellular extract from P. aeruginosa PAOI-N.
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3.3.3 Effect of the quorum sensing systems on the production of the signals inducing
rsmZ transcription
The inability to enhance the rsmY promoter activity by adding extra-cellular P. aeruginosa
extracts prompted us to use exclusively the PASH50 reporter strain (rsmZ-lux) in the further
studies aimed to the identification of the signal(s) modulating GacAiS. The role of the
Gac/Rsm system in the control of the QS system has been reported previously. The
production of AHLs is positively regulated by GacA and negatively regulated by RsmA,
which post-transcriptionally represses rhlI and las! expression [147, 152]. Previous studies
have also shown that the regulation of the Gac/Rsm system in P. aeruginosa and
P.fluorescens is not modulated by 3-oxo-CI2-HSL, C4-HSL or 2-alkyl-4(1H) quinolones QS
molecules [151, 221].
Due to the important role of the QS networks in the modulation of different phenotypes in
P. aeruginosa, it was interesting to investigate whether the three QS systems (las, rhl, and
pqs) were involved in the production of the Gac/Rsm system signal molecules. For this
purpose, it was necessary to construct mutants defective in each of the QS systems. In each
mutant, the synthase gene responsible for the production of the signal molecule was deleted.
The las! mutant (PAKR94) was constructed, while the mutant rhlI (pAOIMhlI) was already
available in our laboratory [229]. These strains have an insertion of a gentamycin (Gm) and a
tetracycline (Tc) gene cassette in the coding sequence of las! and rhlI, respectively. The in-
frame mutantpqsA (PAOpqsA) was already available in our laboratory [193], while the triple
mutant PACP3D, defective in the production of the three QS signal molecules, was
constructed.
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The extracts from PAKR94 (MasI::GmR), PA01&-hlI (~rhlI::TcR), PAOpqsA (~pqsA) and
PACP3D (~lasI::GmR-~hlI::TcR-f¥JqsA) supernatants were analysed for their ability to
activate the expression of the rmsZ-lux reporter fusion. The strains were grown at 37°C in
aerobic conditions in CAA media until they reached the stationary phase of growth. The
OD600was normalised to 1.S before extracting the molecules from the supernatant (Materials
and Methods, 2.16.1). All the extracts were able to induce rsmZ transcription. However, the
extracts derived from the triple mutant, activated rsmZ expression later in growth (Fig. 4).
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Fllure 3-4. Impact of QS systems OD the production of signal molecules acting on rsmZ transcription.
Extracts from WT, PAKR94 (Alasl::GmR), flrhlI (flrhlI::TcR). PAOpqsA (llpqsA) and PACP3D (Alasl::GmR•
IlrhlI::TcR-llpqsA), were tested on the rsmZ-lux reporter PASHSO (rsmZ-lux). The culture:extract ratio used was
1:4. As a control (cntr) only methanol was added to the culture 5% (v/v) ratio.
3.3.4 Impaet of GacAlS, LadS and RetS on the produetion of rsmZ inducing molecules
103
Several studies conducted on P. aeruginosa using a transcriptional rsmZ-lacZ fusion suggest
that, similar to P. fluorescens, P. aeruginosa produces a GacA-dependent signal [221]. The
impact of the three sensor kinases (GacS, LadS and RetS) was investigated and of GacA on
the production of the signals inducing rsmZ transcription, using our -lux based transcriptional
fusion. Each strain was grown overnight and the OD600was normalised to 1.5. The extracts
were prepared as described in the previous section and added in a ratio of 1:4 (culture:
corresponding volume extracted). Surprisingly, the results previously obtained by Dubuis and
Haas (2007) were not reproducible when using the rsmZ-lux fusion [221]. Extracts from
PAKR29 (~gacS), PAKR43 (~gacA), PAKR45 (MadS) or PAKR52 (~retS) strains, all
retained a wild-type inducing activity (Fig. 5).
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Figure 3-5. Impact of GacA/S, LadS and RetS mutation on the production of rsmZ activating signal
molecule.
Extracts from WT, PAKR29 (~gacA), PAKR43 (~gacS), PAKR45 (MadS) and PAKR52 (MetS) tested on the
reporter strain PASH50 (rsmZ-Iux). The culture:extract ratio used was 1:4. As a control methanol, the solvent
used to dilute the extracts, was added 5% (v/v).
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3.3.5 Effect of RsmA on the production of rsmZ-inducing molecule
To continue the analysis of rsmZ-lux modulation in P. aeruginosa PAOI-N strain, the effect
of the global post-transcriptional regulator RsmA on the production of signal molecules
activating rsmZ was investigated. Previous studies suggested that the two CsrA homologues
RsmA and RsmE, found in P.fluorescens, are indirectly involved in modulating the Gac/Rstn
system by repressing the signal production (Fig. 6) [223].
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Figure 3-6. Model for lene relulation in the GaelRsm system of P.fluorescens
The GaclRsm regulatory system autoregulates its activity (figure extracted from Kay et al., 2005).
To find the optimum conditions for the production of high levels of signal molecules, extracts
derived from an rsmA-inducible strain PASKIO were used. This strain is an RsmA negative
mutant in the absence of IPTO and RsmA overproducer in the presence of IPTO (1 mM).
Interestingly, the extracts resulting from the RsmA over-expressed strain (grown with IPTG
addition) or from the rsmd mutant (no IPTO added) were equally effective at inducing rsmZ-
105
lux fusion, with respect to WI extracts, indicating that in our P. aeruginosa PAOI-N strain,
the signal production is not regulated by RsmA (Fig. 7).
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Figure 3-7. Impact ofRsmA on the production signal molecule activating rsmZ transcription.
Effect on the reporter PASHSO (rsmZ-lux) of extracts derived from PASKIO strain in inducing conditions
(PASKIO I) and in non inducing conditions (PASKIO NI). The culture:extract ratio used was 1:4. As a control
only methanol, the solvent used to dilute the extracts, was added at 5% (v/v).
3.3.6 Fractionation of P. aeruginosa culture supernatants extracts in search for the
molecules inducing rsmZ
As no strain enhanced in the signal molecules production were found, further analysis were
conducted using the extracts derived from P. aeruginosa PAOl-N. Fractions derived from
this strain were tested for their activating potential on the PASH50 (rsmZ-lux) reporter strain.
P. aeruginosa was grown in the aforementioned conditions and the extracts were concentrated
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200 fold in methanol. The extracts (final volume of 50 Ill) were then injected into the HPLC
column and were analysed in order to determine the spectra profile. The eluate was
fractionated and collected at different time points (Materials and Methods, 2.14). Each of the
seven fractions collected was dried and diluted in 10 III of methanol. Each fraction was then
added to the reporter and the activity of the rsmZ-lux reporter was assayed. More than one
fraction was capable of activating the rsmZ-lux fusion in strain PASH50, while only one
showed a weak inhibitory activity (Fig. 8). Further sub-fractionation of fractions 1, 4 and 7
was conducted using the same method. Unfortunately, the activity of the extracts resulting
from this second purification was lost, due to insufficient starting material (200 ml of culture
supernatant).
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Figure 3-8. Activation of the rsmZ-lux reporter by different fractions of the P. aeruglnosa extracellular
extracts.
Maximum activity of the PASH50 (rsmZ-Iux) reporter when incubated with extracts derived from HPLC
fractionation. The fractions obtained were added to the biosensor in a 1:4 ratio. Also shown is the activity
obtained when adding all the fractions together (tot). As a control (cntr), only methanol was added to the reporter
strain at 5% (v/v).
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3.3.7 Identification of PQS in one of the fractions activating rsmZ expression
In order to investigate whether any of the active compounds corresponded to known
molecules for which synthetic standards were available, the HPLC fractions were analysed
using mass spectrometry (MS). This technique allowed to compare fractions according to
retention times and fragmentation patterns. Interestingly, PQS was identified in one of the
fractions (F6) activating the rsrnZ-lux reporter PASH50 (Fig. 9). This led to the hypothesis
that PQS was acting on the promoter of rsrnz' Although previous experiments conducted on
P. jluorescens CHAO showed that PQS does not activate PrsrnZCHAO [221], the results
obtained here suggest that PQS can activate rsrnZ expression in P. aeruginosa (see Chapter 4
for a further development).
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Figure 3-9. Le-MS analysis of different supernatant fractions from P. aeruginosa cultures.
The m/z peak of260 corresponding to PQS, was identified in fraction 6.
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3.3.8 Analysis of P. aeruginosa ApqsA supernatants for the presence of rsmZ inducing
molecules
The aim of this study was to search for unknown molecules, which can activate the GaclRsIll
cascade. The discovery that PQS was partially responsible for the activation of rsmZ
transcription, prompted us to use P. aeruginosa extracts derived from a t¥qsA mutant (unable
to produce PQS). Moreover, the reporter rsmZ-lux fusion integrated into the ¥qsA
background (PAKR08) was used. In order to identify additional signalling molecules, it was
important to rule out the involvement of PQS on the observed effect on rsmZ induction. In
accordance to previous observations, it was shown that 30CI2-HSL and C4-HSL molecules
were not capable of activating rsmZ transcription in P.fluorescens and P. aeruginosa [151,
202] (Chapter 4 for further details). For this reason, a t1pqsA mutation was considered
sufficient to prevent detecting known molecules.
3.3.9 Ihin ~.yer ~hromatography (TLC) analysis of extracted supernatants from
P. aeruglnosa ApqsA
.The HPLC based fractionating method was not sensitive enough to identify the signal
molecules present in the extra-cellular extracts. For this reason, it was decided to analyse the
P. aeruginosa extra-cellular extracts using a more direct way. TLC analysis on extracts
derived from the ApqsA mutant background (PAOpqsA) (unable to produce PQS) was carried
out and coupled with an overlay of the reporter PAKR08 (ApqsA rsmZ-lux). Using this
method, the molecules, which are present in the extra cellular extracts, can be separated
according to their polarity (Materials and Methods section 2.13). Once the molecules have
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migrated, the TLC plate is overlaid with the reporter strain and incubated at 37°C. From this
experiments the detection of specific active spots on the plate was expected, corresponding to
the molecules inducing rsmZ transcription. Because the chemical identity of the signal
molecules is unknown, different TCL plates and liquid phases were used.
The extraction procedure was identical to the one described previously, and the extracts
derived from the PAOpqsA (1¥qsA) strain were concentrated 200 times in methanol to a final
volume of 10 ul. The whole volume was then loaded into the TLC plate (Materials and
Methods, 2.14). After the migration of the liquid phase, the plate was dried and an overnight
culture of the reporter strain PAKR08 (1¥qsA rsmZ-lux) was used to overlay the plate. The
light production was checked each 30 min for an 8 hrs period using the light camera.
Unfortunately, the background light emission of the reporter was too high to visualise a light
spot corresponding to the signal molecule. Hence, it was carried out the construction of an
alternative biosensor.
3.3.10 Construction of a double transcriptional-translational reporter in P.j1uorescens
CHAO for the detection of rsmZ inducing molecules
In order to minimise the background effect observed when conducting the TLC analysis of the
extracellular P. aeruginosa extracts using the strain PAKR08 (1¥qsA rsmZ-lux), an
alternative biosensor was constructed. The aim was to generate a biosensor whose activity
would be repressed in the absence of the signal molecules, while strongly activated in the
presence of the signal molecules. This biosensor was constructed in the P. fluorescens CHAO
background, which is unable to produce AHL or 2-alkyl-4(1H)-quinolones signals [202].
Extracts from P. aeruginosa PAO} were previously found to be capable of inducing
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P. jluorescens CHAOrsmZ transcription [2211.Moreover, this strain is capable of growing at
room temperature, thus facilitating the detection process using fluorescence imaging
equipment. The reporter was constructed using the promoter rsmZCHAOfused to the ribosome-
binding site (RBS) of aprAcHAo, a gene that is strongly regulated at the post-transcriptional
level by RsmA [230]. The promoter and RBS were linked to the open reading frame (ORP)
encoding the red fluorescent protein gene DsRedE2 (Material and Methods, 2.4.5).
The final double transcriptional-translational report was carried on the plasmid pMW02 and
transformed into P. jluorescens CHAO strain. This bioreporter was regulated both
transcriptionally and post-transcriptionally by the P. jluorescens GaclRsm system. In the
absence of the signal molecules, RsmA binds to the RBS of aprACHAO inhibiting the
translation of DsRedE2. In this way, the background noise is minimised. On the other hand,
the addition of extra-cellular extracts activates both the intrinsic rsmZCHAO promoter,
activating the transcription of rsmZ and the promoter controlling the transcription of
DsRedE2. The enhanced production of the small regulatory RNAs, rsmZ, rsmYand rsrnX
[223] would titrate out RsmA, which is then incapable of binding to the RBS of aprAcHAo,
The translation of DsRedE2 protein is thus activated (Fig. 10).
The result is a reporter system activated both transcriptionally and post-transcriptionally by
the signal molecules. A reduced background and an amplified sensitivity to the molecules are
expected.
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Figure 3-10. Model for the double trasnscriptional-translational GaclRsm-dependent DsRed2 reporter
fusion.
At low concentrations of signal molecules, RsmA exerts its post-transcriptional negative regulation on aprAcHAo
RBS thus inhibiting the DsRedE2 translation (A). When adding signal molecules activating GacA, the
transcription of the reporter fusion is induced (rsmZcHAO promoter) and the effect of RsmA on the post-
transcriptional repression is simultaneously alleviated of by the small RNAs (B).
The response in liquid media of the P. jluorescens/pMW02 strain to the addition of signal
molecules was investigated. The extracts derived from PAOpqsA (/1pqsA) strain were added
at a range of different culture to extract ratio. The results indicated a stronger activation of the
new biosensor and a significant decrease of the background activation level, compared to the
activation of the biosensor P. aeruginosa PAKR08 (/1pqsA rsmZ-lux) (Fig. 11).
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Figure 3-11. P.fluorescens CHAODsRedE2 reporter compared to P. aeruglnosa PAKR08.
Culture supernatant extracts derived from P. aeruginosa PAOpqsA (tJ.pqsA) were added to the reporters
PAKR08 (&pqsA rsmZ.lux) squares, and to the double transcriptional·translational DsRedE2, triangles. The
maximal fluorescence was measured over an incubation time of nine hrs (OD600 = 0.8),
The promising results obtained with the new reporter strain in liquid media, compared to the -
lux based reporter strain PAKR08 (~qsA rsmZ-lux), prompted us to further analyse
P. aeruginosa PAD 1 extra-cellular. A TLC analysis was carried out using DsRedE2 reporter
as the overlaying strain. Extracts from PADpqsA (~qsA) strain were loaded into a TLC plate
as previously described. The DsRedE2 biosensor (P.j1uorescens CHAO/pMW02) was then
overlaid onto the dried plate and the appearance of red fluorescence was analysed every half
an hour. Although the background noise was drastically reduced, it was not possible after 48
hrs of incubation to visualise any defined red spot on the TLC corresponding to activating
signal molecules. The results obtained in liquid and in TLC conditions indicate a different
sensitivity of the detection method used. When fluorescence was analysed in liquid, the
detection was performed in micro titre plates using the sensitive TECAN reader (material and
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methods section 2.12). On the other hand, when the TLC plate was analysed for fluorescence
a visual method was used.
3.3.11 Impact of cis-2-decenoic acid on rsmZ and rsmY expression.
It has been found that P. aeruginosa produces a novel signal molecule, namely cis-2-decenoic
acid (CDA) (Fig. 12), which is important for biofilm dispersal [225]. This signal belongs to a
family of molecules known as diffusible signal factors (DSF), which are present in a number
of human and plant related pathogens [231-233].
Figure 3-12. Cls-2-decenoic acid (CDA).
Since the swanning (thus biofilm dispersal) phenotype has already been linked to the activity
of the RsmA in P. aeruginosa [151], the interaction between CDA and the Rsm post-
transcriptional system was investigated. The hypothesis was that CDA could act on biofilm
dispersal by repressing the expression of the sRNAs RsrnZ and RsmY. The concentration of
free RsmA in the cell would increase, promoting swarming. The reporters PASH50 (rsmZ-
lux) and PAKR04 (rsmY-lux) were assessed for their activity after the addition of CDA. As
expected, CDA was shown to inhibit the expression of both sRNAs (Fig. 13).
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Figure 3-13. Effed of cis-l-decenoic acid on rsmZ-lux and rsmY-lux reporter fusions.
The maximum activity ofPAKR04 (rsmY-lux) (A) and PASH50 (rsmZ-lux) (B) biosensors after the addition of
increasing concentrations of CDA. The ICso (half maximal inhibitory concentration) was calculated as 33 j.lM
(R2 = 0.99) and 45 j.lM (R2 = 0.94), respectively.
It was previously reported that the RsmlGac system is negatively regulated by the action of
the sensor RetS on GacS [154, 156]. It was investigated whether the action of CDA exerted
on these two small regulatory RNAs was channelled through this sensor kinase, hoping to
uncover the identity of a signal molecule acting on RetS. To test this hypothesis, we analysed
the effect of CDA in the PAKRS3 (l'lretSrsmZ-lux) background. The results indicated that the
activity of rsmZ promoter was significantly higher in the PAKR53 background compared to
the PASHSO (rsmZ-lux), in agreement with previous results [155]. However, CDA was still
able to repress rsmZ transcription in both strains (Fig. 14). This rules out a possible
involvement of this signal molecule in the RetS-mediated regulation of RsrnZ.
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Figure 3-14. Modulation of rsmZ transcription by CDA in the WT, refS andfleQ mutant backgrounds.
Effect of the addition of 50 JlM CDA on rsmZ transcription in the PASH50 (rsmZ-Iux), PAKR53 (MefS rsmZ-
lux) and PAMM94 (/t,.jleQrsmZ-lux) strains. As negative control methanol (used to dissolve CDA) was added to
a corresponding concentration of 5% (v/v),
3.3.12 Cis-2-decenoic action on biofilm dispersal is not dependent on FleQ
Previous studies indicate that bis-(3' -5'j-cyclic di-guanosine monophosphate (c-di-GMP) is a
key intracellular signal controlling the equilibrium between biofilm formation and biofilm
dispersion phenotypes. An increase in c-di-GMP levels enhances biofilm formation while
decreasing swarming motility [234-237]. A possible way in which c-di-GMP might impact on
biofilm formation could be by activating the Rsm/Gac system. This hypothesis was supported
by the observation that high intracellular concentrations of c-di-GMP induce the rsmZ-lux-
based fusions (M. Messina, PhD thesis). Since CDA is involved in biofilm dispersion, the
hypothesis that the CDA molecule could act by promoting the turnover of c-di-GMP seemed
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plausible. Intracellular levels of c-di-GMP have been found to be linked to the DSF signal
transduction in studies conducted on Xanthomonas campestris [232]. Moreover, FleQ has
been recently demonstrated to be a c-di-GMP-responsive transcriptional factor, repressing
genes required for biofilm formation when c-di-GMP levels in the cells are low [238]. This
regulator was also found to be involved in modulating c-di-GMP turnover (M. Messina, Phf
thesis).
The formulated hypothesis was that CDA was acting on biofilm dispersal through FleQ
activation. FleQ would promote c-di-GMP turnover, thus decreasing rsmZ transcription and
increasing RsmA positive regulation on swarming. Lower concentration of c-di-GMP would
in turn promote FleQ repression activity on biofilm formation genes. In order to test this
hypothesis, the ability of CDA to inhibit rsmZ transcription was compared in the wild type
PASH50 (rsmZ-lux) and PAMM94 (4fleQ rsmZ-lux). These experiments showed that CDA
was still able of reducing rsmZ activity in both strains (Fig. 14). Hence, FleQ does not
mediate the effect of CDA on rsmZ expression. However, this data does not exclude the
possible direct effect of CDA on intracellular c-di-GMP concentrations. Further experiments
are needed to prove this hypothesis.
3.4 DISCUSSION
The GaclRsm global post-transcriptional regulation system regulates the expression of many
virulence associated genes in P. aeruginosa [154, 155, 157]. The signals acting on the sensors
GacS, LadS and RetS remain unknown. In this study, it was examined the modulation of the
signal synthesis, in an attempt to identify these molecules and, to understand the mode of
action of the biofilm dispersal molecule CDA via the GaclRsm system.
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The behaviour of the rsmZ and rsm Y transcriptional fusions was analysed for the first time
using the lux operon as the reporter gene instead of the commonly used laeZ. A higher
promoter activity of rsmY compared to rsmZ was observed (Fig. 2), confirming previous data
[228]. Recently, the lower activity of the rsmZ promoter was shown to be caused by the
presence of a region containing the binding site of MvaT or MvaU, which act as repressors
[226]. While adding P. aeruginosa extra-cellular extracts can further enhance rsmZ
transcription, the same extracts failed to activate rsmY (Fig. 3). This is in discordance to what
was previously observed [221], and can be explained by the difference in the reporter genes
used to create the fusion (-laeZ based transcriptional fusion used in the past, compared to the
-lux based fusion used in this study).
Since the identification of signal molecules activating the RsmlGac system was the aim of this
study, the investigation continued using the rsmZ-lux reporter exclusively.
The regulatory pattern of the rsmZ expression, in particular its growth-phase dependance,
could be linked to a cell density-dependent type of regulation such as QS. For this reason, it
was investigated whether the production of signal molecules activating the RsmlGac system
was somehow modulated by one of the three QS systems of P. aeruginosa. Therefore, we
focused our attention on the activation of the rsmZ-lux transcriptional fusion by extra-cellular
extracts derived from strains mutated in each of the three QS systems. Extracts derived from
strains defective in the las, the rhl and the pqs systems were analysed. The QS defective strain
(Alas!: :GmR, Srhll»: TeR, ApqsA) was also examined.
The extracts derived from the strains mutated in each of the QS systems activated the rsmZ-
lux reporter in a similar way to the extracts derived from the wild type strain. However, the
triple QS mutant extracts (Alas!::GmR, ArhlI::TeR, ApqsA) activated rsmZ transcription later
in the growth-phase (Fig. 4). This result suggests that the production of the signal(s)
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activating the RsmlGac system is partially modulated by the QS systems. A link between the
RsmlGac system and the production of signal QS molecules has been previously shown
[147]. Therefore, it is not surprising to find that in P. aerugniosa the QS systems have an
effect on the production of signal molecules modulating RsmlGac. It would be interesting to
analyse the effect of rsmZ activation in the triple mutant compared to the WI reporter strain
PASH50.
It was also interesting to investigate whether the effect of the triple QS mutant extracts on
rsmZ transcription was due to a general decrease in the concentrations of AHL signal
molecules content. However, neither the 30C12-HSL nor the C4-HLS molecules have an
effect on the fusion (Chapter 4). The finding that PQS activates the rsmZ-lux fusion suggests
that the effect seen on the signal production is due to the decrease in PQS content in the extra-
cellular extracts of the triple mutant. However, extracts from the pqsA mutant induce the
rsmZ-lux fusion in the same way as the extracts from the WT. Hence, the QS network is
partially involved on the indirect modulation of RsmlGac signal generation. The effect and
the dynamics of PQS interaction with the RsmlGac system are further investigated in Chapter
4.
The importance of the RsmlGac system in the production of the signal was also investigated.
Contrary to what was previously observed in P. fluorescens and P. aeruginosa [202, 221], the
signal production is independent from the RsmlGac system. Extracts derived from strains
defective in each of the sensor kinases (LadS, RetS and GacS) were able to activate rsm2
transcription similarly to extracts derived from the WT. In addition, the response regulator
(GacA) and the fmal post-transcriptional regulator (RsmA) did not affect the production of
signal molecules activating the rsmZ promoter. Our results are difficult to reconcile the
previously accepted model in which GacS/A partially regulates the production of its own
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signal in a positive feedback loop. In P. fluorescens the RsmlGac system has a strong global
effect on genes important for biocontrol activity [223] by allowing the bacterium to survive in
the natural environment. It is possible that this post-transcriptional regulation system, which
allows the bacteria to quickly adapt to changes in the environment, positively auto-regulates
its activity in a pattern that is common to QS regulation. On the other hand, in P. aeruginosa,
the QS systems are the main regulatory pathways acting on virulence genes, while two-
component response systems are rather involved in promoting adaptability to different
environmental conditions.
Thus, it seems possible that while P. fluorescens has a way to positively autoregulate
Gac/Rsm system using the signal molecules, in P. aeruginosa this TCS is regulated in a more
complex way. On one hand, the RsmlGac system senses for changes in the environment and
modulates the synthesis of QS molecules. On the other hand, the QS system is partially
involved on the signal generation modulating RsmlGac. This could explain why in a defective
QS strain the RsmlGac signal generation is affected, while when mutating the components of
this rcs system (such as GacS, LadS, RetS, and GacA) the effect on the signals production is
not so apparent as for P. fluorescens.
Due to the large variety of phenotypes controlled by the RsmlGac system, it was not
surprising to find that many HPLC fractions activate (through GacS or LadS activation) or
repress (through RetS activation) rsmZ transcription. The diversity and multiplicity of
molecules acting on the RsmlGac system confers complexity to its modulation. Although
fractions activating rsmZ were found, the activating effect on the reporter strain was lost after
the second round of fractionation, probably due to the dilution beyond active levels of the
signal molecules during the process. For future studies it would be interesting to analyse the
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HPLC fractions by using the double transcriptional-translational reporter fusion DsRedE2,
which is more strongly activated by the extra-cellular extracts (Fig.l l).
In parallel to the HTLC fractionating method, a TLC approach was used in order to identify
signals acting on the RsmlGac system. An extract from the I1pqsA mutant was separated by
TLC and analysed using two different reporter strains. The PAKR08 (l1pqsA rsmZ-lux)
reporter strain in P. aeruginosa and the more elaborated and sensitive P.fluorescens CHAO
double transcriptional-translational DsRedE2 reporter. Unfortunately, it was not possible to
identify any spot on the TLC plate corresponding to active molecules, although the
background noise effect observed using the -lux based reporter (PAKR08) was drastically
reduced when using the new fluorescence-based sensor. Further studies have to be carried out
to maximise the detection method. Previous studies conducted on the GacS sensor kinase of
Pi fluorescens have shown that the periplasmic loop is not essential for GacS activity [224].
Thus, the signals are able to activate GacS by directly entering into the cytoplasmic
membrane. This observation suggests that the signal molecules are highly lipophilic. This
explains why the standard TLC method failed to to separate and identify the signal molecules.
Hence, specific TLC plates and soluble phase for highly lipophilic compounds should be used
instead.
The results obtained in liquid cultures of P. fluorescens CHAO double transcriptional-
translational biosensor DsRedE2 showed that this biosensor responds to extra-cellular
P. aeruginosa extracts in a more sensitive way when compared to the PAKR08 biosensor
(Fig. 11). This bioreporter strain could be used for future fractionation studies.
Finally, it was discovered that the CDA signal molecule represses small regulatory RNAs,
rsmZ and rsmY, thus increasing the abundance of free RsmA and possibly promoting biofilm
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dispersal. This molecule does not act on the rsmZ and rsmY transcription through modulating
the activity of the sensor kinase RetS.
Previous findings linked the diffusible signal factor (DSF) to c-di-GMP turnover in
X campestris [239]. It is possible that CDA could act on rsmZ transcription through the
modulation of intracellular levels of c-di-GMP. Further studies have to be conducted in order
to measure the variation in c-di-GMP concentration in the strain treated with CDA.
Nevertheless, it was possible to exclude the indirect effect of CDA on c-di-GMP homeostasis
via FleQ.
The action of CDA on P. aeruginosa biofilm dispersal is very significant [225]. Thus,
understanding how CDA acts on biofilm dispersal is essential for the development of new
classes of antimicrobial compounds for the treatment of P. aeruginosa infections. In this
study, it was shown that CDA represses rsmZ and rsmY transcription, suggesting that this
molecule is involved in the more global modulation of the RsmlGac system. Further studies
are needed to understand whether the effect of CDA on biofilm dispersal can be entirely
attributed to the modulation of this post-transcriptional regulatory system.
3.5 CONCLUSIONS
The identification of the molecules modulating the Gac/Rsm pathway is crucial for the
development of compounds able to target the sensor kinases at the top of this transductional
cascade. In this study new sensor strains based on rsmZ-lux and rsmY-lux reporter fusions
were developed with the aim to detect and identify the signal molecules activating the
Gac/Rsm system in crude extracts cultures. These reporter strains, together with the
fluorescence based double transcriptional-translational reporter, represent a powerful
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biomolecular tool for future studies aiming to uncover the nature of the Gac/Rsm signal
molecule(s). Although neither TLC nor HPLC fractionation studies allowed the identification
of novel signal molecules, it was possible to identify PQS as a signal molecule activating
rsmZ transcription (see Chapter 4 for further details).
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ChaIJter 4
Modulation of the Gac/Rsm
system by PQS
4 Modulation of the GaclRsm system by PQS
4.1 INTRODUCTION
In certain bacterial species, the production of virulence factors and secondary metabolites is
subject to the expression of genes which are regulated both at the transcriptional and post-
transcriptional level.
In P. aeruginosa, the GaclRsm two component regulatory system directly regulates the
production of secondary metabolites and is involved in controlling motility. It also exerts a
global effect on P. aeruginosa production of virulence determinants by controlling the
expression of the synthase genes las! and rhlI of the QS network [81, 141, 147, 151].
One of the genes found to be controlled by RsmA is lecA, which codes for the lectin LecA
(also known as PA-IL) [152]. Although LecA protein levels were shown to be strongly
enhanced in an rsmA mutant, there was no evidence supporting the hypothesis of RsmA
directly binding the lecA mRNA. Since LecA production is regulated via the las/rhl QS
cascade [80, 240], the formulated hypothesis was that RsmA repression was a consequence of
a reduction in the levels of AHLs. This hypothesis was supported by the finding that a strain
overproducing RsmA was shown to have reduced levels of 3-oxo-CI2-HSL and C4-HSL
[152]. However, the inability to restore the levels of lectin by exogenously adding AHLs to
the RsmA-overexpressing strain, suggested that RsmA was also involved in lecA modulation
in a QS-independent way.
The regulation of LecA has been extensively studied for its importance in biofllm
development. LecA and LecB function together as adhesins, which are important for biofilm
architecture, and exert a cytotoxic effect towards the respiratory epithelial cells [241-243].
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The production of LecA was found to be regulated VIa QS, as a leeA::luxCDABE
transcriptional fusion (the lux operon was inserted into the leeA gene at the 73rd codon in
P. aeruginosa chromosome) was shown to be activated by RhIR and its cognate autoinducer
molecule C4-HSL. The finding of a conserved lux-box in leeA promoter region suggested that
RhIR could promote leeA transcription binding to this region [194]. The involvement of the
QS system in the regulation of leeA, was confirmed by Diggle et al. (2003). PQS was shown
to enhance the production of RhIR and C4-HSL, and to act on the sigma factor RpoS that is
also involved in leeA transcriptional regulation [94].
From these data it is not possible to have a clear understanding of the way PQS regulates the
transcription of target genes. A pqsE mutant does not produce LecA, but it produces wild type
levels of PQS. This finding suggested that this metallo-Belactamase-like protein could act on
leeA transcription as a mediator ofPQS action [94, 104].
An analysis of transposon mutants conducted on the leeA::lux reporter strain constructed by
Winzer (2000) revealed that MvaT is another important regulator of leeA expression, which
acts negatively on leeA transcription [244]. MvaT is a transcriptional regulator belonging to a
family of proteins functionally related to the H-NS proteins [245]. Moreover, it was found
that the deletion of a second regulator belonging to the H-NS protein family, namely MvaU,
was also causing the derepression of leeA transcription [246].
A more recent study, aiming to detect the determinants involved in biofilm formation,
revealed that the sigma factor RpoE (AlgU) was critical for the formation of key matrix
biofilm components, by indirectly acting on leeA transcription (Fig. 1) [247].
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Figure 4-1. Schematic representation of lecA transcriptional and post-transcriptional regulation.
Dashed arrows indicate the indirect effect of the regulators (this is the case of RpoE and PqsE), that the exact
binding site of the regulator to the promoter is unknown (as in the case of MvaU and MvaT), or that the
regulation has not been previously proved (this is the case of RsmA post-transcriptional regulation).
Finally, it is important to note that the majority of experiments conducted to unravel lecA
transcriptional modulation described here, were obtained using the lecA::lux fusion
constructed by Winzer et al. (2000) [194]. In this reporter strain, the lux operon was inserted
at the 73rd codon of the lecA gene in the chromosome of P. aeruginosa. Thus, the effects of
the post-transcriptional regulation on this reporter cannot be excluded.
Swarming motility is another phenotype regulated by RsmA. In this case the regulation is
positive, as an rsmA mutant is impaired in the ability to swarm [151]. Rhamnolipids are
essential for swarming motility [248]. RsmA was shown to be involved in the post-
transcriptional regulation of the rhamnolipid biosynthetic operon rhiAB. However, the lack of
swarming of the rsmA mutant is not solely due to the reduced rhamnolipid synthesis, since
additional factors could be implicated [151]. The way RsmA exerts its positive effect on the
translation of rhlA is still unknown. In E. coli, the RsmA analogue CsrA has been shown to
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exert positive effects at the level of the jlhDC operon that regulates flagellar motility [249].
CsrA binds to a 5' region of the jlhDC mRNA, stimulating its translation and stabilizing the
transcript [135]. Possibly, in P. aeruginosa there is an equivalent mechanism by which RsmA
modulates rhlA translation.
As previously found (Chapter 3), HPLC fractionating studies conducted on the extracellular
extracts of P. aeruginosa PAO I revealed that PQS is able of activating rsmZ-lux
transcriptional fusion. This signal molecule is involved in the cell-to-cell communication
mechanism known as QS, and is generally considered to control virulence gene expression at
the transcriptional level. It was investigated whether PQS was able to exert its post-
transcriptional control on target genes, by altering the levels of rsmZ sRNA.
4.2 AIM OF THE STUDY
It was interesting to analyse the mode of action of PQS on rsmZ transcription in order to
demonstrate the role of PQS in the control of target genes such as swarming and LecA
production, through the modulation of the Gac/Rsm system.
4.3 RESULTS
4.3.1 PQS induces the rsmZ promoter and delays rsmY promoter inactivation
Extracellular extracts from P. aeruginosa were able to activate rsmZ-lux fusion. In particular,
HPLC fractionation of solvent-extracted supernatants revealed the presence of more than one
fraction responsible for the induction. Further HPLC/mass spectrometry analysis revealed the
presence of PQS in an active fraction. The induction of both rsmZ and rsmY by PQS was
analysed on a pqsA mutant background PAKR08 (llpqsA rsmZ-lux) and PAKR09 (llpqsA
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rsmY-lux). Overnight cultures of PAKR08 and PAKR09 reporter strains were diluted 1000
times in LB media with the addition of 80 IlM PQS or 5% (v/v) of methanol as a negative
control, and then grown in a TECAN assays (Material and Methods, 2.11). It was shown that
PQS activates rsmZ transcription, and delays rsmY transcriptional inactivation (Fig. 2).
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Figure 4-2. Activation of the rsmZ-lux and rsmr-tux fusions by PQS.
Effect ofPQS addition to the strains PAKR08 (t'!.pqsA rsmZ-lux) (A) and PAKR09 (t'!.pqsA rsmY-lux) (B). 80 f.1M
of PQS added (circles) compared to the control, 5% (v/v) methanol (squares).
4.3.2 .Dose-response curve of PQS inducing the rsmZ promoter
Since it was not possible to further enhance rsmY activation (in agreement with earlier
observations, see Chapter 3), the rsmZ-lux reporter was used to create a dose response curve
for PQS induction in the reporter stain PASH50. Under the conditions used, the half-maximal
effective concentration (EC50) was calculated to be 13 +/- 3 IlM (Fig. 3). A higher
concentration of PQS was required to obtain similar induction levels when using the
corresponding pqsA mutant reporter PAKR08 (EC50 25 +/- 4 IlM). The pqsA mutant is
defective in the production of a large number of AQs molecules [114]. The results obtained
here indicate that PQS is the main AQ responsible for the activation of rsmZ.
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Figure 4-3. Dose response curve of the maximal activation or the rsmZ-lux reporter.
The maximal activity of the rsmZ-lux reporter at different PQS concentrations was plotted in the wild type
(PASH50) (circles) and in a pqsA mutant PAKR08 (squares), ECso= effective concentrations at which 50% of
the maximal activation of each reporter system is obtained,
4.3.3 PQS induces the rsmZ promoter independently of PqsR, PqsE, and in synergy
with the Gac two component system
PQS binds and activates the transcriptional regulator PqsR that in turn induces the expression
of the pqsABCDE operon required for PQS biosynthesis and signaling [97], Whilst the
proteins encoded by pqsABCD are required for the biosynthesis of the molecule, the function
of PqsE remains unclear. However, PqsE is essential for the regulation of PQS-controlled
genes and can exert this function on its own [94, 104, 109, 250]. It was therefore assessed
whether the induction of rsmZ expression by PQS was dependent on PqsR or PqsE. Thus, the
ability of PQS to induce the rsmZ was analysed in the strains PAKR48 (llpqsR rsmZ-lux) and
PAKR42 (llpqsE rsmZ-lux). Interestingly, PQS was able to activate the rsmZ promoter in the
absence of either PqsR or PqsE, suggesting the existence of an alternative mechanism
responsible for this activation (Fig.4). Moreover, although rsmZ-lux response curve was
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different in the PAKR08 strain (/j,pqsA rsmZ-lux) compared to the corresponding wild type
reporter strain PASH50 (rsmZ-lux) (Fig. 5), a pqsA mutation did not affect rsmZ induction by
PQS (Fig. 4).
Since GacA and GacS are key regulators of rsmZ expression, it was investigated the
possibility that PQS might induce rsmZ transcription via the GacA/GacS two-component
system. Hence, the effect of PQS were tested on the rsmZ promoter fusion in the strains
PAKR40 (/j,gacA rsmZ-lux) and PAKR29 (/j,gacS rsmZ-lux) respectively. As expected, the
activity of the fusion was very low in both of these mutants compared to the wild type.
However, by adding PQS it was able to double the residual maximal activity of the reporter.
This suggests that PQS acts in synergy with the GacA/GacS two-component system for the
induction of rsmZ transcription (Fig. 4).
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Figure 4-4. Activation of the rsmZ-lllx fusion in different mutants by PQS.
PQS was added (in gray) at a concentration of 80 )!M in the strains PASH50 (rsm2-lux), PAKR40 (~gacS rsm'Z-Iux),
PAKR29 (~gacA rsm2-lux), PAKR44 (MadS rsm2-lux), PAKR42 (~pqsE rsm2-lux), PAKR48 (~pqsR rsm2-lux), PAKR08
(~pqsA rsm2-1ux), PAKR75 (~rhIR rsm2-lux) and PAKR74 (MasR rsm2-lux). Maximal promoter activity is defined as the
maximum relative light units (RLU) per optical density of the culture at 495 nm (OD49S) obtained over the duration of the
experiment. As control (in white) methanol 5% (v/v) was added. .
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Furthermore, it was interesting to investigate the importance of LadS and RetS for rsniZ-lux
activation by PQS. As expected, the rsmZ-lux fusion was strongly derepressed in the PAKR53
(/).refS rsmZ-lux) strain (Chapter 3, Fig. 13), and hence the addition of PQS to this mutant
failed to affect the maximal bioluminescence levels observed (data not shown). Induction of
the fusion by PQS did not appear to be affected by the ladS deletion in the strain PAKR44
(MadS rsmZ-lux) (Fig. 4). Thus, PQS induces rsmZ transcription in a RetS and LadS
independent way.
Interestingly, when ladS was deleted, the expression of rsmZ-lux fusion was not affected.
LadS does not seem to be essential for rsmZ activation, indicating that, under the conditions
used, the main elements controlling rsmZ expression are GacS/GacA (in a positive way) and
RetS (in a negative way). This observation is in contrast to what was previously shown in the
P. aeruginosa PAK strain by Ventre et al. (2006) [155].
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Figure 4-5.rsmZ-lux activity in the WT andpqsA mutant background.
Induction ofPASHSO (rsmZ-lux) (squares) and PAKR08 (t.pqsA rsmZ-lux) (circles).
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4.3.4 PQS induces the rsmZ promoter independently of RhlR and LasR
Detailed analysis of the rsmZ promoter reveals the presence of an unreported lux-box located
immediately upstream of the -35 site. This 20-nucleotides sequence, although not an inverted
repeat, shows significant sequence similarity to the putative luxI, rhlI and rhlA lux-boxes (Fig.
6) [251].
-35,
gac box
TGTAAGCATTAACTTACA
-192 -17S
-55
lux box
CG~GGTTTTCTGG~GT
~ ~ -36
CGilGGGTTTTCTGGcllrTPAKR54
rsmZ
rhlA
luxI
Figure 4-6.0rganization of the rsmZ promoter.
Upstream the gac-box activating sequence, while immediately upstream of the -35 site the lux-box of which eTG and eAG
nucleotides (underlined) are conserved in other promoters containing a lux-box (rhll, rhlA and lux! promoters are compared).
Of these, the 2nd and 3' nucleotides (CT) and the 15,h and 16th(AG) were mutated to give rise to the strain PAKR54 (rsmZ'-
lux). The conserved nucleotides present in lux-box from other promoters are also shown (in grey).
These observations led to the hypothesis that rsmZ is also controlled by the RhIR and/or the
LasR systems (Fig. 7). Confirming this hypothesis, multi copy overexpression of lasR
(PKR69) or rhlR (pKR 70) in the strain PASH50 (rsmZ-lux) caused a strong induction of the
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rsmZ-lux reporter. However, the addition of C4-HSL and 3-oxo-C12-HSL to the strains
carrying the plasmids pKR69 and pKR 70 failed to increase rsmZ expression (Fig. 8).
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Figure 4-7. Effect of different QS signal molecules on rsmZ-lux activity
Impact of QS signal molecules on the PASH50 strain: C, methanol 5% (v/v); C12, 3-oxo-CI2-HSL; C4, C4-HSL; PQS,
HHQ; MPQS. All the molecules were added at a final concentration of80 11M,
To investigate whether rsmZ activation by RhIR and LasR requires the intact lux-box, 4 point
mutations were performed as described in Material and Methods (section 2.4.4) (Fig. 6). The
plasmids pKR70 and pKR69, containing full length rhlR and lasR genes respectively, were
transformed into the strain PAKR54 (rsmZ*-lux). In this fusion, the lux operon is under the
regulation of the rsrnZ* promoter mutated in the putative lux-box. Neither RhIR nor LasR
were activating the rsrn?:' promoter, suggesting that RhlR and LasR activate the rsmZ
promoter through its lux-box (Fig. 8).
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Figure 4-8. Effect of mutating the lux-box element on the activity of the rsmZ promoter.
The activity of the rsmZ promoter in the strain PASH50 (in light gray) was compared with the activity of the rsmZ* promoter
(mutated lux box) in the strain PAKR54 (dark gray) measured in the presence of P. aeruginosa extracellular extracts, PQS
(80 I-IM), and when overexpressing RhlR and LasR. As a control, methanol 5% (v/v) was added.
The effect of rhlR and lasR overexpression on rsmZ-lux in a gacA (PAKR29) and gacS
(PAKR40) mutant background were also analysed. As observed in the wild type, both in the
gacA and gacS mutant background RhlR and LasR were capable of activating the rsmZ
promoter. Therefore, these regulators acted independently from GacA and GacS, probably
binding to a yet unidentified region in rsmZ promoter (Fig. 9).
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Figure 4-9. Effect of LasR or RhlR overexpression on rsmZ-lux activity in a gucA and gucS mutant.
The strains PAKR29 (LlgacA rsmZ-lllx) and PAKR40 (LlgacS rsmZ-lux) were analysed in the presence of the pKR70
(RhIR++) and pKR69 (LasR++) plasm ids. As a control (white bars) the strain carrying the empty plasmid to create the
genetic bank (pME6000) was used.
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These observations led to the hypothesis that PQS had an indirect effect on rsmZ-lux
activation by promoting rhlR transcription. This hypothesis is in line with the fact that PQS
modulates many genes through the activation of the rhl system [93]. However, both PAKR74
(6.lasR::GmR rsmZ-lux) and PAKR75 (6.rhIR rsmZ-lux) strains responded to the addition of
PQS as the wild type strain (PASH50) (Fig. 10).
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Figure 4-10. Effect of rhlR and lasR mutation on the activation of the ,tmlZ promoter by PQS.
The activation of the rsmZ promoter by PQS addition (80 ~M) (in dark gray) was compared in the PASH50 (rsmZ-lux),
PAKR75 (!':.rhIRrsmZ-lux) and PAKR74 (MasR::Gmll rsmZ-lux) mutant with respect to the addition of solvent methanol 5%
(v/v) (light gray).
4.3.5 Construction of an E. coli heterologous system for the study of RhlR regulation
on rsmZ transcription.
To further analyse whether RhIR could regulate rsmZ independently from the genetic context,
it was analysed the effect of RhIR overexpression in a heterologous system. For this purpose,
a specific plasmid pKRI8 was constructed (Materials and Methods, 2.4.6). This plasmid
carries the rsmZ-lux fusion. The rhlR gene is under the stringent regulation of an inducible tae
promoter (Fig. II). The tae promoter is repressed by LacIQ, whose effect is hampered upon
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the addition of IPTG. In inducing conditions (1 mM IPTG), RhIR is expressed and can bind
the rsmZ promoter. To avoid unwanted interaction of the LuxR homologue (SdiA) with rsmZ
[252], pKR18 was transformed in the E. coli RVH-E1 strain (~diA) [190].
pKR18
1
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Figure 4-11. Schematic representation of the pKR18 vector.
This vector is derived from pME6032. rhlR was cloned into the multicloning site under the regulation of the tac promoter. In
the absence of IPTG, Lac! (whose transcription is constitutive) is active and binds to the tac promoter repressing rhlR
transcription. Adding IPTG (1 mM) causes Lac! to detach from the tac promoter, rhlR is expressed and RhIR is able to bind
(in the presence or absence of the cognate signal molecule C4-HSL) to the rsmZ promoter which transcribes the luxABCDE
operon.
In non-inducing conditions (no IPTG), significant levels of bioluminescence expression were
detected. This indicates that rsmZ is active in the E. coli heterologous background. However,
when inducing rhlR expression, the level of rsmZ transcription increased approximately
threefold (Fig. 12). On the other hand, when the experiment was repeated using the plasmid
pKR19 (rsmZ*, lux-box mutated), the induction of rhlR failed to increase rsmZ expression
(Fig. 12).
It was then tested whether the addition of the RhlR cognate signal molecule C4-HSL waS
affecting the levels of rsmZ transcription. No alterations of rsmZ expression were observed
(data not shown), suggesting that, in this heterologous system, RhIR acts as a transcriptional
activator ofrsmZthrough its lux-box in a C4-HSL independent way.
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Figure 4-12. Effect of the overexpression of rlllR on the activation of rsmZ-lux in an heterologous E. coli
system.
Activity of the rsmZ promoter in an E. coli (t1sdiA) strain carrying pKR 18 (rsmZ-lux) (triangles) or pKR 19 (rsmZ*-lux)
(squares), The experiment was conducted in non-inducing conditions (empty symbols), and when rhlR expression was
activated (filled symbols),
4.3.6 PQS induces the rsmZ promoter independently from pyocyanin
Phenazines are amongst the virulence factors produced by P. aeruginosa in response to PQS
signaling [109]. These molecules are redox-active compounds which exert their toxicity on
other prokaryotes and eukaryotes [253]. Recently, the phenazine pyocyanin was suggested to
act as a QS signaling molecule involved in the activation of a specific set of genes during late
exponential growth phase [254]. It was interesting to assess whether PQS might induce the
rsm2 promoter via increased pyocyanin production. Thus, it was analysed the effect of
pyocyanin on the rsm2-lux fusion. Pyocyanin was extracted from P. aeruginosa cultures
(Material and Methods, 2.16.2) and then added to the growth medium at a concentration of
100 JlM. Under physiological conditions, pyocyanin is a zwitterion [255]. Therefore, when
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adding pyocyanin to the growth media, it was important to buffer the culture to a defined pH
(PHs ranging from 5.0 to 9.0 were tested). The expression of the rsmZ-lux reporter increased
with pH independently from the addition of pyocyanin. This indicates that pyocyanin does not
mediate the PQS-dependent induction of rsmZ (Fig. 13).
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Figure 4-13. Effect of pH and pyocyanin on the activity of the rsmZ promoter.
Maximum bioluminescence of the PASH50 (rsmZ-lux) strain when adding water (white bars) or pyocyanin (gray bars) in
different pH buffered media.
In order to exclude the possibility that phenazines were involved in rsmZ modulation, the
rsmZ-lux transcriptional fusion was introduced in a strain unable to produce phenazines. In P.
aeruginosa PAO1, the production of phenazines is controlled by two operons, namely phzl
andphz2. The mutant defective in both operons PAKR76 (l1phz1l2 rsmZ-lux) was created and
then tested for its ability to respond to PQS. PAKR76 reporter was still able to respond to
PQS addition (Fig. 14). It was concluded that pyocyanin and in general phenazines are not
necessary for the physiological induction of rsmZ by PQS.
Recent studies showed that pyocyanin exerts its signaling function through the activation of
the transcriptional factor SoxR [256]. This is a redox-responsive regulator that activates the
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transcription of genes containing a specific upstream binding site (sox-box). However, an
analysis of rsmZ promoter showed that this box is not present, suggesting that the response
regulator SoxR is not involved in PQS action on rsmZ transcription. To exclude this
hypothesis, a soxR mutant carrying the rsmZ-Iux fusion should be tested for PQS activation.
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Figure 4- 14. Effect of phenazines mutant on the activation of rsmZ-lux by PQS.
Activity of the rsmZ-Iu.x fusion in the PASH50 (rsmZ-Iux) and PAKR76 (t:.phz//2) strains in the presence (gray bars) ofPQS
(80 IlM). As a control, methanol 5 % (v/v) was added (white bars).
4.3.7 PQS induces the rsmZpromoter independently from the formation of membrane
vesicles
Recently, the role ofPQS in the formation of membrane vesicles (MVs) was described [257].
PQS, unlike HHQ, can interact strongly with the membrane lipids promoting the formation of
the MV s. These vesicles are involved in important biological processes, such as delivering to
the neighbouring cells PQS and other antimicrobial quinolones [257]. HHQ was shown to
have no effect on rsmZ-lux. Moreover, it is believed that this molecule is not involved in MV s
formation. Thus, it was interesting to investigate if the effect of PQS on rsmZ promoter
140
activation was due to its physiological effect on the lipid membrane, rather than acting as a
signal molecule. For this purpose, PQS derivatives that interact with the outer membrane
lipids were tested for their ability to induce rsrnZ expression. A range of PQS derivatives with
altered acyl side-chain lenght were tested; PQS acyl side-chain is composed of seven corban
atoms, for this reason we refer to it as C7-PQS. Among all the analogues tested, only C3-PQS
had a slight inducing effect on the rsmZ-lux fusion (Fig. 15).
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Figure 4-15. Effect of different PQS analogues on the TsmZ-IIiX fusion.
The activity of PASH50 (rsm2-lux) after the addition of PQS (C7·PQS) or different PQS analogues varying in the acyl chain
length (from I to 9 carbons) or in the ring substitutions (NO group). 80 j.lM of each molecule were added. As a control 5%
(v/v) methanol was added.
4.3.8 PQS induces the rsmZ promoter independently from its 'iron chelating activity
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Previous studies have revealed that PQS is able to chelate iron, thus facilitating siderophore-
mediated iron delivery into the cell [98]. Therefore, it was important to understand if PQS
was acting on rsmZ transcription through its signaling properties, or by modulating the iron
availability in the cell. To evaluate the importance of iron chelation for the PQS-dependent
regulation of rsmZ, the rsmZ-lux induction was examined after the addition of methyl PQS
(MPQS). This molecule is structurally similar to PQS and chelates iron with a similar affinity.
However, MPQS does not have signaling properties [98]. The addition of MPQS did not
affect rsmZ transcription (Fig. 7). This suggests that PQS induces rsmZ only through its
signaling properties, rather than by acting on the iron availability in the medium. To confirm
this, saturating amounts of Fe3+ (100 ~M) were added to the media, in alternative 80 ~M of
preformed PQS-Fe complex (in a 3:1 ratio). The expression of rsmZ is not affected neither by
iron in its soluble form, nor by its PQS-chelated form, confirming previous results (Fig. 16).
400 r-------------------------------------------------------------------------------------------~
--cnlr
-C7pas
300 --Cl paS·Fe(3:1)
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8
Growth lOO ",0)
Figure 4-16. Effect of iron and ofiron-PQS complex on the activation ofrsmZ-lllx.
Activity of rsmZ-lux fusion when adding PQS (80 ~M), PQS chelated with iron (3:1 ratio) or only iron at physiological
concentration (100 ~M). As a control 5% (v/v) methanol was added.
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4.3.9 Farnesol inhibits rsmZ transcription
Farnesol is a compound produced by many organisms involved in inter- and intraspecific
interactions [258, 259]. This volatile sesquiterpene was recently shown to inhibit the
production of PQS by repressing the pqs operon [260]. For this reason, it was decided to
investigate the effect of famesol on the expression of rsmz' Interestingly, famesol reduced
rsmZ-lux activity in a WT strain (Fig. 17). When adding famesol to the /1pqsA mutant this
effect was not evident, supporting the hypothesis that famesol modulates rsmZ transcription
by repressing PQS production.
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Figure 4-t7. Effect offan1esol on rsmZ-lux activity.
Effect of the addition of increasing concentrations of farnesol on rsm2 promoter activity in the PASH50 strain (gray) and in
the PAKR08 (/lpqsA rsm2-lux) mutant background (white).
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4.3.10 Dynorphin promotes rsmZ transcription
The ability of P. aeruginosa to intercept the opioid compounds produced by the host, and to
integrate them into the quorum sensing circuit, has been recently reported [261]. During stress
conditions, the host organism releases opioids. P. aeruginosa has developed the ability to
sense the dynorphin opioid produced by mammalian intestinal cells, enhancing its virulence.
Recently, the synthetic analogue U-50488 was shown to directly induce the production of
multiple virulence factors and in particular of the PQS signal molecule. Therefore, the effect
of dynorphin on the rsmZ-lux fusion was explored. As expected, this molecule was shown to
activate the rsmZ-lux fusion in a PQS-dependent way. Indeed, when adding dynorphin U-
50488 to PAKR08 (tJ.pqsArsmZ-lux), the effect on rsmZwas not evident (Fig. 18).
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Figure 4-18. Effect ofdynorphin on rsmZ-lux activity.
Addition of dynorphin 100 J.lM (in gray) has an effect on rsmZ-lux activity in a PASH50 background compared with a
PAKR08 (pqsA rsmZ-lux) mutant strain. As a control 5% (v/v) methanol was added (in white).
4.3.11 PQS inhibits swarming motility
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It is known that in P. aeruginosa, an rsmA defective strain does not swarm [151]. Hence,
since PQS induces rsmZ transcription, addition of PQS should result in a reduction in
swarming caused by the titration of RsmA by RsmZ. To investigate this, the effect of the
addition of 80 J.lMofPQS, HHQ or MPQS on P. aeruginosa PA01 swarming phenotype was
tested (Materials and Methods section 2.1). As predicted, whilst MPQS and HHQ have little
or no impact on swarming, PQS shows a substantial inhibition of this phenotype (Fig. 19).
control HHQ MPQS PQS
Figure 4-19. Effect ofPQS on swarming.
Effect of the addition of80 liM ofPQS on swarming motility of P. aeruginosa.
4.3.12 Dual transcriptional and post-transcriptional control of lecA by PQS.
The data previously obtained suggest a clear involvement ofPQS in the Gac/Rsm pathway. In
order to further support this hypothesis, it was necessary to analyse the effect of PQS on a
gene whose expression is modulated by the GaclRsm system. It was analysed the impact of
PQS on lecA expression by constructing both transcriptional and post-transcriptional fusions.
The complex regulation of lecA can be divided into transcriptional and post-transcriptional
regulation (Fig. 1). The expression of this gene has been extensively studied for its
importance in biofilm development [241].
4.3.12.1 RsmA directly controls the expression of lecA at the post-transcriptional level
Using a teen-lux transcriptional reporter and Western blot analysis, the global post-
transcriptional regulator RsmA was found to exert a negative control on the production of the
LecA (PA-IL) galactophilic lectin [94, 152]. However, the mechanism by which RsmA
regulates the expression of lecA remained to be elucidated, as it was not clear whether this
control was direct or through another regulator. To investigate whether RsmA directly
controls lecA mRNA translation, the 5' untranslated transcribed region (UTR) of this gene
was translationally fused to lacZ (lecA '-'lacZ) and transcribed from a constitutive kanamycine
resistance gene promoter (PKm)'This resulted in the generation of the plasmid pMM44 (PKm
lecA '-'lacZ). When this plasmid was transformed into the wild type PA01, the B-galactosidase
activity remained constant during the first 5 hrs of incubation, until the end of the exponential
phase, after which the reporter was induced (Fig. 20). However, when the same plasmid was
introduced in strain PASK09 (overexpressing rsmA), the B-galactosidase activity remained at
basal levels (Fig. 20). These results indicate that RsmA controls lecA expression by acting
directly on the lecA 5' UTR.
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Figure 4-20. Regulation of a translational PKm-lecA '- 'lacZ reporter fusion by RsmA.
Plasmid pMM44 carrying the translational reporter fusion was introduced in the wild type P. aeruginosa PAO} (diamonds)
and in strain PASK09 overexpressing rsmA (triangles).Il-galactosidase activity (in Miller Units) was followed in time.
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Previous studies demonstrated that RsmA interacts directly with lecA 5' VTR. These studies
were performed by RNA electrophoretic mobility shift assays, as described elsewhere (S.
Kuehne, PhD thesis). Briefly, transcripts corresponding to the 5' VTR of lecA from the +1
nucleotide to the start codon were produced in vitro, incubated with increasing amounts of
purified RsmA and subsequently resolved by non denaturing polyacrylamide gel
electrophoresis. The complexes were electro-transferred onto a nylon membrane and the RNA
was detected using a lecA 5' VTR DIG-labeled DNA probe. Increasing amounts of RsmA
caused an RNA mobility shift, demonstrating that RsmA directly interacts with the lecA 5'
VTR. The 115-nt 5' VTR of the carA gene (PA4758), encoding a putative carbamoyl-
phosphate synthase, was used as a negative control. No alteration in the RNA mobility
patterns of carA was observed, confirming that the binding of RsmA to the lecA mRNA is
specific.
4.3.12.2 PQS exerts its control of lecA expression both at the transcriptional and the post-
transcriptional level
At the transcriptional level, the lecA gene is controlled by two QS signal molecules, C4-HSL
and PQS [94, 194]. The fusion used to study lecA transcriptional regulation was made by
inserting the luxCDABE operon at the 73rd codon of lecA in the chromosome of P. aeruginosa
[194]. Consequently, there was a possibility that the 219 nucleotides encompassing these first
73 codons could be subjected to an unexpected post-transcriptional regulatory effect. In order
to exclusively assess the transcriptional control of the lecA promoter, a new lecA-1UX
transcriptional fusion was used. In this fusion, the 5' VTR region of the lux operon waS
directly fused to the+1 lecA transcription start nucleotide (M. Messina, PhD thesis).
To study the post-transcriptional modulation of /ecA, a second fusion was created. This
construct encompassed the 5' VTR of lecA and the 18th first codons (C. Pustelny, PhD thesis).
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Contrary to the construct used previously by Winzer et al (2000), the new lecA -lux constructs
were made using the mini-CTX::luxCDABE transcriptional reporter delivery system carried
by pHKBS 1, which effectively integrates the fusions in the chromosome at the CTX
attachment site [198]. In the fusion used by Winzer et al. (2000), the lecA coding sequence
was replaced by a double homologous recombination with the lecA -lux fusion, resulting in a
LecA-negative strain.
Both the PlecA'(18 codons)-luxand the PlecA(+I)-lux were cloned into pHKBS 1, resulting in the
pCP2 and pMM84 plasmids, respectively. These plasmids were then introduced into the wild
type strain PA01 to generate the PACP2 and PAMM84 strains, respectively (Fig. 21).
PAO chromosome PlecA-lux fusion (Winzer et al., 2000)
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Figure 4-21. Schematic representation of the different lecA fusions utilized in this study.
In line with previous studies, both new fusions were induced by PQS and by a C4-HSL-PQS
mixture [194]. Interestingly, the induction of the lecA'(18codons)-luxby the culture supernatant
was higher than that of the lecA(+1)-lux, indicating the existence of post-transcriptional control
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of lecA expression by culture supernatants (Fig. 22). In the attempt to identify the molecule in
the culture supernatant responsible for lecA '(18 codons)-IUX activation, the HPLC-derived
fractions previously found to activate rsmZ was tested (Chapter 3). Fraction 6 (the one
containing PQS) was found to activate the lecA '(18 codons)-Iux fusion, suggesting that PQS is
one of the molecules responsible for lecA post-transcriptional activation. These results
reinforce the hypothesis that the control of lecA expression by PQS and RsmA can occur at
the translational level, and that the key elements of this regulation are present within the
region encompassing the 5' UTR and the first few codons of lecA.
CTX::lecA+1-1ux
~ 14 ..----------- .....
Q
Q 12
;J
~ 10
?: 8
......,
i:
'; 2
1$
:s 00 4 8 12 16 20
time after inoculation [h]
CTX: :lecA l8cod-lux,...,J14
Q 12
::>
~ 10
§ 8
......,
i :
.~ 2
'0:s o~o~~--~--~--~--~
4 8 12 16 20
time after inoculation [h)
Flpre 4-11. Induction or ebromosomal/ecA-lux fusions by culture supernatant extracts in P. aeruginoS{J
baekaround.
Transcriptional lecA(+lr/ux compared with the lecA(+I8)-lux. Extracts were added to the reporter strains (1:2 culture to extract
ratio) (diamonds). Methanol was added as negative control (squares).
4.3. J2.3 Study of leeA regulation by the pqs system and by its own product
It is known that quorum sensing regulates lectin production. More specifically, the expression
of leeA is induced directly by RhlR and indirectly by PQS [94, 194]. In order to understand
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the way PQS was modulating lecA, it was analysed the lecA transcriptional (lecA(+wlux) and
translational (lecA'(l8 codons)-lux)fusions in different mutant backgrounds (Fig. 23A and 238).
In particular, it was tested the effect ofPQS in the wild type background PAMM84 (lecA(+l)-
lux) and in the mutants PAKR60 (6pqsA lecA(+l)-lux), PAKR61 (6pqsE lecA(+wlux),
PAKR62 (f¥JqsR lecA(+w1ux), PAKR63 (f¥JqsA//lpqsR lecA(+w1ux), PAKR64 (f¥JqsA//lpqsE
lecA(+w1ux), PAKR65 (/lrhIR lecA(+l)-lux) and PAKR87 (f¥JqsA//lrhIR lecA(+l)-lux). PQS was
found to activate the lecA(+l)-lux fusion in all the tested backgrounds, suggesting that PQS
transcriptional activation of lecA is dependent on a yet unknown regulator (Fig. 23 A).
To analyze the post-transcriptional effect of PQS on lecA, the translational fusion
(lecA'(l8 codons)-lux)was inserted into the wild type (PACP2) and into different backgrounds,
giving rise to the PAKR88 (f¥JqsA lecA'(I8codons)-lux), PAKR68 (6pqsE /ecA'(l8codons)-lux),
PAKR89 (6pqsR /ecA'(l8 codons)-/UX), PAKR84 (f¥JqsA//lpqsR lecA'(l8 codons)-lux),PAKR85
(/lpqsA//lpqsE /ecA'(l8 codons)-/ux), PAKR83 (/lrhIR /ecA'(l8 codons)-/UX) and PAKR86
(/lpqsA//lrh/R /ecA'(I 8 codons)-/ux). As previously observed with the /ecA transcriptional fusions,
PQS was found to activate the /ecA'(l8 codons)-/UX fusion in all the tested backgrounds. These
results suggest that PQS acts on /ecA translation through a yet unidentified regulator (Fig.
23 B). Curiously, in the strain PAKR8S (/lpqsA//lpqsE lecA'(l8 codons)-/UX) the activity of the
fusion is ten time higher than what observed in the other backgrounds. Moreover when adding
PQS to this train, the fusion is further enhanced.
As expected, PQS addition had a stronger effect on the lecA'(l8 codons)-Iuxfusion compared to
the /ecA(+l)-/UX fusion, both in the wild type and in the mutants background. This difference
can be explained by the presence in the /ecA'(l8 codons)-/UX fusion of the RBS of /ecA, which is
positively regulated by PQS.
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Figure 4-23. Effect of PQS addition to different mutant backgrounds on transcriptional and translational
teen-lux fusions.
(A) PQS (80 J.1M)was added to different mutant backgrounds to the lecAwlux fusion (in grey). As a control, 5% (v/v) MeOH
was added (in white). (B) PQS (80 J.1M)was added to different mutant backgrounds to the lecA+I8cod-lux fusion (in grey). As a
control, 5% (v/v) MeOH was added (in white).
Itwas also observed that the levels of lee.A-lux expression were significantly higher in the first
fusion used by Winzer et al. [194], which was obtained by gene replacement insertion of the
luxCDABE operon at the 73rd codon of lecA in the chromosome, thus creating a lecA-
defective mutant. For this reason, it was studied the role of lectin in the modulation of its own
expression. For this purpose, the strain PAOI lecA-lux was transformed with a plasmid
expressing lecA (PLECA). When the expression of lecA is restored, the levels of lecA-1UX
expression are significantly reduced, suggesting that lecA could modulate its own expression.
However, lecA expression is not restored to the levels observed using the lecA'(I 8 codons)-lux
and iecA(+I)-lux fusions (still 20 times higher) (Fig. 24). This can be explained by the
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Figure 4-24. Effect of lectin overexpression on lecA-lux transcriptional fusion.
The lees-lux fusion created by Winzer et al (2000) (triangles) was complemented with the pLECA plasmid overexpressing
lecA (squares). PAPCP2 (iecA'(I8 oodons)-Iux) and PAMM89 (iecA(+l)-lux) fusions are also shown (line and circles,
respectively).
4.3.12.4 Study of lecApost-transcriptional regulation by PQS
These results suggest that PQS activates an important switch in the post-transcriptional
control of lecA expression. Thus, a pqsA mutant (unable to produce this signal molecule)
should show a reduction in lecA translation. To investigate this, pMM44 (PKm lecA'-'!acZ)
was introduced into the PAOpqsA (¥qsA) strain. Deletion of pqsA resulted in reduced B-
galactosidase activity (Fig. 25A) when compared to the parent strain. Furthermore, addition of
80 J.1MPQS to this PAOpqsA (¥qsA) increased B-galactosidase activity up to two folds,
confirming the positive post-transcriptional control of lecA expression by PQS (Fig. 25B).
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As a negative control, the pMMll (PKm lacZ'-'lacZ) plasmid was used. This plasmid
contained the lacZ coding sequence and its 5' UTR, under the transcriptional control of PKm
constitutive promoter. pMMl1 was transformed into the wild type and the PAOlpqsA
background. The addition of PQS did not have an effect in the B-galactosidase activity (data
not shown).
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Figure 4-25. Effect of PQS on a PJ(m-lecA '-'lacZ translational reporter fusion.
(A) pMM44 carrying the translational reporter fusion was introduced in the wild type P. aeruginosa PAOI (diamonds) and
its ApqsA derivative (squares). B-galactosidase activity (in Miller Units) was followed in time. (B) As before, using the strain
~pqsA/pMM44. The medium was supplemented with either methanol (squares) or PQS (80 f.1M)(circles).
4.3.J2.5 PQS post-transcriptional action on lecA, through rsmZ and rsmY
PQS seems to act positively on lecA post-transcriptional regulation, and in opposition with the
negative regulation exerted by RsmA. The suggested model was that PQS induced the
transcription of the regulatory sRNAs (RsmY and RsrnZ), which would in turn titrate out
RsmA. The concentration of free RsmA in the cell would decrease, preventing the action of
this protein on lecA mRNA. Indeed, a deletion of either rsmY or rsmZ in the tJ.pqsA
background, PAKRIOI (¥qsAlrsmy) and PAKRI02 (¥qsAlrsmZ), abolished PQS post-
transcriptional regulation of the translational reporter carried by pMM44 (Fig. 26).
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Figure 4-26. Effect of PQS on a PKm-lecA '-'lacZ translational reporter fusion in the llrsmZ and llrsmY
background.
pMM44 carrying the translational reporter fusion was introduced in the double (A) PAKRI02 (l'lpqsAlrsmZ) or (B)
PAKRIOI (/¥JqsAlrsmY) mutant strain. B-galactosidase activity (in Miller Units) was followed in time after the addition of
PQS (circles) or methanol solvent control (squares).
4.3.12.6 PQS post-transcriptional action on swarming is not dependent on rsmZ and rsm Y.
To carry out a more general analysis of PQS action on phenotypes regulated by RsmA, it was
decided to investigate if PQS was acting on swarming through the induction of rsmZ and
rsm Y expression. The effect of PQS addition on swarming phenotype was tested on the
double mutants PAKRIOI (6.pqsAlrsmY) and PAKRI02 (6.pqsAlrsmZ) background. In both
cases, PQS is still able to inhibit swarming. Hence, its effect appears to be unrelated to its
modulation of the Rsm/Gac system, and is due to a mechanism that remains to be elucidated
(Fig. 27).
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Figure 4-27. Effect of PQS on swarming in the wild type, the double PAKR101 (f1pqsAlrsmY) and
PAKRI02 (f1pqslrsmZ) background.
PQS was added to a final concentration of 80 ~M to the swarming plates. As a control, 5% (v/v) methanol was added.
4.3.12. 7 Epistatic analysis on PQS and rsmA expression
In order to demonstrate that PQS exerts its effect on lee.Aexpression through rsmZ and not by
negatively modulating rsmA expression, epistatic analysis were carried out.
Previous microarray analysis conducted on the PQS regulon indicates that PQS does not
affect rsmA mRNA levels [262, 263]. Itwas performed a western blot analysis comparing the
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levels of RsmA produced in the wild type and in the pqsA mutant, with the latter being
supplemented with 80llM of PQS. The results indicate that PQS does not affect RsmA
protein levels. Thus, its effect on rsmZ transcription is not through the modulation of RsmA
protein levels (Fig. 28).
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Figure 4-28. Effect of PQS on RsmA protein levels.
SDS-PAGE analysis of P. aeruginosa protein extracts derived from (I) PAOI, (2) PASH03, (3) PAOpqsA (6pqsA) and (4)
PAOpqsA with the addition or80 ~M ofPQS in the growth media.
4.4 DISCUSSION
The finding that PQS had an effect on rsmZ-lux activation led us to the hypothesis that PQS
had a role on post-transcriptional regulation. Thus, it was decided to investigate whether PQS
signal molecule was involved in the modulation of the Gac/Rsm system.
Although the addition of 10 flM of PQS to the medium did not induce the homologous rsmZ-
lacZ fusion in P. jluorescens CHAO, the effect of this molecule on P. aeruginosa had not been
previously tested. PQS has been reported to be produced by P. aeruginosa at concentrations
ranging from 6 to 25 flM [92, 94, 111], hence the concentrations of synthetic PQS that induce
the rsmZ-lux fusion used in this study (ECso = 13-25 flM depending on the endogenous
production of PQS) are well within the physiological range.
Firstly, the possibility that PQS action on rsmZ-lux was through its iron chelating potential or
through its interaction with the membrane lipids was excluded. Then, the identification of the
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regulator responsible for PQS activation of rsmZ transcription was carried out. This analysis
was among the regulators known to respond to PQS (PqsR, PqsE, RhIR),.
It was also interesting to understand the hierarchy of PQS modulation. Although functional
OacS and OacA proteins were shown to be required for more than 90% of the full expression
levels of rsmZ, PQS was able to double the residual activity of the rsmZ promoter in the gaeS,
gaeA and ladS mutants, suggesting that PQS acts independently of and synergistically with
the Gac system. In particular, it was observed that LadS was not affecting rsmZ transcription.
Unfortunately, we still cannot provide an explanation for this data, which disagree with
previous experiments. However, it needs to be considered that earlier experiments showing
LadS modulation of rsmZ, were conducted on the P. aeruginosa PAK strain [155]. Therefore,
it is possible that the genetic diversity of P. aeruginosa PAO1 and PAK may account for the
dissimilar rsmZ modulation.
Apart from the AQs, it was also evaluated the potential of the AHLs, 3-oxo-C12-HSL and
C4-HSL to modulate rsmZ expression. The GaclRsm system has been previously shown to
control QS by modulating the Las and Rhl systems and the amounts of AHLs produced over
growth [147. 152]. However. evidence for the inverse regulation, i.e. the post-transcriptional
regulation of the Rsm system by the Las and/or Rhl systems, has not been found. Here it was
shown that the overexpression of lasR or rhlR from multicopy plasmids induced the rsmZ-IUX
reporter, whereas deletion of the chromosomal/asR or rhlR had no significant effect on the
induction of the rsmZ fusion by PQS. The positive impact of RhlR and LasR overproduction
on the activity of the rsmZ promoter in the absence of AHLs is interesting. Given that rsmZ
contains a lux box that is required for RhlR, LasR-dependent activation, it is possible that the
two LuxR homologues are capable of acting in the absence of AHLs, although this remains to
be confirmed.
Interestingly, disruption of the lux box also made the reporter unresponsive to exogenous
PQS, and it is important to note that the rsmY promoter seems to lack this regulatory region.
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However, the presence of an intact lux box was not required for substantial induction of the
rsmZ promoter by spent culture extracts. This suggests the existence of additional activating
signal molecules, which could act via the Gac two component system on different regions of
the promoter.
The effect of RhIR overexpression on rsmZ-lux was also analysed in the heterologous E. coli
system. The results suggest that RhIR acts on rsmZ promoter in a direct way, independently
from the genetic context, and that this regulation is dependent on the integrity of the lux box.
It was also investigated whether PQS was modulating rsmZ through the activation of
phenazines and in particular of pyocyanin. This metabolite has been suggested to function as
the terminal signal of a sequential QS cascade involving the ordered activation of the Las, Rhl
and PQS systems. This cascade results in the expression of a sub-set of genes designated as
the PYO stimulon [254]. Although pyocyanin was not found to activate rsmZ promoter, it was
interesting to observe the effect of pH on rsmZ-lux fusion.
In E coli, the function of BarA and UvrY (the orthologues of GacS and GacA) depends on the
pH of the growth medium. Indeed, the expression of rsmZ analogues csrB and csrC is reduced
under acidic conditions [264]. Although a similar effect of acidic pH on the expression of
rsmZ was observed, our results are too preliminary to conclude that pH is involved in rsmZ
regulation in P. aeruginosa. It is also probable that pH modulates the light output of the lux
reporter by affecting the presence of the substrates required for the bioluminescence.
Finally, it was investigated the role of PQS on post-transcriptional regulation. The proposed
hypothesis was that this molecule could indirectly modulate RsmA target genes such as lecA
by modulating the amount of free RsmA.
RsmA negatively controls the production of the galactophilic lectin LecA and represses a
chromosomally-encoded transcriptionallecA-lux fusion. This repression can be overcome by
supplying PQS to the medium [94, 152].
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Firstly, it was demonstrated that RsmA directly binds to the leeA mRNA leader sequence.
This confirms that RsmA exerts its negative effect on leeA at the post-transcriptional level (S.
Kehune, PhD thesis). A post-transcriptional PKm-leeA'-'laeZ fusion was also shown to be
negatively regulated by RsmA overexpression.
Secondly, it was shown that PQS controls leeA expression both at the transcriptional (using
the leeA+I-lux transcriptional fusion) and post-transcriptional level (using the PKm-leeA'-'laeZ
post-transcriptional fusion).
At the transcriptional level, PQS seems to activate the leeA(+l)-lux independently from RhlR,
PqsR and PqsE. This observation is in disagreement with previous data (Fig. 1). Thus, it
seems possible that PQS transcriptional activation of leeA depends on a yet unidentified
regulator, and is unrelated to the rhl or to the pqs systems.
Curiously, when using the fusion leeA'(l8 codons)-Iux, PqsE seems to act in synergy with PqsA
for the repression of the fusion. Indeed, in the strain PAKR85 (!¥JqsAIll.pqsE leeA'(l8 codons)"
lux) the fusion is highly active (10 times more than in the other backgrouds). This activation
is further increased when adding PQS.
At the post-transcriptional level, it was shown that PQS regulation of leeA is mainly through
the modulation of rsmZ transcription, since rsmY transcription is not affected by PQS.
However, the presence of a functional rsmY gene is required for PQS to fully induce the PKm-
lecA '. 'lacZ translational fusion. As rsmY promoter is one of the most highly expressed in
P. aeruginosa [228], a deletion of this gene will itself have a strong impact on the RmsA-
sRNA balance in the cell. This effect cannot be overcome by the induction of rsmZ by PQS.
Itwas also show that PQS does not affect RsmA protein levels, hence the possibility that PQS
acts through the negative modulation of rsmA expression can be discarded. Our data is
confirmed by previous microarrays analyses, which indicate thatPQS does not affect rsmA
mRNA levels [113,262].
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Altogether, the above results strongly support the hypothesis that rsmZ, in concert with rsmY
and in opposition to rsmA, is the principal gene mediating the post-transcriptional control of
gene expression by PQS. In particular, it was shown that RsmA and PQS have opposite
effects on LecA production: whilst RsmA acts as negative regulator acting on lecA 5' UTR,
PQS has a positive effect, both on its transcription and indirectly on its translation rates (Fig.
27).
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Figure 4-29. Schematic representation of PQS action on both the QS and the Gac/Rsm regulatory
systems.
4.5 CONCLUSIONS
In this chapter, we present a better understanding of the global control of virulence in
P. aeruginosa. The importance of this study resides on the fact that we demonstrate that QS
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signal molecule PQS controls global gene expression at the post-transcriptional level. In
particular, we showed that the expression of virulence factors such as lecA is positively
controlled by PQS at the post-transcriptional level, and that this regulation is essentially
occurring via RsmZ. Moreover, it was established that rsmZ expression is enhanced by PQS
in synergy with the Gac system, although the intermediate regulator by which PQS regulates
rsmZ transcription remains unknown.
To date, the molecular basis by which PQS controls virulence remains obscure. This is mainly
because PqsE, an enzyme of the metallo-beta-lactamase superfamily, still remains unknown,
while the transcriptional regulator PqsR only appears to directly bind to the pqsA promoter.
This study adds a further layer of complexity to the QS driven regulation of virulence in
P. aeruginosa.
161
Chanter 5
Study of rsmZ
transcriptional regulation
162
5 Study of rsmZ transcriptional regulation
S.l INTRODUCTION
The GacS/GacA two component system is conserved in different bacteria, as it regulates a
broad range of virulence and stress response factors [265]. GacS/GacA homologues are also
found in Erwinia and Vibriofisherii species, VarSNarA in Vibrio cholerae, BarAlUvrY in E.
coli, BarNSirA in Salmonella, and LetSlLetA in Legionella.
When activated by phosphorylation, the GacA response regulator promotes the transcription
of small regulatory sRNAs, which in turn bind and reduce the activity of the free post-
transcriptional regulators belonging to the RsmA/CsrA family. This two component system
modulates the expression of the target genes through the regulation of small regulatory RNAs
(sRNAs) [136, 223, 228, 266-268]. To date, there has been no evidence showing the direct
transcriptional regulation of target genes by this two component system (independently from
the sRNAs).
In P. aeruginosa, the GacS/GacA TCS acts exclusively through the modulation of rsmZ and
rsmYexpression [226]. Studies conducted on the rsmZ and rsmY promoter regions allowed
for the identification of two conserved regions, which may represent the upstream activation
site (VAS) recognized by the phosphorylated form of GacA [202, 228, 269]. Transcriptional
r9mZ and r9mYfusions lacking the VAS region were shown to lose their activity in a similar
way to what observed when mutating the GacA response regulator [226]. These results
confirmed the importance of the VAS sequences for GacA activation, and suggested that the
phosphorylated GacA binds these sequences.
Similar sequences have been found in the promoter region of the regulatory sRNAs of Vibrio
jischeri, P.fluorescens and L. pneumophila [202, 268, 269].
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The difference in length and structure of rsmZ and rsmY promoters suggests that they are
differently regulated. Indeed, it was recently demonstrated that two members of the H-NS
family of global regulators, namely MvaT and MvaV, could bind to an A-T rich region
located 174-bp between the VAS and the transcriptional starting site of the rsmZ promoter.
This A-T rich region is not present in rsmY [226]. MvaT and MvaV act as repressors. This
explains the higher activity of the rsmY promoter when compared to the one of rsmZ [228].
On the other hand, the HptB signaling pathway was shown to control exclusively rsmY
through a yet unidentified sigma factor [160]. In details, HptB is the histidine-containing
phosphotransfer module of a hybrid system, and its phosphorylation is activated by three
hybrid sensors, namely PA2824, PAI611 and PA1976 [140]. When HptB is active, it
represses the PA3346IPA3347 cascade, inhibiting the release of a yet unknown a factor that
promotes rsmYtranscription [160].
Although the GacS/GacA system acts solely through the modulation of rsmZ and rsmY
transcription, these two sRNAs are regulated in a different way by complex networks (HptB)
or regulators (MvaT and MvaV). These further layers of regulation of rsmZ and rsmY may
have evolved to allow for a more precise response to specific environmental conditions.
5.2 AIM OF THE STUDY
In the previous chapter, it was analysed the effect of the PQS signal molecule on rsmZ
transcriptional activation. The results presented in this chapter are aimed at the identification
of new regulators of rsmZ and rsm Y transcription, and in general at the discovery of new
pathways modulating this post-transcriptional regulatory system.
For this purpose, three different approaches were used. On one hand, a series of promoter pull
down experiments were performed on rsmZ and rsmY promoters, which allowed for the direct
identification of regulators binding in vitro to the promoters. On the other hand, we used the
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genetic bank and transposon mutagenesis approach to identify new regulators acting in vivo
on the rsmZ promoter.
5.3 RESULTS
5.3.1 Construction and screening of a genetic bank
Three independent genetic banks were generated using the chromosomal DNA from
P. aeruginosa PAO-L strain (Materials and Methods, section 2.5), and were used to transform
the strain P. aeruginosa rsmZ-lux (PASH50). A total of 6000 colonies were screened for
increased or decreased light production compared to the PASH50 strain with the empty
pME6000 plasmid.
If we consider the size of P. aeruginosa PAO! chromosome, the number of clones screened
and the average size of the cloned chromosomal fragment, we can calculate that by screening
6000 clones we are covering 94% of the genome, as determined by Poisson's distribution
p = 1 - (1- ( 1/ g))n ,
where p is the probability of cloning a particular fragment (which corresponds to the genomic
coverage), g is the size of the genome (6270 Kb), I is the average size of the chromosomal
fragments cloned (2-4 Kb, I = 3), and n is the number of mutants screened [270, 271].
5.3.2 RhIR and LasR enhance rsmZ transcription
Using the genetic bank approach, we identified two clones with enhanced light production.
The chromosomal fragment cloned into the plasmids pKR69 and pKR 70 contained the lasR
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and rhlR coding regions, respectively (Fig. 1).
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Figure 5-1. Effect of overexpression of genetic bank fragments on rsmZ transcription.
Activity of rsmZ-Iux fusion at OD495 = 0.5 in PASH50/pME6000 (rsmZ-Iux) (cntr), and with the plasmids
pKR69 (lasR), pKR70 (rhIR) and pKR71 iupf). Error bars are standard deviation between three independent
experiments.
5.3.3 An unknown fragment of PAO! genome promotes rsmZ transcription
A third clone carrying the plasmid pKR71 derived from the genetic bank, was found to
greatly enhance rsmZ promoter activity (Fig. 1). The plasmid pKR71 was sequenced and
analysed using the P. aeruginosa Genome Sequence database
(http://www.pseudomonas.com). However, the 3.1 Kb fragment cloned in this plasmid did not
correspond to any known region. Further analysis was conducted using the BLAST programs
available from the NCBI web site (http://www.ncbi.nlm.nih.gov/). The analysis revealed that
this fragment had not been previously sequenced and it contains three ORFs potentially
coding for a hypothetical protein homologue to the Pmen_2122 from P. mendocina ymp, a
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novel serine/threonine phosphatase and a novel serine/threonine protein kinase (Fig. 2).
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Figure 5-2. Organization ofORFs in upjfragment from pKR71.
The upjregion identified with the genetic bank approach is a 3.1 Kb fragment which carries three open reading
frames (ORFs). The second and the third ORF were cloned separately in the expression vector pME6032, giving
rise to the plasm ids pKR73 and pKR72. Moreover, the first ORF and each combination of the three ORFs were
cloned into the pME6000 vector, giving rise to pKR78, pKR80, pKR79 and pKR81.
Further peR analysis, which was conducted using primers specific to the unknown fragment,
revealed that this sequence was present not only in the PAO l-L strain (from which the genetic
bank fragments were derived) but also in the strains PAOI-N and PAOI-DSM.
To confirm this, a Southern blot analysis was performed on different strains of P. aeruginosa-
The 3.1 Kb sequence was excised from pKR71 and used to produce a DIG-labeled probe
(Materials and Methods, section 2.9). This probe was tested against the chromosome of the
167
different PAOl sublines derived from the laboratory collection (PAO-N, PAO-L, PAO-DSM)
(Fig. 3). The chromosomes derived from these strains were extracted and digested with two
restriction enzymes, namely Psti (non cutter) and NdeI (cuts the cloned fragment once, giving
rise to two digestion products of 1.S Kb and ].6 Kb). As a negative control, the chromosomal
DNA from PA14 was used, as the 3.1 Kb fragment appeared by peR to be absent from this
strain. When cutting the chromosomal DNA with NdeI, only a single fragment of molecular
weight higher than 23 Kb was visible in all the P. aeruginosa PAO sublines tested. When
cutting the chromosome with PstI, a shorter band of approximately 10 Kb was visible (Fig.
3).
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Figure 5-3. Southern blot of genome from different P. aeruglnosa PAOl strains, using up! frament as a
probe.
The up! region identified with the genetic bank approach. Lanes 1 and 5 represent bands obtained using the
genomic from PAI4, while Lanes 2 and 6 represent bands obtained using the genomic from PAOI-N; lanes 3
and 7 represent bands obtained using the genomic from PAOI-DSM; lanes 4 and 8 represent bands obtained
using the genomic from PA01-L. M represents the marker (DNA Molecular Weight Marker £I, DIG-labeled,
Roche).
Previous studies conducted on the analysis of different P. aeruginosa clinical isolates showed
that the PAO 1 genome is highly diversified among different strains. In the P. aeruginosa
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genome, there are specific segments called regions of genomic plasticity (RGP), which are
characteristic of each strain. The RGP include regions of at least four contiguous ORFs and
have been acquired by horizontal transfer. The RGP regions are thought to confer greater
diversity to P. aeruginosa, enabling it to adapt and to survive in a wide range of niches [272].
In some cases, these DNA segments derive from prophages that are integrated into the
chromosome. The organization of the ORFs phosphatase/kinase/kinase observed in the 3.1 Kb
fragment is similar to the organization of the genes in some prophages integrated into the
bacterial chromosome [273]. For this reason, we decided to call this 3.1 Kb region the
Unknown ~hage fragment (up.!).
5.3.4 The up/is not present in the clinical isolates tested
It was interesting to investigate if the up/region present in strain PAO} was also found in
P. aeruginosa strains in chronicle infection. Therefore, we performed a Southern blot analysis
to study the presence of the up/ region in eight clinical isolates from cystic fibrosis patients.
The strains are derived from pediatric (isolates number }, 4, 7 and 9) and adult patients
(isolates number 14,23,35 and 73). The up/region was not detected in any of these isolates,
suggesting that it is strain-specific.
5.3.5 The entire up/is needed for the induction of rsmZ promoter
To analyse which of the three complete ORFs were responsible for the activation of the rsmZ-
lux transcriptional fusion, the second and third ORFs, coding for a threonine/serine
phosphatase and a kinase respectively, were amplified and then cloned into the inducible
expression vector pME6032, giving rise to pKR73 (ORF 2) and pKR72 (ORF 3). The
hypothesis was that the kinase or the phosphatase could modulate the GacAiGacS
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phospohorilation state. pKR73 and pKR72 were transformed into the PASH50 (rsmZ-lux)
strain to assess the induction of bioluminescence.
However, neither ORF2 nor ORF3 restored rsmZ promoter activation, suggesting that two or
more ORFs might cooperate for the activation of rsmZ transcription. Thus, we decided to test
all the ORFs combinations (Materials and Methods, 2.4.5). The resulting vectors are pKR78
(1 ORF), pKR80 (I and 2 ORFs), pKR79 (2 and 3 ORFs) and pKR81 (1 and 3 ORFs) (Fig.
2). These vectors were transformed into PASH50 and tested for rsmZ-lux activation. None of
the ORFs combination tested was capable of acting on rsmZ transcription, suggesting that the
entire up/was required for the activation ofrsmZ.
5.3.6 The upI acts on rsmZ independently from GacA and GacS
We were interested in understanding whether the up/region was acting on rsmZ activation in
a GacA or GacS dependent way. However, when transforming the pKR71 plasmid into the
strains PAKR29 (/lgacA rsmZ-lux) or PAKR40 (/lgacS rsmZ-lux), we could still observe an
induction of rsmZ transcription by upf, suggesting that this activation is GacAiGacS
independent (Fig. 4). Although up/region codes for a serine/threonine phosphatase/kinase, its
effect is not due to a modulation of the GacA or GacS phosphorylation. Further studies have
to be performed in order to understand if the up! fragment modifies the phosphorilation state
of another component of this TCS system, such as RetS or LadS.
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Figure 5-4. Impact of up/overexpression on rsmZ-lux reporter fusion in the gacA and gacS mutant
background.
The vector pKR71 carrying the up/fragment was introduced in the PAKR29 (f'.gacA rsmZ-lwc) and PAKR40
(f'.gacS rsmZ-lwc) strains. The maximal promoter activity is defined as the maximum relative light units (RLU)
per optical density of the culture at 495 nm (00495) obtained over the duration of the experiment. As a control,
the empty pME6000 vector was introduced into the PAKR29 and PAKR40 strains. The error bars are standard
deviation between three independent experiments.
5.3.7 Screening of a transposon library for mutants with altered rsmZ-lux expression
The results obtained using the genetic bank approach prompted us to develop a transposon
library in the PASH50 strain (rsmZ-lux) to screen for colonies with enhanced or reduced
bioluminescence phenotype. For this purpose, 10 random transposition experiments were
carried out (derived from 10 different conjugations between PASH50 and the strain
containing the transposon delivery vector pLMl). A total of 4000 transposon mutants derived
from PASH50 (rsmZ-lux) were screened for altered bioluminescence. The statistical
probability to inactivate a given gene in the strain PADI (5570 genes) is equal to P= 1- (I-ON,
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where f represents the genomic fraction (1/5570) and N is the number of screened clones
[270]. This equation is valid if we assume that the probability of a transposon insertion is
identical for each gene. Thus, after 4000 clones were screened we statistically covered 50% of
the genome. The site of mini-Tn5 insertion was identified by a plasmid rescue technique
(Materials and Methods, section 2.5) [196].
5.3.8 wspF mutant enhances rsmZ transcription
After screening for 4000 colonies, it was identified one clone (PAKR26) exhibiting increased
bioluminescence compared to PASHSO. The flanking regions of the transposon,
corresponding to the interrupted gene, were recovered and sequenced. The transposon had
inserted into the wspF coding region.
WspF is a methyl esterase that reduces the activity of the WspR c-di-GMP cyclase [274, 275].
When knocking out wspF, WspR is always active, and the intracellular concentration of c-di-
GMP in the cell increases. This mutation causes a very distinct phenotype characterized by a
super wrinkled colony morphology[27S]. The effect of a wspF mutation on c-di-GMP levels
was confirmed by LCIMS and by phenotypic analyses (M. Messina, PhD Thesis).
To be certain that the effect on rsmZ activation was due to the wspF mutation and not to a
polar effect, an in-frame wspF mutant PAKR50 (/:lwspF rsmZ-lux) was contructed. The
activation of rsmZ in this strain was two fold more active compared to PASH50, confirming
the result obtained with the transposon mutagenesis (Fig. 5).
It was investigated whether the effect observed on rsmZ expression was due to the alteration
of c-di-GMP levels. For this reason, it was tested whether the rsmZ activation levels could be
restored by decreasing the concentration of c-di-GMP in the cell. For this purpose, we
overexpressed the phosphodiesterase PA2567 in the PAKR50 (AwspF rsmZ-lux) background.
Phosphodiesterases (PDEs) are known to hydrolyse c-di-GMP, thus decreasing the
intracellular concentration of this signal molecule. The plasmid expressing PA2567 (pMM-
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BIO) was transformed into PAKR50 (f:..wspF rsmZ-lux). Interestingly, the overexrpessed
PA2567 strain showed reduced activity of the rsmZ-lux compared to the levels obtained with
PASH50 (rsmZ-lux) (Fig. 5). Thus, the mutation on the wspF gene causes the activation of
rsmZ transcription by acting on the levels c-di-GMP in the cell.
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Figure 5-5. Effect of c-di-GMP level alteration on rsmZ-lux fusion.
The bioluminescence of PASH50 (rsmZ-lux) and PAKR50 (LlwspF rsmZ-Iux) when overexpressing PA2567.
The measurements were obtained at OD495 = 0.4. Error bars are standard deviation between three independent
experiments.
Finally, it was interesting to study if c-di-GMP was able (through the modulation of rsmZ) to
act on final target genes controlled by the Gac/Rsm post-transcriptional regulatory system.
For this reason, a translational fusion lecA '-'mCherry was constructed, giving rise to pMM43
(M. Messina, PhD Thesis). This plasmid was then transformed into the PA2567 inducible
strain PASH51 (Materials and Methods, section 2.4.2). By inducing (l mM IPTG) PASH51,
we promoted the transcription of PA2567, thus decreasing the levels of c-di-GMP in the cell.
On the other hand, in non-inducing conditions (no IPTG) pASH51 is a MA2567. Hence, we
expect higher levels of c-di-GMP in the cell.
Our hypothesis was that PASH51/pMM43 in inducing conditions (low c-di-GMP levels)
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would have low levels of rsmZ transcript and, thus, low levels of lecA tranlation. In this case,
RsmA would be mostly in its free form (not titrated by rsmZ), able to inhibit lecA translation.
This situation would be reversed when PASHSlIpMM43 was grown in non-inducing
conditions. The results obtained using the lecA '-'mCherry fusion confirmed this hypothesis
(Fig.6).
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Figure 5-6. Effect of PA2567 overexpression on lecA'- 'mCherry fusion.
Comparison of the fluorescence derived from the strain PASH51 (PA2567 inducible strain) carrying the pMM43
plasmid (lecA '- 'mCherry) when overexpressing PA2567 (IPTG 1mM, squares) and in the PA2567 mutant
conditions (no IPTG, circles). Error bars are standard deviation between three independent experiments.
5.3.9 Promoter puD-down
We were also interested in conducting an in vitro study of rsmZ and rsmY regulation using the
promoter pull-down technique. This method allows for the identification of regulators
(present in a protein extract) able to bind to a biotinylated (BID) promoter DNA fragment that
has been previously mobilized on a streptavidin column. After an elution step, the proteins
bound to the promoter can be recovered and analysed by SDS·page. The bands corresponding
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to the proteins can be then cut and analysed using MALDI-TOF analysis. This analysis gives
us a prediction of a protein identity. The E.-scoreis the probability that the observed match is a
random event. Protein scores greater than 78 are considered significant (p<0.05).
5.3.10 Promoter pull down with the rsmZ-BIO promoter region
The promoter pull down experiment on the rsmZ-BIO or the rsmZ*-BIO (mutated in the lux-
box) promoters were conducted using proteins from crude cell extracts from P. aeruginosa
PAOI-N cultures collected at different time points in the growth curve (OD6oo 0.5, 1 and 2.5).
When necessary, different signal molecules such as agmatine (the AguR binding molecule,
refer to section 5.3.11), PQS and AHLs were added to the growth media.
To amplify the rsmZ or the rsmZ* promoter fragments we used the RVPrsrnZ and the
FWBIOPrsrnZ primers. The latter was biotinylated at the 5' end (Sigma). The SDS-PAGE
bands derived from the promoter pull-down experiment using crude extracts collected at
different growth phases (middle exponential, end exponential and stationary phase) were
differing only in intensity. At OD6OOof 1 (when the rsmZ promoter is highly induced) some
bands became more visible. The addition ofPQS (80 !AM), 3-oxo-CI2-HSL (10 j.lM) and C4-
HSL (10j.LM)signal molecules to the growth media previous to the protein extraction did not
significantly change the band pattern (data not shown).
Here, we present the results obtained using the rsmZ-BIO and rsmZ*-BIO promoters and
protein crude extracts derived from coltures of P. aeruginosa (OD6OO= 2.5). Both promoters
used produced the same protein band pattern. Nine bands were identified (Fig. 7). From these,
only eight gave a high MALDI-TOF E.score, as described below (Tab. I).
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Figure 5-7. SDS-PAGE bands derived from promoter pull-down experiment using protein extracts from
PAD) cell lysate and rsmZBID.
Bands derived using the cell lysate from PAOI, and the rsmZ promoter (1) or the rsmZ'" promoter (lux-box
mutated) (2). Seven bands were analysed by MALDl-TOF. M protein marker (Promega).
Gene Protein description P value
Band I PA4270 RNA polymerase l3-subunit 130
Band 2 PA0779 ATP-dependent Lon protease 98
Band 3 PA3831 Leucyl aminopeptidase PepA 192
Band 4 PA4238 DNA-directed RNA polymerase 0.- 133
subunit RpoA
Band 5 PA0294 Transcriptional regulator AguR 153
Band 6 PA4232 Single-strand DNA binding protein 96
Band 7 PA4315 Transcriptional regulator MvaT 84
Band 8 PA2667 Transcriptional regulator MvaU 103
Table 1.Protein fromPAO wild type, found to bind to rsmZ-BTO promoter in the pull down experiment
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5.3.11 AguR binds to the rsmZpromoter
Amongst the different proteins identified by pull-down experiments, we were able to identify
the protein AguR (Band 5). This regulator is a transcriptional repressor that binds to the
aguBA operon inhibiting its transcription. The aguBA operon is involved in the agmatine
biosynthetic pathway, which leads to the production ofpolyamines [276].
Polyamines (spermidine, spermine, putrescine, cadaverine) are ubiquitous molecules whose
role in bacteria pathogenesis has been recently proven. AguR was found to interact with the
rsmZ promoter from late exponential phase through to stationary phase. Moreover, when
incubating the extracellular protein extracts with the rsmZ* promoter (lux-box altered), AguR
was still recovered in the pull down experiment. This result suggests that AguR does not bind
to the lux-box of the rsmZ promoter (Fig. 7). Furthermore, extracting the crude proteins from
P. aeruginosa cultures grown at different temperatures (37° C and 42° C) and in different
media (LB and CAA) did not alter AguR binding to rsmZ-BIO.
The binding of AguR to aguBA operon is antagonized by agmatine, the precursor of
polyamines [276]. This is a typical negative feedback loop: when the concentration of
polyamines are low in the cell, agmatine binds to AguR impairing its binding to the aguBA
operon. This causes an increase in the synthesis of the polyamines. It was investigated the
possibility that AguR binding to rsmZ could be inhibited by the addition of agmatine.
However, when this compound was added (1 mM) to the growth media prior to the protein
extraction, the band corresponding to AguR was still appearing in the SDS-PAGE.
5.3.12 ApR overexpression shifts rsmZ transcription to a later growth phase
To study the effect of the overexpression of aguR on rsmZ transcription pKR14 was
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contructed. This plasmid contains the aguR inducible gene (plasmid derived from pME6032).
This construct was inserted into the PASH50 (rsmZ-lux) strain. When aguR was
overexpressed (1 mM IPTG), the expression of rsmZ was shifted from the exponential to
stationary phase of growth (Fig. 8). Interestingly, AguR has been shown to bind to a specific
agu-box, which is not present in the rsmZ promoter [276].
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Figure 5-8. Effect of aguR overexpression on rsmZ-lux transcriptional fusion and on growth.
Bioluminescence (left graph) and growth (right graph) of the PASH50 (rsmZ-lux) strain carrying the aguR
inducible vector pKR14. No IPTG added (diamonds); IPTG added (triangles). Error bars are standard deviation
between three independent experiments.
~.3.13 Effect of an aguR mutation on rsmZ transcription and on several phenotypes
To examine the impact of AguR on the Gac/Rsm cascade, an in-frame aguR mutant was
contructed harboring the rsmZ-lux fusion (PAKR56). The transcription of rsmZ in the
PAKR56 strain was subjected to a modest increase (by 10 %) compared to the activity of the
rsmZ-lux fusion in the PASH50 strain. The effect of aguR mutation was not as significant as
expected, suggesting that, in the conditions tested, AguR was not affecting rsmZ transcription.
For this reason, it was decided to test the PAKR56 strain for different phenotypes such as
swarming, biofilm, growth and antibiotic resistance. No significant phenotype difference
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between the mutant and the wild type strain was observed.
5.3.14 Agmatine negatively affects rsmZ transcription
Due to the importance of the agmatine molecule for the modulation of AguR activity [276],
we decided to investigate if this molecule and its polyamine derivatives, namely spermine and
spermidine, were capable of preventing AguR modulation of rsmZ. Adding agmatine to the
PASH50 (rsmZ-lux) strain caused a reduction of rsmZ activity (Fig. 9). This effect was not
observed in the PAKR56 (/laguR rsmZ-lux) background, suggesting that agmatine binding to
AguR increases its capability to repress rsmZ transcription. On the other hand, spermine and
spermidine did not have any effect on rsmZ transcription (data not shown).
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Figure 5-9. Effect ofagmatine addition on rsmZ-lux transcriptional fusion.
Maximal activation of the rsmZ-/ux fusion in the wild type after the addition of increasing concentrations of
agmatine. Maximal promoter activity is defined as the maximum relative light units (RLU) per optical density of
the culture at 495 nm (OD495) obtained for the duration of the experiment. Error bars are the standard deviation
between three independent experiments.
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5.3.15 AguR purification
The finding of AguR binding to the rsmZ promoter is very interesting. To our knowledge,
there are no studies demonstrating the direct binding of a regulator to the rsmZ promoter
region. In order to demonstrate AguR direct interaction with the rsmZ promoter, we decided
to purify AguR and to conduct DNA mobility shift analysis. AguR was cloned in the
pETI8b+ vector resulting in pETaguR (the resulting protein carries a 6-histidine tag at the C-
terminal). The plasmid was then introduced into E. coli BL21 (PLysS) for overexpression.
AguR was always found in the insoluble fraction (Material and Methods 2.6). To purify
AguR in its soluble form, we added 1 mM of agmatine to the induction culture, corresponding
to the physiological concentration found in P. aeruginosa (Fig. 10) [277]. To our knowledge,
this is the first time AguR has been purified in the soluble form.
NI FT Washes
(20. 100mM imidazole)
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(250 mM imidazole)
Figure 5-10. Purification of AguR-6His.
SDS gel containing non induced (lane 1) and induced (lane 2) protein extracts from E. coli BL21 (pLysS)
carrying the plasmid for the overexpression of AguR (pETaguR). Lane 3, flow through; from lane 4 to lane 8,
washes with 20 to 100mM imidazole. From lane 9 to lane 13, elution using 250 mM imidazole. M, protein
marker (Promega).
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5.3.16 Electrophoresis mobility shift assay of AguR on the rsmZ promoter
Unfortunately, although it was possible to purify AguR in the soluble fraction, it was not
possible to observe a shift when incubating the rsmZ-DIG probe with increasing
concentrations of AguR. At the moment, we are conducting further experiments using
rediolabelled rsmZ-p32 probe.
5.3.17 Promoter pull down using rsmY-BIO
The results obtained with the promoter pull down experiments conducted on the rsmZ
promoter encouraged us to use the same approach for the rsmY promoter. The primers
FWBIOPrsmY and RVPrsmY were used to amplify the byotinilated promoter of rsmY. The
promoter pull down experiment on rsmY-BIO was conducted using protein crude cell extracts
from P. aeruginosa PAOI-N coltures collected at different time points in the growth curve
(00600 0.5, 1 and 2.5) (Fig. 11). It was not possible to identify bands corresponding to
transcriptional regulators (Tab. 2).
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Figure 5-11. SDS gel bands derived from promoter pull-down experiment using PAO) cell lysate protein
extracts and rsmYBIO.
Bands derived using the cell lysate from PAOl 00600 ofO.5 (1),00600 of I (2) and 00600 of2.5 (3). The rsmY-
BIO promoter was used for this experiment. M protein marker (Promega).
Gene Protein description P value
Band 1 PA4270 RNA polymerase l3-subunit 102
Band 2 PA0779 ATP-dependent Lon protease 130
Band 3 PA3831 Leucyl aminopeptidase PepA 90
Table 2. Protein fromPAO wild type strain to bind to rsmY-BIO promoter in the pull down experiment
5.3.18 RsmA mediated control of rsmZ transcription through GacA
Previous studies showed that P. jluorescens RsmA (and its homologue RsmE) positively
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regulates rsmZ and rsmY transcription. Moreover, RsmA and RsmE were found to stabilize
both RsrnZ and RsmY transcripts, increasing their half-lifes [278]. Similarly, in E. coli the
RsmA homologue CsrA positively regulates the expression of the small regulatory RNAs
csrB and csrC. This control was shown to be indirect through CsrS and CsrA modulation
[279].
In P. aeruginosa numerous studies have shown how RsmA positively controls rsmZ and rsmY
at the transcriptional level, although the mechanism of action is not yet understood (Fig. 12)
[151]. This positive regulation of rsmZ by RsmA was also observed in our laboratory. When
inserting the rsmZ-lux fusion in an RsmA inducible strain PASKIO (giving rise to PAKR24),
rsmZ transcription was strongly enhanced by RsmA induction (1 mM IPTO), while it was
repressed in a ArsmA mutant condition (no IPTO) (Fig. 13).
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Figure 5-13. Effect of rsmZ-lu.x transcriptional fusion.
Bioluminescence of the P. aeruginosa PASH50 (rsmZ-lux) (diamonds) compared to the one of PAKR24
(PASKIO rsmZ-lux) in absence of [PTG (line) and in inducing conditions (triangles). Error bars are standard
deviation between three independent experiments.
Studies conducted on P. aeruginosa PAO 1 showed that RsmA action on rsmZ transcription
was independent from GacA activation [151]. The effect of RsmA on the activation of rsmZ
transcription was not evident in a gacA mutant strain. When a plasmid overexpressing RsmA
(PSK61) was transformed into the PAKR29 (L'!..gacArsmZ-lux) background, rsmZ expression
could not be enhanced to the levels observed when pSK61 was transformed into the PASH50
(rsmZ-lux) strain. Thus, our results suggest that RsmA induction of rsmZ expression is GacA
dependent (Fig. 14).
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Figure 5-14. Effect of rsmA overexpression on rsmZ-lux transcriptional fusion.
Maximal activation of the rsmZ-lux fusion in the PASH50 (rsmZ-lux) and in the PAKR29 (~gacA rsmZ-lux)
background. The strains were either carrying the empty pME6031 plasmid, or the plasmid overexpressing rsmA
(pSK61). Maximal promoter activity is defined as the maximum relative light units (RLU) per optical density of
the culture at 495 nm (00495). Error bars are standard deviation between three independent experiments.
5.3.19 Small ribosomal subunits linked to RsmA activation of rsmZ
The particularly high activation of rsmZ by RsmA prompted us to perform a pull-down
analysis on rsmZ-BIO using the protein crude extracts derived from the PASKIO strain
(RsmA inducible mutant). The aim was to identify regulators (induced by RsmA) acting in
synergy with GacA for rsmZ activation. The protein crude extracts were collected from a non-
induced PASKIO culture (RsmA mutant) at OD600 0.5, and from two induced PASKIO
cultures (RsmA overexpressing conditions) at different time points of the growth curve
(OD6000.5 and OD600 1).
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The extracts derived from PASKI 0 coltures collected at OD600= 0.5 (when rsmZ-lux fusion is
maximally activated) give rise to two defined bands of approximately 30 KDa (Fig. 15).
These bands are not visible when the protein extracts are derived from a non induced
PASKI0, or from an induced PASKIO at OD600 = 1 (Tab. 3).
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Figure 5-15. SDS-PAGE gel derived from the promoter pull-down experiment using RsmA overexpressing
strainPASK10 cell lysate protein extracts and rsmZBIO.
Bands derived using the cell lysate from PASKIO in MsmA background (no IPTO added) at 00600 = 0.5, and in
the rsmA overexpressing conditions (I mM IPTG added) at OD600 = 0.5 and OD600 = 1. M protein marker
(Promega).
-
Gene Protein description P value
Band 1 PA36S6 30S ribosomal protein S2 RpsB 146
Band 2 PA4257 30S ribosomal protein S3 RpsC 81
Table 3. Protein from PASK10 induced and non induced cultures, found to bind to rsmZ-BrO promoter in
the pull down experiment
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5.4 DISCUSSION
The experiments presented in this chapter were conducted in order to discover new pathways
acting on the regulation of rsmZ and rsmY transcription.
Through the construction of a genetic bank and through random transposon mutagenesis
regulators directly or indirectly controlling rsmZ-lux expression were identified. On the other
hand, by using the promoter pull down technique, new regulators directly binding in vitro to
the rsmZ and rsmYpromoters were identified.
P. aeruginosa PAOl was first isolated in 1954 from a wound in Melbourne, Australia [280],
and by 2000 the complete genome of the strain PAOl, of the subline PAOI-UW, had been
sequenced [5]. Later studies showed that P. aeruginosa strains kept in different laboratories
had diversified their genomes, giving rise to diverse sublines [281]. The ability of
P. aeruginosa to thrive and to adapt quickly to different conditions and environmental niches
can be explained by the incredible genomic plasticity of this bacterium. Thus, it was not
surprising to find a 3.1 Kb region in the chromosome of our PAOl-N strain, which is not
present in the sequenced strain PAOI-UW. This 3.1 Kb fragment was promoting rsmZ
transcription. Although the mechanism behind this activation has not being elucidated, it
appears that the whole 3.1 Kb sequence is essential to induce r8mZ expression. Moreover, the
mechanism by which the up! region acts on rsmZ does not seem to depend neither on GacA,
nor on GacS, suggesting that the proteins encoded by the up! region might promote rsmZ
transcription through a yet unidentified pathway.
The up/fragment was recently found to be part of a genomic island named RGP42 (12 Kb)
present in the PAOI-DSM and MPAO strains but absent in the sequenced strain PAOI-UW
[281]. Apart from the serine/threonine phosphotransferases, this genomic island contains
genes encoding typical phage proteins (integrase and coat proteins) [281]. It is possible that
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the serine/threonine phosphotransferases included in the RGP42 region confer to the phage
the ability to survival in these bacterial strains. On the other hand, when the bacteria are
exposed to different stimuli the prophage region may not be maintained and can be easily lost.
This hypothesis has been confirmed by in vivo studies conducted on the strains containing the
RGP42 region. These bacteria were more virulent than the sequenced PAOI-UW strain [281].
We can thus speculate that the original P. aeruginosa PAD! must have carried RGP42, while
the sequenced subline derived from this strain has lost this sequence.
An analysis of the chromosomal DNA derived from cystic fibroses patients colonised with P.
aeruginosa in the chronic phase of infection showed that the up! region is not present. A
possible explanation is that in the lungs of CF patients during chronic infection, the up!
fragment does not contribute to the fitness of the bacteria and is thus lost. On the other hand,
under laboratory growth conditions, up! enhances the fitness of the strain and is retained in the
genome. This hypothesis is supported by the observation that the strain PAOI-DSM (which
contais the RGP42) has been shown to have a higher fitness compared to the PAOI-UW
(i\RGP42) when grown in laboratory conditions (LB at 37 ·C aerobically) [281]. Finally, we
were able to draw a map of the fragments resulting from the restriction analysis (Fig. 16).
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Figure 5-16. Restriction analysis of up/fragment digested by NdeI and PstI.
In silico analysis conducted on the flanking regions of the sequenced P. aeruginosa PAOI chromosome that
encloses the 12 Kb deletion and the up/fragment (between PA4673.1 and PA4674) [281]. When digesting the
P. aeruginosa PAO sub lines with NdeI, we should observe two fragments of 47 Kb and 71 Kb. On the other
hand, when digesting with PstI, only one band of 14 Kb should be visible.
Using the genetic bank approach, we showed that rsmZ transcription is enhanced by RhIR and
LasR. This regulation was confirmed by the presence of a lux-box in the rsmZ promoter
(Chapter 4).
The transposon approach provided new evidence for the link between the global post-
transcriptional regulation system Gac/Rsm and c-di-GMP signaling. C-di-GMP
concentrations in the cell have been proven to affect rsmZ transcription; higher levels of this
signaling molecule (tlwspF background) activate rsmZ transcription, whilst low
concentrations of c-di-GMP (tlwspF harboring the PDEs protein PA2567) restore rsmZ to
wild type levels. The finding that c-di-GMP can modulate the target gene lecA translation
supports the hypothesis of a link between c-di-GMP and post-transcriptional regulation. When
artificially decreasing c-di-GMP levels by overexpressing the PDE PA2567, the transcription
of rsmZ is reduced. The amount of free RsmA increases, exerting its post-transcriptional
regulation on lecA. Hence, it affects lecA '-'mCherry activity.
By using the promoter pull down approach we have identified AguR, a new regulator that
directly binds to the rsmZ promoter. In vivo studies conducted on a strain overexpressing
aguR show that this regulator dramatically shifts the rsmZ peek of expression later in the
growth curve. AguR is responsible for the polyamine biosynthesis in P. aeruginosa [282]. Its
function seems to be unrelated to the Gac/Rsm post-transcriptional regulation system.
However, recent reports have linked polyamines (spermine, spermidine, putrescine and
cadaverine) to bacteria biofilm formation [283] and other important functions, such as
virulence and survival in the host. These studies were conducted in several human pathogens
such as Yersinia pestis, Vibrio cholerae and Pseudomonas mirabilts [284-286]. Moreover, the
modulation of type III secretion system by polyamines in P. aeruginosa was recently proven
[287]. In P. aeruginosa PA14, agmatine can modulate biofilm formation depending on the
growth phase [282]. This discovery, combined with our observation that high concentrations
of agmatine can affect rsmZ transcripion in an AguR dependent way, suggests that in
P. aeruginosa agmatine could be involved in biofilm regulation through the modulation of
rsmZ transcription. The hypothesis is that P. aeruginosa is able to sense this signal and trigger
a response. AguR could be the response regulator modulating the RsmA post-transcriptional
regulation system, which affects biofilm and other phenotypes.
In an aguR mutant, the activity of the rsmZ-lux fusion is not visibly affected. One possible
explanation is that, since a wide range of regulators, modulates the Gac/Rsm system, by
removing a single regulator, the overall effect on rsmZ expression is negligible. Moreover, in
the laboratory conditions tested, AguR does not seem to be important for r8mZ regulation.
Through the promoter pull down approach we also identified other interesting proteins that
interact with the rsmZ and the rsmY promoters, such as the Lon protease. Recently, the
190
involvement of the Lon protease in the regulation of the QS signaling system in P. aeruginosa
has been demonstrated. In particular, this ATP-dependent protease was found to repress the
expression of the LasRlLasl system by degrading Lasl, the synthethase involved in the
production of the signal molecule 30C12-H8L [288]. The finding that Lon protease was
binding to the rsmZ and rsmY promoters suggests that this protein is involved in the
degradation of a regulator, acting on both rsmZ and rsmY, thus having a general effect on the
OaclRsm cascade. This hypothesis would be in accordance to the finding that Lon protease is
involved in degrading TraR, the LuxR-type protein of A. tumefaciens [289].
In addition, the two H-N8 family global transcriptional regulators, MvaT and MvaU, were
found to bind the r8mZ promoter. These are small DNA-binding proteins, which have been
shown to be involved in the regulation of Q8 responses and in biofilm formation in P.
aeruginosa [208, 246]. MvaT and MvaU associate with regions of the chromosome where the
percentage (A+T) is high [290]. The region between the OacA binding site and the rsmZ
transcriptional start site is highly A+T rich. Hence, it is possible that these two proteins act on
the r8mZ promoter in this region. Brencic et al. recently confirmed this finding, showing that
MvaT and MvaU were acting as repressors of the rsmZtranscription [226].
We also obtained interesting results from the promoter pull down analysis of the cultures
derived from P. aeruginosa strain overexpressing RsmA (PASKIO +IPTO). When RsmA
expression was induced, two ribosomal proteins were recovered, bound to rsmZ: 82 RpsB and
S3 RpsC. These proteins are part of the small ribosomal subunit.
There are many studies on the eukaryotic cells showing that the ribosomal protein 83 (Rp83)
is linked with transcriptional regulation. Although the ribosome is a protein-synthesizing
machine, numerous ribosomal proteins have been shown to have a bifunctional role [291,
292]. In particular, the mammalian RpS3 protein is involved in translation, DNA repair and
apoptotic pathways [293, 294]. Studies suggested that S3 has an extraribosomial function in
mammalian cells as a regulator of gene expression, providing evidence that the CHOP
191
transcriptional factor interacts with the S3 ribosomal protein [295]. More recently, the finding
that mammalian RpS3 is a key subunit of the transcriptional complex NF-KB [296] implied a
possible secondary function of ribosomal proteins in eukaryotes. In accordance with these
observations, it can be hypothesized that the S3 ribosomal protein might also be involved in
transcriptional regulation in bacteria. In particular, S3 might regulate rsmZ transcription in
P. aeruginosa. The proposed hypothesis is the following: when RsmA is artificially
overexpressed (PASKIO +IPTG), it binds to mRNAs in a non-specific way. This causes the
ribosomes to stall, thus releasing some subunits. S3 could form a complex with a yet
unidentified transcriptional regulator, promoting rsmZ transcription. The small regulatory
RNA RsrnZ would titrate RsmA, allowing the ribosome to proceed with translation. Although
there are no studies on mammalian cells showing the impact of RpS2 on translation, the same
hypothesis can be applied to this ribosomal protein.
The RsmA effect on rsmZ transcription, previously observed in P. aeruginosa, has been
suggested to be indirectly via GacA. Thus, it was interesting to investigate if the positive
regulation of rsmZ-lux by RsmA was due to an enhanced production of the signal molecule,
which would then activate the GacS/GacA system. However, when extracting extracellular
signal molecules from a strain over expressing RsmA, the effect on rsmZ-lux activity was
similar to the one from extracts derived from the wild type strain. We thus tested the
possibility that RsmA could act through GacA. We found that, in the absence of GacA, RsmA
was not able of inducing the rsmZ promoter, suggesting that the RsmA effect on rsmZ is due
to the positive effect of RsmA on the gacA transcript. This hypothesis is supported by
previous studies on CsrA, the homologue of RsmA in E. coli, which was found to act as a
positive regulator by stabilizing and thus increasing the translation of certain target mRNAs
[135]. The fact that the mRNA of gacA was found in the microarray analysis conducted on
the RNAs copurified with RsmA supports this hypothesis (S. Kuehne PhD Thesis).
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s.s CONCLUSIONS
Using a variety of different approaches, we managed to identify new regulators modulating
rsmZ and rsm Y transcription. Some of the regulators found to directly bind to the rsmZ
promoter, such as AguR, have not been previously linked to the GaclRsm pathway. On the
other hand, the finding of MvaT and MvaU confirmed previous data.
Other regulators were shown to modulate rsmZ expression, such as LasR and RhIR. This
provided evidence for the existence of the lux-box in the rsmZ promoter, which was then
found to be important for PQS induction ofrsmZtranscription (Chapter 4).
Cyclic di-GMP was also found to promote rsmZ transcription. This observation may provide
us with an important link between this intra-cellular signal molecule and the regulation of
biofilm through the Gac/Rsm post-transcriptional pathway.
Finally, these methods allowed us to identify a previously uncharacterized DNA region of
P. aeruginosa genome (upJ), whose presence in multicopy activates rsmZ transcription. Our
results form a platform for further studies on global post-transcriptional regulation by QS and
internal signal molecules such as c-di-GMP.
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Figure 5-17. Representation of the regulators and pathways involved in rsmZ and rsmY transcriptional
modulation.
Full arrows represent regulators whose interaction with the promoters has already been described. Dashed
arrows are the regulators and signal molecules found to be involved in the rsmZ and rsmY transcriptional
regulation. In brackets molecules, proteins or coding sequences that have an effect on rsmZlrsmY transcription,
through an unknown pathway.
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6 QS Inhibition by synthetic molecules
6.1 INTRODUCTION
In P. aeruginosa, AHL and AQs signal molecules are essential for QS-mediated gene
expression of multiple virulence determinants such as secondary metabolites, type III
secretion machinery and expression of stationary-phase genes [6, 194]. Further research
showed that 3-oxo-CI2-HSL and PQS may also function directly as virulence factors by
interacting with the host eukaryotic cells modulating inflammation and immune responses.
These findings suggest a critical role of these molecules in the pathogenesis of P. aeruginosa
infection [19, 162, 165, 297, 298]. Further studies showed that 3-oxo-CI2-HSL interferes
with the eukaryotic immune response by down regulating human lymphocyte proliferation
[297] and by attenuating the oxidative burst caused by polymorphonuclear leukocytes
(PMNs) [299]. The immune suppressive ability of 3-oxo-CI2-HS was further demonstrated
by Pritchard et al (2005), by successfully administrating this molecule for the treatment of an
autoimmune disease on diabetic mice [163,297].
On the other hand, in vivo studies conducted on the activity of higher dosage of 3-oxo-C12-
HSL (lOO ~M) showed that 3-oxo-C12-HSL has pro-inflammatory activity and directly
interferes with the eukaryotic transcriptional regulation for the production of interleukin-8.
Interleukines are pro-inflammatory cytokines which activate or chemo-attract leukocytes to
the site of infection [164, 300]. Moreover, it was shown that high dosage of 3-oxo-CI2-HSL
promoted apoptosis in macrophages and neutrophils and had vasorelaxant properties on blood
vessels [298].
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The discordant data presented on the role of 3-oxo-CI2-HSL on the immune system can be
explained by the different dose of signal molecule used for the studies. However, there is no
doubt on the biological activity of this signal molecule in immunological assays.
Further experiments conducted on P. aeruginosa showed that PQS is involved in the
modulation of the immune system. In particular, PQS was shown to inhibit T cell
proliferation [106, 301].
These experiments, together with the fact that both AHL and AQs signal molecules were
detected in infected CF sputum at a concentration comparable to the one used in
immunological assays in vitro [103], support the hypothesis that these molecules function in
synergy as immune modulators [11, 94, 103, 114]. During the first stages of the infection, the
signal molecules produced allow P. aeruginosa to evade from the host immune system. Once
a higher cell population density is reached, the QS response is triggered activating the
production of virulence factors. This response is coordinated with the wave of activation of
the immune system caused by the higher levels of signal molecules produced, sufficient to
trigger pro-inflammatory and tissue-damaging determinants. Therefore, the study of QS signal
molecule analogues as a way to attenuate virulence and to disrupt the interference with the
immune system is crucial for the development of novel therapeutic agents.
As it was illustrated, it is not yet clear how these signal molecules act on the eukaryotic
immune system. The most direct way of searching for molecules capable of interfering with
the natural QS signal molecules is to produce a range of synthetic analogues so that a single
or combination of structural components of the molecule are modified. Using this approach,
Chhabra et al. (2003) studied the overall effect of 3-oxo-CI2-HSL as an immune suppressor.
They constructed synthetic 3-oxo-CI2-HS analogues, which were altered in their acyl-chain
or lactone ring, and found that the optimal bioactivity of the molecule is dependent on an
intact homoserine lactone ring with an acyl side-chain ofCll or greater [184].
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In view of the fact that far more is known on the mechanism of action of the 3-oxo-C12-HSL
on QS system activation through LasR, more specific approaches were used to screen for QSI
compounds. QS antagonists were generated by taking the 3-oxo-CI2-HSL molecule and
altering its ring and acyl-chain structure [302]. In the majority of studies, these analogues
failed to have a potent antagonistic effect, or the concentration required to obtain significant
inhibition was too high from a therapeutic perspective (in the 100 j.lMrange).
A different approach was to modify natural inhibitors such as the furanones. However, this
strategy has gathered little success. Finally, a more general method to search for QS inhibitors
was to look for the active compound responsible for the QSI activity from herbal and fungal
sources such as carrot, soybean, water lily, tomato, pea seedlings, habanero and garlic [180,
303].
6.2 AIMS OF THIS CHAPTER
The present study was undertaken in order to determine whether 3-oxo-C12-HSL synthetic
analogues, previously tested for immune modulatory activity (R. Gopal, PhD thesis), could
interfere with LasR-mediated regulation resulting in agonistic or antagonistic effects. For this
purpose, two reporter fusions were constructed using the promoters of two genes known to be
regulated by LasR: lasB and lasl
The finding of one or more molecule(s) with a strong antagonistic effect on LasR activity and
a high immune modulator potential would be the first step for the development of new QSI
molecules.
6.3 RESULTS
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6.3.1 Construction of biosensors to screen for quorum sensing inhibitors compounds
In order to test the ability of compounds to interfere with QS, a series of biosensors were
constructed which consist of a transcriptional fusion between the promoter of a QS regulated
gene (lasB or different portions of the las! promoter) and the luxABCDE operon from
Xenorhabdus luminescens [198]. The background strain for the construction of these reporters
was P. aeruginosa PAKR94 (Slasl: :GmR). By choosing this mutant it could be possible to
artificially add a specific concentration of 3-oxo-C12-HSL, which would activate the reporter
to half of its maximum activity (Kind). It would be possible to have a clearer understanding of
the efficiency of the tested compounds for QS inhibition.
The lash-lux and lasl-lux fusions were inserted into the chromosome of PAKR94 in the
unique attB site of prophage CTX insertion. The sensor strains were called PAKR02
(Mas!::GmR lasH-lux), PAKR38 (MasI::GmR lasll-luxi, PAKR46 (llIasI::GmR lasI2-lux),
PAKR39 (llIasI::GmR lasI3-lux), PAKR47 (llIasI::GmR lasI4-1ux), PAKR66 (llIasI::GmR
lasI5-1ux)and PAKR67 (MasI::GmR lasI6-1ux), (Material and Methods, section 2.4.2).
6.3.2 Determination of the Kind for the biosensors
It is known that the biosensor strains do not produce the signal molecule 3-oxo-C12-HSL.
The concentration of 3-oxo-C12-HSL at which the activity of the promoter was half of its
maximum (Kind) was therefore determined for these strains. The concentration of 3-oxo-C12-
HSL would then be used in the competition assay (between QSI compounds and 3-oxo-CI2-
HSL, for the binding to LasR). In the assay, it was maintained a specific concentration of 3-
oxo-C12-HSL (corresponding to the Kind), adding a range of concentrations of the antagonist
compound. Using this method, it could be assessed the strength with which the tested
molecules would compete for the binding of the regulator.
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6.3.2.1 Determination of Kind for the lasE-lux reporter
The ability of the AHL derivatives to act as activators or as inhibitors of LasR was analysed
by measuring the activity of the lasE promoter, which is transcriptionally regulated by LasR
and RhIR [240]. For this purpose, a strain PAKR02 (las!::GmR lasE-lux) reporter fusion was
used. Since the biosensor strain lacks the ability to produce 3-oxo-CI2-HSL, due to the
disruption of the las! synthase gene, it was firstly necessary to determine the Kind values. For
this purpose, a range of 3-oxo-C12-HSL concentrations was tested. The dose response curve
for the lasli-lux reporter was obtained as follows. The reporter strain was incubated with
increasing amounts of 3-oxo-CI2-HSL and the maximum peak of activation of the reporter
(measured as the bioluminescent activity) was plotted against the logarithm of the
concentration of 3-oxo-C12-HSL added (Materials and Methods, 2.12). The Kind for the
fusion for 3-oxo-C12-HSL was calculated to be 5 J.lM(Fig 1).
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Figure 6-1. Dose response curve to 3-oxo-Ctl-HSL for lasl-Iux and lasB-lux reporter fusions.
Comparison of the expression of two biosensors in the PAKR02 (!:t./asl::GmR lasB-lux) background (triangles)
and PAKR47 (!:t./asl::GmR las14-lux) (squares) in the presence of increasing concentration of 3-oxo-CI2-HSL.
The half maximal expression for PAKR02 and PAKR47 is350 and 1200 RLUlOD, respectively. The calculated
Kindwas 5 JiMand 0.5 JiM3-oxo-CI2-HSL, respectively.
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6.3.2.2 Determination of Kind for lasl-lux reporter
In order to characterize the antagonistic potential of the 3-oxo-C12-HSL analogues, we
analysed the effect of the most promising molecules on another promoter, which is also
regulated by LasR. The lasl-lux fusion was inserted into the P. aeruginosa PAKR38 strain
(Mas!::GmR lasl-luxy background. This fusion was first tested for its activation by 3-oxo-
C12-HSL (Fig. 2). Unexpectedly, although the las! promoter fusion lasl-lux (amplified using
the primers PlasIFWl and PlasIRVI) included the known LasR binding site (lux-box)
previously determined (Fig. 3), the promoter was not induced by the addition of increasing
amounts of 3-oxo-C12-HSL (Fig. 2). However, when constructing the fusion PAKR46
(Mas!::GmR las!2-lux) comprising a larger fragment of las! promoter (amplified using the
primers PiasIFW2 and PlasIRV2) and including part of rsaL and lasR, the fusion was
properly induced by 3-oxo-CI2-HSL (Fig. 3). Hence, the existence of a previously
unidentified region of the las! promoter activated by the LasR-3-oxo-CI2-HSL complex
seemed possible.
In order to investigate this hypothesis, different lasl-lux fusions were constructed to identify
the minimum promoter region sequence necessary for the activation by 3-oxo-C12-HSL
(Fig. 3). Both the PAKR39 (Mas!::GmR las!3-lux) and the PAKR47 (Mas!::GmR lasts-lux)
strains were induced by 3-oxo-CI2-HSL as much as PAKR46 (Mas!::GmR las!2-lux),
(Fig. 2). These results suggest that there is a specific sequence between -153 bp and -119 bp
(between PlasIFWl and PlasIFW4) or between +15 bp and +54 bp (between PlasIRVl and
PlasIRV2) responsible for las! activation by LasR and 3-oxo-C12-HSL. To investigate this
further, two additional fusions were constructed. The PAKR66 (Mas!::GmR las!5-lux) and
PAKR67 (Mas!::GmR las!6-1ux) fusions were tested for their response to 3-oxo-CI2-HSL.
While las!6-1ux and lasll-lux showed a similar low response to 3-oxo-CI2-HSL addition,
lasli-lux were highly induced (Fig. 2). However, the levels of las!5-1ux activation when
adding 3-oxo-CI2-HSL were not restored to the ones observed when using las!4-1ux.
201
1160
Cl
o
.....
:>
..l
"..... 1208
c
~
'"
"e
's 80
:l
'0
;0
e
~ 40
s
~
o
PAKR38 PAKR46 PAKR39 PAKR47 PAKR66 PAKR67
Plas/l·ll/x P/asl2·ltLY P/asll·ll/x P/as14·/tLr P/asJ5·ll/x PlasI6·ll/x
Figure 6-2. Induction of the las! fusion by 3-oxo-C12-HSL.
The lasl-lux fusions amplified with different primers respond differently to the addition of the 3-oxo-C12-HSL
(20 11M) signal molecule (dark) compared to the addition of the solvent as a control (light gray).
Bioluminescence intensity was divided by OD495 of cell culture. The highest activity obtained with lasl4-lux was
set to 100% and all other values are relative. The standard deviation was derived from 3 independent
measurements .
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Figure 6-3. The rsaL-las! intergenic region and primers used to amlify different fragments of the las!
promoter.
The lasl ATG starting codon and the nucleotides complementary to the starting codon of rsaL (CAT) are in
boldface. The principal lasl transcriptional starting site is marked as +1, the G in bold indicates the secondary
transcriptional starting site [78]. The 5'-AAnTTATGnAA-3' inverted repeats are indicated by arrows. The
potential a7°-dependent -35 and -10 consensus sequences are indicated by dashed lines. The sequence bound by
RsaL is purple shaded, while the sequence bound by LasR is green [304]. Schematic representation of the way
the different promoter las! fusions were made is presented.
202
In addition, the levels of expression of the lasI4-lux and lasli-lux fusions were compared. The
fusions were monitored using a range of 3-oxo-C12-HSL concentrations. The maximal
expression of PAKR47 (Mas!::GmR las!-lux4) was 4 fold higher than PAKR02 (Mas!::GmR
lasE-lux) expression (Fig. 1). The Kind value for PAKR47 (MasI::GmR lasI-lux4) was
determined to be 0.5 J.1M.
6.3.3 Molecules tested: 3-oxo-C12-HSL and tetramic acid analogues
A total of 33 analogues of 3-oxo-C12-HSL were tested at a range of concentrations. From
these, 20 were molecules derived from 3-oxo-CI2-HSL with alterations on the alkyl chain,
the 3-oxo substituent or the heterocyclic ring. These molecules were divided into 7 groups
depending on their chemical substitution: the 4-aza-analogues, the 3-aza-analogues, the 3-
thio-analogues, the 4-oxo analogues, the sulphonamide motif containing analogues, other ring
containing 4-aza analogues and other ring analogues (Tab. 1).
The other 13 molecules tested were derived from the natural non-enzymatic product of
degradation of 3-oxo-CI2-HSL: the 3-(1-hydroxydecylidene)-5-(2-hydroxyethyl) pyrrolidine-
2,4-dione, tetramic acid and its tetronic acid derivative. The tetramic acid and tetronic acid
analogues were altered in the acyl chain and the ring moiety (Tab. 2). All the molecules used
in this study were also monitored for their impact on growth at the concentrations used for the
assays. None of them was affecting growth. Methanol, the solvent used to dilute these
molecules (MeOH), showed no inhibitory effect on cell growth or on the lasE or las!
promoter activity.
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Table 2. Structure of the tetramic (TA) and tetroni<JTO) acid analogu~ -,
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6.3.4 Screening of AHL analogues for agonistic activity on the lasB-lux reporter
Each molecule was tested individually at a concentration of 100 IlM in the absence of 3-oxo-
C12-HSL for its ability to activate lasB expression by inducing luminescence in the reporter
strain.
Out of20 of the 3-oxo-C12-HSL analogues tested, only GPJ005 and GPJ007 displayed partial
inducing activity, suggesting that these molecules possibly bind to LasR and activate it (Fig.
4). On the other hand, the tetramic acid analogues showed no significant agonistic activity
(Fig.5).
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Figure 6-4. Agonistic activity of3-oxo-C12-HSL analogues on lasB-lux reporter fusion.
The Mas! lasE-lux reporter was grown in the presence of methanol, the solvent used to dilute the compounds as
a negative control (green), and in the presence of 5 11Mof 3-oxo-C12-HSL as a positive control (orange) or 100
11M of 3-oxo-CI2-HSL analogues. Bioluminescence intensity was divided by the OD495 of the cell culture.
Positive control was set to 100% and all other values are relative. The standard deviation was derived from 3
independent measurements .
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Figure 6-5. Agonistic activity of tetramic and tetronic acid analogues on lasB-lux reporter fusion.
The Mas! lasll-lux reporter was grown in the presence of MeOH, the solvent used to dilute the compounds as a
negative control (green), and in the presence of 5 11Mof 3-oxo-C12-HSL (orange) as a positive control. Tetramic
(TA) or tetronic (TO) analogues at a concentration of 100 11Mwere added for the study. Bioluminescence
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intensity was divided by 00495 of cell culture. Positive control was set to 100% and all other values are relative.
The standard deviation was derived from 3 independent measurements.
6.3.5 Screening of AHL analogues for antagonistic activity on the lasB-lux reporter
With the exception of two molecules, the AHL analogues tested failed to show any agonistic
activity on lasB-Iux reporter, suggesting that the majority of molecules available were
potentially able to interfere with LasR for its activity on lasB promoter. To corroborate this
hypothesis, the molecules were further tested at a range of concentrations, for their ability to
compete with the natural signal molecule for the activation of the the lasB promoter. The
results were calculated as percentage of inhibition of relative bioluminescence by an analogue
compared to 3-oxo-C12-HSL (100% positive control).
6.3.5.1 Antagonistic effect of 3-oxo-C 12-BSL analogues
Amongst the 3-oxo-C12-HSL analogues, at least five (GPJ029, GPJ003, GPJ033, GPJ023,
GPJ016) showed QS inhibition (about 25%,54%,45%,53% and 55% respectively) at 20-fold
excess concentration over 3-oxo-C12-HSL (Fig. 6). These molecules belong to the 4-aza-
AHL group (GPJ003 and GPJ033), to the 3-aza-AHL group (GPJ029), to the 3-thia-AHL
(GPJ016), and to other ring substitution groups (GPJ023). Thus, a great variety of
substitutions both in the acyl and in the lactone ring moiety appear to be capable of
antagonising 3-oxo-C12-HSL interaction with LasR and the subsequent activation of PlasB.
Moreover, it is interesting to note that GPJ005 alone, or in synergy with 3-oxo-C12-HSL, is
capable of activating LasR in the agonist and antagonist assays (Fig. 4, 6).
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Figure 6-6. Antagonistic activity of 3-oxo-C12-HSL analogues on lasB-lux reporter fusion.
PAKR02 (Masl lasB-Iux) reporter was grown in the presence of MeOH, the solvent used to dilute the
compounds (green), and in the presence of 5 flM of 30CI2-HSL (orange). The gray bars represent lasB
promoter activation in the presence of 5 flM of3-oxo-C12-HSL and in the presence of 100 flM, 10 flM and 1 flM
of tetramic (TA) or tetronic (TO) analogues. Bioluminescence intensity was divided by OD495 of cell culture.
Positive control was set to 100% and all other values are relative. The standard deviation was derived from 3
independent measures.
6.3.5.2 Antagonistic effect oftetramic and tetronic acids
Amongst the tetramic and the tetronic acid derivatives, four compounds were identified that
showed strong QS inhibition. 3-oxo-C16 and D3-oxo-C12 tetramic acids showed a strong
inhibitor activity of 11% and 18% respectively, while 3C12 and 3-oxo-C14 tetronic acids
showed an inhibition of 36% and 25% respectively (Fig. 7). Although tetramic acids are
known to be potent Gram-positive and Gram-negative growth inhibiting agents [173], the
concentration of tetramic acids used in this study did not affect P. aeruginosa growth.
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Figure 6-7. Antagonistic activity of tetronic and tetramic acid analogues on lasB-lux reporter fusion.
Activity of the PAKR02 (Mas! lasB-lux) biosensor is measured in the presence of 5 IlM of 3-oxo-C12-HSL as a
positive control (orange). Negative control represents background expression in the absence of 3-oxo-CI2-HSL
or any analogues with the presence of 5 % (v/v) MeOH (green). The gray bars represent the lasB promoter
activation in the presence of 5 IlM of 3-oxo-CI2-HSL and in the presence of 100 IlM, 10 IlM and 1 IlM of
analogues. Bioluminescence intensity was divided by OD495 of cell culture. The positive control was set to 100%
and all other values are relative. The standard deviation was derived from 3 independent measurements.
6.3.6 Screening of analogues for antagonistic activity on the lasl-lux reporter
The 3-oxo-C12-HSL analogues GPJ029, GPJ022, GPJ033, GPJ023 and GPJ016, previously
identified as antagonists of LasR in the induction of lasB transcription, were also tested on the
strain PAKR47 (MasI::GmR lasI4-lux). The majority of the molecules tested on this reporter
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fusion inhibited the activity of the promoter (GPJ029 33%, GPJ022 47%, GPJ033 35%,
GPJ023 30%), confirming that these molecules were acting as antagonists of LasR (Fig. 8).
On the other hand, GPJ016 does not exert such a strong inhibitory activity on the PAKR47
reporter (1'!.IasI::GmR lasI4-lux) (97%) as it does on the PAKR02 (MasI::GmR lasB-lux)
reporter fusion (55%). This suggests that GPJ016 might act as antagonist ofRhIR on the lasB
promoter. However, the inhibitory effect exerted by this molecule cannot be observed when
using the lasI4-lux reporter fusion, which is only regulated by LasR.
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Figure 6-8. Antagonistic activity of 3-oxo-C12-HSL analogues on lasI4-1ux reporter fusion.
Activity of the PAKR47 (l1las!::GmR las!4-lux) biosensor measured in the presence ofO.5 flM of30CI2-HSL
(orange). Negative control represents background expression in the absence of 30C12-HSL or any analogues
(green). Gray bars represent las! promoter activation in the presence of 1 flM of the 30C12-HSL and in the
presence of 100 flM, 10 flM and 1 flM of analogues. Bioluminescence intensity was divided by OD495 of cell
culture. Positive control was set to 100% and all other values are relative. The standard deviation was derived
from 3 independent experiments.
6.4 DISCUSSION
Following previous work on the optimisation of the immune modulatory activity of 3-oxo-
CI2-HSL (R. Gopal, PhD Thesis), 33 compounds were tested. These molecules were derived
from the P. aeruginosa signal 3-oxo-CI2-HSL and from its tetramic acid derivative, and were
screened for their agonistic and antagonistic activity towards the las QS system.
The purpose of this study was to find immune modulatory molecules able to inhibit LasR
activity on P. aeruginosa QS mediated virulence phenotype (lasB expression was chosen as
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way of measuring LasR activity); Amongst the compounds previously found to have immune
modulatory activity, only GPJ005 and GPJ009 were found to have agonistic activity on the
las QS system by activating the transcription of the lasB target gene. For this reason, these
molecules could not be used as immune modulators, as they would activate the QS regulatory
network. All the other molecules tested failed to activate lasB-lux fusion in an agonistic way.
The aforementioned molecules could represent the starting point for the construction of new
immune modulatory drugs, which can be used for the treatment of CF patients. The 3-oxo-
CI2-HSL analogues would inhibit QS mediated expression of virulence factors. They would
also disrupt the interference of 3-oxo-C 12-HSL with the host immune system.
Although the concentrations at which the molecules were tested were very high, the results
obtained with the antagonistic analysis on the lasB-lux fusion are very promising. Among the
3-oxo-CI2-HSL analogues, five compounds were found to inhibit LasR-RhIR induction of
the lasB promoter. This preliminary analysis was conducted using a bio-reporter system based
on the lasB promoter. However, it is well known that the transcription of this gene is both
regulated by LasR and RhlR [240]. DNaseI protection assays conducted on the lasB promoter
allowed for the identification of two operators containing lux-box sites: OPl (located -42 bp
from the +1 transcription starting site), controlled by RhIR, and OP2 (located -101 bp from
the +1 transcription starting site), LasR regulated [77].
Since the lasB promoter fragment used in this study comprised 480 bp from the +I
transcriptional starting site, the molecules tested could exert their agonistic and antagonist
effect by modulating RhlR activity on the lasB promoter. For this reason, a second las!
reporter fusion was constructed using the promoter region known to be uniquely activated by
the LasR-3 ..oxo-CI2-HSL complex [77]. The five molecules which showed an effect on the
lasli-lux fusion were thus tested on last-luxe. From this analysis, it appears that four out the
five molecules tested were acting as LasR antagonists. Although GPJO16 shows a strong
inhibitory activity on the lasB promoter, this effect is abolished when testing the compound
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on the las! fusion. This could be due to the fact that GPJ016 acts as an antagonist of RhIR
(modulates lasE expression) rather than on LasR (modulates both lasE and las! expression).
The hypothesis is that GPJ029, GPJ033, GPJ022 and GPJ023 compete with the signal
molecule for the binding to the active site of LasR, failing to activate it (competitive
inhibition). However, recent studies suggest an alternative model of action of QS inhibiting
molecules. These would compete with 3-oxo-C12-HSL for the binding to the nascent
polypeptide of LasR, thus inhibiting the correct folding and/or solubility of the protein [305].
Further studies should be carried out in order to understand the way the newly identified QS
inhibiting molecules act on LasR.
Amongst the four LasR antagonists, two did not have any immune modulatory effect: GPJ022
and GPJ023. The other two compounds, namely GPJ029 and GPJ033, are both good immune
modulators and capable of acting as good inhibitors of QS (R. Gopal, PhD Thesis). In
particular, GPJ029 appears to be the most interesting one since it is a stronger immune
modulator compared with the P. aeruginosa natural signal molecule. Moreover, GPJ029
displays the strongest QS inhibitor effect (25%) compared with the 3-oxo-C12-HSL
analogues tested.
In the lungs of CF patients infected with P. aeruginosa, the main cause of tissue damage is
not due to the bacteria per se, but rather due to the activation of a prolonged immune
inflammatory response. This inflammatory response is ultimately responsible for the necrosis
of the lung tissue and the loss of the pulmonary function [306]. For this reason, the molecules
GPJ029 and GPJ033 could represent a good starting point for the development of drugs used
in the treatment of P. aeruginosa disease, in which both the immune repression and the QS
inhibition activity is required (for example in cystic fibrosis chronic infections).
The 3-oxo-C12-HSL analogues tested were constructed docking the potential analogues into
the active pocket of two LasR homologues. The known crystal structures of TraR, from the
plant pathogen Agrobacterium tume!aciens, and SdiA, from E. coli, were used for this
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purpose [307, 308]. The identification of 3-oxo-C12-HSL analogues competing for LasR
binding represents a significant contribution to the understanding of the active site pocket of
the LasR regulator.
The recent determination of the LasR crystal structure provides a new approach for the
screening of LasR antagonists [305]. It is thus possible to create QS inhibitors modelled to fit
ad hoc the active site of LasR.
The molecules derived from 3-oxo-CI2-HSL non enzymatic degradation, namely tetramic
acids (TA), were previously tested for immune modulation (R. Gopal, PhD Thesis). Although
these molecules were shown to act as good immune inhibitors, they also displayed a strong
antibacterial activity against many Gram-positive strains [173]. Hence, TA (and any other
molecules derived from tetramic acids) can interfere with the commensally natural bacteria
present in the human system. Therefore, these molecules are not good candidates for the
development of immune modulatory therapies.
Finally, the analysis conducted on the las! promoter allowed for the identification of two
important regions required for the las! promoter activation by 3-oxo-C12-HSL. These are
located between the -153 and -119 bp region and between the +15 and +54 bp region. In
particular the region downstream the second transcriptional starting point (G) is essential for
the capability of the promoter to respond to the addition of the signal molecule, while the
region from -153 to -119 is important for the amplitude of the response. These results suggest
that there is a region between +15 bp and +54 bp, which is involved in the promoter's
response to the addition of the signal molecule 3-oxo-C12-HSL. In addition, a second ATG
translational starting site was found a few bp downstream of the first one, suggesting that
there is a third potential +1 transcriptional starting site and an ATG translational start further
downstream. These findings suggest the existence of additional regulators acting on las!
transcription. However, a second lux-box or another visible palindromic repeat was not found
on the promoter of lasl. It is possible that the regulation occurs at the post-transcriptional
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level. The mRNA resulting when using RV2Plas! could be more stable than the one resulting
when amplifying with RVIPlas!. To investigate this, an in silico analysis was performed on
the sequence comprised between the two reverse primers, RV2PlasI and RVIPlasI. In order to
find secondary structures, the RNA/old WebServer was used (http://ma.tbi.univie.ac.atlcgi-
binlRNAfold.cgi). A secondary RNA stem loop structure forming between the + 1 (A) and
+21 bp was found.
The hypothesis suggested is the following: LasR could bind with the same affinity to the
promoters tested, however the mRNA derived when including the +21 region is more stable
than the one derived when amplifying the las! promoter until the +1 (A). Since two
transcriptional starting sites were identified, [78] this hypothesis seems to be feasible.
At lower 3-oxo-CI2-HSL concentrations, the transcription of las! might start from the second
transcriptional starting site (G), giving a basal level of transcription, and the mRNA generated
could be degraded (possible post-transcriptional regulation). On the other hand, in the
presence of high 3-oxo-C12-HSL the transcription could start from the first transcriptional
starting site (A), giving rise to the more stable mRNA. This hypothesis would fit with our
observations. When using the PiasIRV2 primer in combination with the PlasIFWl primer to
amplify the las! promoter, the resulting mRNA would include the stem loop that stabilizes the
transcript. On the other hand, when the PlasIRVI is used, the stem loop could not be formed,
promoting the mRNA degradation (Fig. 9).
To test this hypothesis, it would be necessary to study the degradation (e.g. Real Time PCR)
of a target gene cloned downstream of the two different promoter fragments.
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Figure 6-9. Schematic representation of the region between the RVlIasI and the RV21asI of the lasl
promoter and the resulting transcript.
The formation of the secondary RNA structure depends on the transcriptional starting site. This influences the
stability of the resulting mRNA. When using the PlaslRVI (blue) to amplify the lasl promoter, the secondary
structure is disrupted and the resulting mRNA is less stable. When using PlasIRV2 (red) to amplify the las]
promoter, the secondary structure is included in the transcript, promoting mRNA stability.
6.5 CONCLUSION
The structural homology of the LuxR-proteins family (SdiA and TraR) allows for the use of
these homologues as a reference for docking studies of AHLs derived compounds. A range of
3-oxo-C12-HSL derived molecules with an altered acyl-chain or lactone ring was analysed for
its agonistic and antagonistic activity toward the LasR QS regulator. From this study, it is
apparent that by analyzing these molecules' indirect effect on the transcription of lasB and
las!, a preliminary selection of the molecules with the strongest QSI activity can be obtained
(Fig. 10). The reporters constructed and tested here are available for future screenings of new
potential QS modulator molecules designed to interfere with the las QS system.
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Figure 6-10. Compounds derived from 3-oxo-C12-HSL potentially able to have an antagonistic effect on
LasR.
Through the analysis of the ability of these compounds to inhibit lasl, new inhibitor molecules altered in their
acyl-chain or lactone ring, can be produced.
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7 General conclusions and future directions
The ability to coordinate a particular behaviour in a population density-dependent fashion has
several obvious advantages for bacteria. In the case of pathogenic microorganisms, the
regulation of virulence determinants during the infection process is thought to play an
important role in pathogenicity. Evading host defenses is a major goal of pathogens. Hence,
the ability to finely modulate the expression of virulence factors is a great advantage. For this
purpose, bacteria use the quorum sensing (QS) system of communication. By timing the
expression of their virulence genes, bacteria can reach high densities before virulence
determinants are expressed. In this way, bacteria prevent the host immune response from
operating during the early stages of infections. The virulence determinants are activated only
when the bacteria population has a concrete possibility to overwhelm the host immune
response.
Bacteria have also evolved ways to efficiently respond to extracellular signals. By this means,
bacteria induce the expression of a series of genes, which allow them to survive in a
constantly changing environment. For this purpose, they have developed a wide range of two
component systems (rCS), which sense external stimuli and activate responses.
The importance of both QS and rcs systems for the control of P. aeruginosa virulence
determinants implies that the study of these networks is essential to develop new
antimicrobial strategies. Understanding the modulation of these networks will contribute to
the discovery and development of new antibacterial targets.
In Chapters 3, 4 and 5, we concentrated on the study of RsrnZ and RsmY expression, which is
modulated by regulators (AguR, RhlR), extracellular (PQS, CDA), and intracellular (cyclic-
di-GMP) signal molecules. In Chapter 6, we were interested in testing the potential of QS
inhibition in vitro using synthetic molecules. A clinical pilot study was also conducted to test
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the potential of natural occumng QS inhibitor molecules to promote the clearance of
P. aeruginosa infections (see Appendix).
In particular, this study investigated the regulation of RsrnZ and RsmY at a molecular level.
These two sRNAs are part of the complex GaclRsm global post-transcriptional regulatory
network. Although their function seems to be redundant, their transcriptional regulation is
dissimilar [156, 160]. The target of RsrnZ and RsmY is RsmA. This global post-
transcriptional regulator is involved in operating a switch between acute and chronic type of
infection. Thus, it is not surprising to find that the expression of these sRNAs is fine-tuned by
a plethora of regulators. These regulators might integrate the response to cell density and to
other stimuli, thus orchestrating the response of the whole bacterial population to
environmental and metabolic changes.
Using diverse techniques, we uncovered a complex network of regulators and pathways
modulating RsrnZ and RsmY.
Using the promoter pull down technique, we identified a new regulator, AguR, which affects
the timing of the rsmZ transcription. This regulator is responsible for the modulation of the
polyamine synthetic pathway. Recent studies show that polyamines are important for biofilm
formation and modulate type III secretion system, suggesting a link between polyamines and
the RsmA global regulatory network [287]. AguR could exert its role on biofilm and type III
secretion through the modulation of rsmZ and thus RsmA. In the future, it will be interesting
to use the purified AguR protein to conduct band-shift analysis on the rsmZ promoter.
Using the transposon mutagenesis approach, we were able to link the Gac/Rsm pathway to
cyclic-di-GMP, a key secondary messenger molecule. The involvement of this molecule in
biofilm formation, adhesion and virulence has been extensively studied [309-311]. In
particular, high levels of cyclic-di-GMP are usually associated with biofilm formation. On
other hand, RsmA negatively regulates this phenotype. The discovery that rsmZ is positively
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regulated by cyclic-di-GMP suggests that this second messenger molecule can act on the
biofilm phenotype through the modulation of RsmA.
In 200 I, Pessi et al. discovered the link between QS and the global post-transcriptional
regulator RsmA [152]. Using translational fusions, they found that RsmA negatively regulates
the expression of lasl and rhlI encoding for the two QS HSL synthase enzymes. Using a
genetic bank approach, we found that both RhIR and LasR are capable of activating rsmZ
transcription. Supporting this result, we discovered a lux box on the rsm'Z promoter region,
which is not present in the rsmi' promoter. These findings, together with the discovery of the
PQS molecule in one of the fractions activating r8mZ transcription, prompted us to analyse
the role of QS on the Gac TCS.
Until now, QS system signal molecules were known to have an effect on the transcription of
target genes binding to a regulator protein belonging to the LuxR family. This protein would
then act at a transcriptional level on the expression of target genes. The discovery of PQS
activation of r8mZ transcription suggests that this QS signal potentially modulates the
expression of target genes also at the post-transcriptional level. This hypothesis was verified
by constructing a translational fusion based on the lecA gene, which is negatively regulated by
RsmA [94].
We also conducted epistasis analysis to prove that PQS action on lecA was actually mediated
by inducing rsmZ transcription. The presented data demonstrate that rsmZ is involved in the
PQS-mediated post-transcriptional regulation, acting in antagonism with RsmA-mediated
repression of lecA. In contrast with what was initially thought, we showed that PQS acts
weakly on the lecA promoter. This suggests that QS regulation on this important virulence
factor is mainly exerted post-transcriptionally.
Finally. although PQS activation of rsmZ transcription was found to act through the lux box,
its action appears to be independent from PqsR, PqsE, LasR and RhIR.-It would be interesting
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to investigate if PQS action goes through the "orphans" LuxR proteins QscR or VqsR [90,
312].
In conclusion, the finding that PQS acts on post-transcriptional regulation of gene expression
increases the complexity of the P. aeruginosa QS regulon. Furthermore, it is clear from our
work that rsmZ and rsmYare differently regulated by PQS, MvaT, MvaU, and possibly by
other regulators, in agreement with what has been previously observed [156, 160].
Investigating the regulation of target genes by QS and the Gac/Rsm pathway could lead to a
deeper understanding of the regulation of virulence by P. aeruginosa. In this study, we gave
evidence for the existence of a bidirectional link connecting QS and the Gac/Rsm pathway in
a complex network. Infection studies (using in vivo models) must be carried out to appreciate
the biological relevance ofPQS post-transcriptional modulation of target virulence genes.
In the course of this study, new vectors and a whole range of chromosomal mutants have been
generated. Of particular interest, the double transcriptional-translational reporter fusion
(PMW02), which will be used in future studies aimed to the identification of the extracellular
signal(s) modulating the Gac/Rsm system. We also produced a wide range of mutants both in
the QS and the GaclRsm system, as well as a range of transcriptional and translational fusions
that represent an excellent starting point to reveal PQS (and in general QS) involvement in
post-transcriptional regulation of target genes.
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8 Appendix: Garlic against Pseudomonas aeruglnosa infections - a clinical
study
8.1 INTRODUCTION
Eukaryotes and bacteria have coexisted for millions of years, it is then not surprising that
many plants and fungi have evolved ways to interfere with the bacterial cell-to-cell
communication system. This allows them to inhibit virulence, or to promote the growth of
beneficial bacteria. The search for quorum sensing inhibiting (QSI) compounds has been
extended to the natural environment. In particular much effort has been dedicated in the study
of plants such as carrot, soybean, water lily, tomato, pea seedlings, habanero and garlic, which
have been found to produce molecules capable of interfering with QS in bacteria [180, 303].
Garlic is known to be an antimicrobial agent since the ancient times. Garlic extracts have been
reported to exhibit a broad antibacterial spectrum against both Gram-positive and Gram-
negative bacteria [313-315]. This bactericidal activity has been recently coupled with QS
inhibition properties. Recent in vivo studies, which were conducted on a pulmonary mouse, on
a Caenorhabdttis elegans and on nematode infection models, showed that treatment with
garlic extracts lowers P. aeruginosa infection by improving the clearance of the infection
[299, 316]. The hypothesis that garlic inhibits QS was further corroborated by results obtained
in vitro. Microarray data indicates that garlic extracts specifically inhibit QS-regulated genes,
probably by interacting with the signal sensor/response regulator proteins [316]. Moreover, it
was demonstrated that addition of garlic extracts to P. aeruginosa biofilms reduces the
tolerance of the bacteria to tobramycin treatment [180]. Finally, it has been found that
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P. aeruginosa culture treated with garlic extract produces lower amounts of signal molecules
and, consequently, of virulence factors [317].
Raw garlic extracts contain the compounds responsible for QS inhibition activity (still
unknown) and the molecules mediating its antimicrobial activity. In vitro studies showed that
when the concentration of garlic extracts is too high, the antimicrobial effect prevails
affecting bacterial survival [318]. Thus, in order to use garlic extracts in the future treatment
of P. aeruginosa infections, we need to identify the QSI molecule(s). It is also essential to
understand the real potential of garlic extract to act as QS inhibitor in human treatments.
8.2 AIM OF THE STUDY
The aim of this study was to conduct an analysis on the impact of macerated garlic oil on
P aeruginosa infection clearance in CF patients.
A group of CF paediatric and adult patients with chronic P. aeruginosa lung infection was
given garlic (or placebo) capsules for a period of two months. The levels of QS signal
molecules, both in the sputum and in the blood, were analysed before and after the treatment
to monitor P. aeruginosa infection. The general clinical improvement of the patients was also
monitored.
Our goal was to demonstrate the QS inhibitor potential of garlic extracts in vivo, and to
determine whether it was associated with clinical improvement. This pilot study was the first
study of a QS inhibitor to be conducted in humans.
The study was conducted in collaboration with Alan Smyth (Division of Child Health,
/
University of Nottingham, UK), who conducted the clinical trial, and Catherine Ortori
(Centre for Analytical Bioscience, School of Pharmacy, University of Nottingham, UK), who
conducted the analysis of the extracted sputum and plasma samples.
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8.3 RESULTS
8.3.1 Garlic extracts effect on the lasB-lux biosensor
Prior to the clinical study, we performed some in vitro experiments in order to test the
potential of the crude garlic extracts for QSI activity. For this purpose, we used the strain
PAKR02 (MasI: :GmR lasB-lux) and tested the effect of increasing amounts of garlic extracts
on the activation of lasB-lux fusion (Fig. 1). At a concentration of 5% (v/v), the garlic extract
significantly reduced the activation of the lasli-lux reporter by lowering the induction by
about two folds. However, when lower concentrations (1%) were added, we again observed a
significant reduction on lasB-lux activation. The garlic concentration did not influence growth
when used at concentrations below 2%. These results confirm previous observations [180],
which showed that crude garlic extracts have an effect on QS regulated genes such as lasll.
The observed effect is caused by a still unknown molecule, which may act as an antagonist of
the LasR regulator.
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Figure 1. Influence of garlic extracts on growth and on the activation of the lasli-lux fusion.
On the left, growth curve of the strain PAKR02 (Mas! lasB-Iux) tested in the presence of the 3-oxo-C12-HSL
signal molecule and of different concentrations of garlic extracts.
On the right, the maximum activity of the PAKR02 sensor strain in the absence and in the presence of 3-oxo-
CI2-HSL (5 uM) or in the presence of3-oxo-CI2-HSL (5 uM) and a range of garlic extract concentrations (1%
or 5% v/v).
8.3.2 Ajoene effect on the lasB-lux biosensor
The compound(s) acting as QSI in garlic extracts are still unknown. However, previous
studies found that the antimicrobial activity of garlic is related to the presence of growth
inhibitory sulfur-containing compounds such as allicin and ajoene [319, 320]. Since allicin is
not the QSI compound [321], we decided to analyse the effect of ajoene on the PAKR02
sensor strain. Ajoene was found to have an effect inhibiting P. aeruginosa growth at a
concentration of 5~M, in discordance with previous publications [320]. Therefore, the
observed effect of ajoene on lasB transcription appears to be due to its growth inhibition
potential (Fig.2).
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Figure 2. Influence of ajoene on growth and activation of the lash-lux fusion.
On the left, growth curve of the strain PAKR02 (Mas! lasB-lux) tested in the presence of the 3-oxo-C 12-HSL
signal molecule and of different concentrations of ajoene.
On the right, the maximum activity of the PAKR02 sensor strain in the absence and in the presence of 3-oxo-
CI2-HSL (5 11M)or in the presence of3-oxo-CI2-HSL (5 11M)and a range ofajoene concentrations.
8.3.3 Patient enrolment
We tested the hypothesis that garlic treatment would reduce P. aeruginosa QS signal
molecule levels in the sputum and plasma of 97 cystic fibrosis patients, colonized by
P. aeruginosa. We randomised 34 patients, 8 patients withdrew, leaving 26 patients for the
analysis (Fig. 3). Enrolment took place between May and September 2007 at a single centre
(the Cystic Fibrosis Centre at Nottingham University Hospital's NHS Trust).
225
97p.lwall were _oed for
ellalbUlry
17 .Uoc.led 10 I.rlk
6J p.IWI" tldadell
37 dsd not respond to invitanon letter
7 .. en: not interested
~ already talunllllirlic
S not enough time in cl inle to enrol
4 not chnically liable
2 conccrnc:d about side effects
2 did not want bluod tC!lb
I non-adherent
17 .Hoc.ted 10 pillftbo
.... IIIId....... wllbdre.o
I received lunK IranKplant
I lillll(~ tu take caPKul.:.
I.ide.ne","
2 to,pll to take c.... uk.
I .ide .11'ect.
I could not attend to vi.it 2
I could not attend 10 visit 2
13 .a.lyoed u• • •1yted
Figure 3. Patient enrolment and follow-up.
8.3.4 Clinical outcome
Thirteen patients received garlic treatment and thirteen received placebo treatment.
The garlic capsules were 656 mg of garlic oil macerate and 10 mg of cardamom oil, the
placebo capsules were 656 mg of olive oil and 10 mg of cardamom oil. The cardamom oil
was used as an odour control agent. The dose of garlic was chosen following the
recommended dose of garlic as a nutritional supplement.
At entry into the study, the two groups were comparable regarding sex, age distribution,
weight, FEVl (forced ~xpiratory yolume in 1 second) and clinical score (Tab. 1). At the end
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of the treatment, five garlic patients reported minor adverse effects such as diarrhoea,
halitosis, abdominal pain, dysuria. In the/ placebo group, one patient reported a minor
haemoptysis. Otherwise, the treatment was well tolerated and no other clinical of
haematological adverse reactions occurred.
Placebo Garlic Total
Total 13 13 26
Adults 9 (63%) 8 (62%) 17
Children 4 (31%) 5 (38%) 9
Mean (SO) Mean (SO) Mean (SO)
FEV1 1.91 (1.05) 1.84 (0.79) 1.87 (0.91)
Weight (Kg) 54.2 (14.1) 46.7 (14.6) 50.4 (14.5)
Median (Range) Median (Range) Median (Range)
Clinical score 4 (0,6) 2 (0,6) 3 (0,6)
Table 1. Baseline characteristics of study participants
The clinical scores at the start of the treatment did not differ significantly between the twO
groups of patients completing the study (Tab. 2), even though the FEV} values showed a
greater decline in the placebo group (-3.6%) than in the garlic group (-2.0%). Both groupS
showed an increase in weight. The mean increase was greater in the garlic treated group than
in the placebo. Concerning the Jensen clinical score (Material and Methods section 2.18.6),
the values obtained at the beginning of the study were subtracted to the ones measured at the
end of the study. Therefore, a negative score means decreased symptoms. In the garlic group
the median change in clinical score was -1, while in the placebo group was calculated as +1.
Moreover, the amount of antibiotic received during the 8 weeks of treatment was compared.
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In the garlic group seven patients had the antibiotic treatment, while in the placebo group only
five patients took the antibiotic treatment.
Placebo Garlic Mean difference P
Mean (SO) Mean (SO) Garlic-Placebo value
% Change from -3.60 (11.31) -2.01 (12.30) 1.59 0.8
baseline In FEV1
% Change from 0.61 (2.00) 0.99 (2.03) 0.38 0.6
baseline In weight
(Kg)
Median
(Range)
Change In symptom 1 (-1,4)
score
Median
(Range)
-1 (-3,5)
Median difference,
Hodges-Lehmann
-1 (-3,0) 0.16
Table 2. Results for clinical outcome measures
8.3.5 Sputum and Plasma analysis
Before and after the treatment, both sputum and plasma samples were collected and analysed
for the levels of AHLs, as described in Material and Methods (section 2.18.11). The levels of
3-oxo-CI2-HSL and C4-HSL were determined using LC-MSIMS analysis, and their relative
concentration was obtained by calculating the peak area produced after the LC-MSIMS run.
The concentrations of C4-HSL and 3-oxo-CI2-HSL collected before the treatment in sputum
were much higher than the ones detected in plasma (Fig.4 and 5).
In sputum, with the exception of patient number 2,34 and 40, 3-oxo-C12-HSL was detectable
in all the samples collected. On the other hand, C4-HSL was detected in lower amounts and
only in few patients (Fig. 4).
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In plasma, 3-oxo-C12-HSL was detectable in all the patients samples, with the exception of
patient number 34 and 53. C4-HSL was detected only in patient number 33 (Fig. 5).
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Figure 4. Presence of AHL molecules in sputum samples collected from CF patients.
Peak area C4-HSL (in black) and 3-oxo-C12-HSL (in gray) in sputum samples collected at the beginning of the
treatment.
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Figure 5. Presence of AHL molecules in plasma samples collected from CF patients.
Peak area C4-HSL (in black) and 3-oxo-C12-HSL (in gray) in plasma samples collected at the beginning of the
treatment. Squared is the patient number in which the levels of 3-oxo-C12-HSL and C4-HSL was below the
detectable levels.
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Although this analysis represents a starting point for future studies on garlic extracts efficacy
on P. aeruginosa infection clearance in CF patients, there were insufficient patients
completing the treatment to evaluate the effect of garlic.
However, it was interesting to compare the levels of 3-oxo-C12-HSL in the sputum and
plasma samples of the patients receiving the placebo. Measurable concentrations of 3-oxo-
C12-HSL were obtained for both plasma and sputum samples from seven patients. There is a
highly significant correlation between plasma and sputum measurements of 3-oxo-CI2-HSL
(Pearson correlation coefficient = 0.914, P = 0.004) (Fig. 6). This result although promising,
derives from a very small group of patients, thus a larger study is needed to corroborate this
findings. It is worth mentioning that when considering the plasma and sputum samples from
all the patients entered into the study, the correlation between 3-oxo-C12-HSL in sputum vs.
plasma is not evident (data not shown).
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Figure 6. Correlation between concentration of 3-oxo-C12-HSL found in plasma vs. concentration of 3-
oxo-C12-HSL found in sputum. .
Samples derive from seven placebo patients collected at the beginning of the treatment.
8.4 DISCUSSION
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This is the first study of QS inhibition conducted in human. Although no significant results
were obtained comparing the placebo with the garlic treatment therapy, this study provides
the basis for a bigger study conducted on a larger number of patients. Garlic capsules do not
seem to affect the general clinical state of the patients, although there were some adverse
effects reported, many of these were mild or intrinsic features of CF.
Up to now the QS signal molecules from CF patients colonised by P. aeruginosa have been
detected only in sputa and lung tissue. The molecule 3-oxo-C12-HSL has been found at
nanomolar concentrations [322].
In this study, by analysing the 3-oxo-CI2-HSL content in blood and sputum with a LC-
MSIMS, it was possible for the first time to show that plasma levels correlate closely with the
levels found in sputum. The mean level of 3-oxo-C12-HSL in plasma present in the seven
patients (Fig. 5) was measured to be 1.380 (arbitrary unit). This compares to the 89.817 for
sputum, indicating that the levels in sputum are more than fifty fold greater than those in
plasma. This is not surprising, as QS molecules are produced in the lungs of CF patients and
thus accumulate in the sputum. The QS molecules detected in plasma are likely the result of
diffusion down a concentration gradient into the blood. Moreover, the presence of
paraoxonases enzymes (PON) in the blood, may also account for the lower concentrations of
these molecules detected in sera [323].
Measuring these small levels of 3-oxo-C12-HSL in plasma represents an analytical challenge.
The low levels of C4-HSL detected in sputum goes in accordance with the results previously
obtained [322]. On the other band, the absence of C4-HSL in plasma may be a result of lower
levels of this molecule produced and differences in the rate of metabolism or transfer from the
lungs to the blood. However there were not sufficient patients that ended the study to compare
the difference levels of 3-oxo-C12-HSL between the beginning and the end of the study in
placebo and garlic treated patients.
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The 3-oxo-CI2-HSL molecule was previously detected using a biosensor system, in blood
from sepsis patients and its presence has been correlated with the severity of the disease in
these patients [324]. Hence the correlation between 3-oxo-C12-HSL detected in blood and
sputum from CF patients could be used in the future to establish a connection between the
presence of these molecules in sputum and their clinical status. Moreover the detection of 3-
oxo-CI2-HSL in plasma could be used as a biomarker for P. aeruginosa in CF patients.
Further studies must be conducted to improve the sensitivity of the detection and to determine
if the 3-oxo-CI2-HSL levels correlate with the amount of P. aeruginosa in the lungs of CF
patients. One of the main problems after a lung transplantation event is that often the
transplanted lungs are re-colonised by P. aeruginosa [325]. For this reason it is important to
monitor the presence of 3-oxo-C12-HSL signal molecule in order to proceed with specific
antibiotic treatments. However once the signal molecules are detected in sputum, the infection
has reached the chronic state [326]. It was recently shown that bronchoalveolar lavages from
patients which had a lung transplant, had QS molecules even in the absence of apparent
infection [327], supporting the idea that the detection of these molecules may be possible
before P. aeruginosa is identified in sputum. Hence the early detection of 3-oxo-CI2-HSL in
plasma may allow for a more timely eradication therapy to be applied.
8.S CONCLUSION
Although there are many studies conducted in animal models demonstrating the efficiency of
natural and synthetic compounds for the treatment of P. aeruginosa infections by down
regulating QS dependent virulence genes, up to now there have been no previous trial
designed to evaluate the potential of a drug as QS inhibitor in humans. This trial was however
too small to demonstrate statistically significant improvements in clinical outcomes and/or
decrease in the signal molecule present in plasma and sputum. A much larger study would
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therefore be needed to determine if garlic treatment is beneficial. Moreover, since garlic has
been proven to have a strong anti bactericidal potential, further studies must be carried out for
the identification of the active QS inhibiting component (or components) among the
heterogeneous mixture of sulphur containing compounds found in macerated garlic oil [328].
This would allow for a more specific and probably more powerful treatment.
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